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Summary 
 
T2DM is a growing health problem worldwide. It is now increasingly being diagnosed 
earlier in life. The factors involved in such an epidemic are complex. The intrauterine 
environment has long been known as an important contributor to many diseases 
including metabolic disorders such as T2DM. Recently, there is emerging evidence for 
maternal micronutrients affecting vital developmental processes in utero which can 
adversely “programme” the offspring to develop metabolic disorders in later life. Thus, 
“gene-diet” interaction during foetal development is likely to be a significant 
contributor to the epidemic of T2DM. In particular, the intrauterine imbalance between 
the two related vitamins, vitamin B12 and folate, affect DNA methylation and in turn 
programme the foetus for the whole life. Evidence from mandatory folic acid 
fortification studies suggests that in the presence of adequate folate, neural tube defects 
due to vitamin B12 insufficiency have tripled. In India, children born to mothers with 
“high folate and low vitamin B12” had higher adiposity and insulin resistance. 
Therefore, micronutrient status during pregnancy is likely to have a significant impact 
on the metabolic risk of the offspring. This thesis examines whether vitamin B12 
insufficiency is prevalent in pregnancy, especially in a non-vegetarian population across 
the world as well as the Saudi pregnant population. As estimated intake is an accepted 
measure for micronutrient levels, we also examined the relationship between estimated 
vitamin B12 and folate intake with actual levels in the blood. We have found that 
vitamin B12 insufficiency was not uncommon during pregnancy across the world even 
in the non-vegetarian population and is also common in the Saudi population. 
Surprisingly, vitamin B12 insufficiency was observed in 50% of the tested population 
even in the presence of adequate vitamin B12 intake. In addition, we have also shown 
for the first time in the Saudi population that maternal BMI is inversely related to 
 xix 
 
vitamin B12 levels, particularly in pregnancy. Even though we have shown a similar (or 
worse) picture in mothers with gestational diabetes, this study needs to be replicated, as 
our numbers are too small. Prospective studies linking the role of vitamin B12 
insufficiency especially in the presence of high folate on birth outcomes in the Saudi 
population as well as intervention studies investigating the role of vitamin B12 
supplementation in women of childbearing age and in pregnancy are urgently needed. 
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Chapter 1 
Introduction  
 2 
 
1.1 Diabetes Mellitus (DM): General background 
DM is considered to be a genetically and clinically heterogeneous group of metabolic 
disorders that share glucose intolerance in common (Patel 2003). It is characterised by 
chronic hyperglycaemia with disturbances of carbohydrate, fat and protein metabolism 
resulting from defects in insulin secretion, insulin action, or both (ADA 2010; WHO 
Consultation 2011). Because of its chronic nature, DM is becoming one of the main 
threats to human health now-a-days.  It increases the risk of coronary heart disease and 
stroke, and it is a leading cause of blindness, renal failure and limb amputations (Patel 
2003; IDF 2011). 
DM occurs in different types; the two major classes are type 1 diabetes (T1DM) 
and type 2 diabetes (T2DM). T1DM, a most common chronic disease of children, is an 
autoimmune disease caused by the destruction of pancreatic β-cell islets, leading to 
absolute insulin deficiency. T2DM may range from predominantly insulin resistance 
with relative insulin deﬁciency to a predominantly secretory defect with insulin 
resistance (ADA 2011). People with T1DM are treated with insulin for survival to 
prevent the development of ketoacidosis, while people with T2DM may require insulin 
only if the blood glucose level is not achieved through diet alone or with oral 
hypoglycaemic agents (Zimmet et al. 2001). T2DM is more prevalent and accounts for 
approximately 90 – 95% of all cases of DM (ADA 2011). T2DM is a condition which 
has a linear progression and may pre-exist for many years at least 4 - 7 years before 
clinical diagnosis (Harris et al. 1992). Gestational diabetes mellitus (GDM) is defined 
“as carbohydrate intolerance of varying severity with onset or first recognition during 
pregnancy” (Coustan 2000). It is the most frequent metabolic disorder occurring during 
pregnancy (Jimenez-Moleon et al. 2000) and is a risk factor for affected mothers to 
develop T2DM in the future (Dabelea et al. 2005). Indeed, a mother with a history of 
 3 
 
GDM has at least a seven-fold increased risk of developing T2DM later in her life 
(Bellamy et al. 2009). Moreover, the risk of developing GDM is about 2, 4 and 8 times 
higher among overweight, obese and severely obese women, respectively, compared 
with normal-weight pregnant women (Chu et al. 2007). GDM has many deleterious 
effects in terms of maternal and foetal outcomes (Xiong et al. 2001). It has been found 
that exposure to maternal hyperglycaemia during pregnancy is associated
 
with birth 
defects (Kjos 1999), effects on childhood growth and
 
glucose regulation (Dabelea 
2007). Among the Pima Indians, most of
 
the increased prevalence of childhood T2DM 
over the past 30 years was attributable to increased exposure to maternal
 
diabetes during 
pregnancy (Dabelea et al. 1998).  
 
1.1.1 Epidemiology of DM 
The prevalence of DM is increasing dramatically worldwide. It is expected to 
rise from 6.4%, affecting 285 million adults, in 2010, to 7.7%, and 439 million adults 
by 2030. Between 2010 and 2030, there will be a 69% increase in the numbers of adults 
with DM in developing countries and a 20% increase in developed countries (Shaw et 
al. 2010). According to the IDF, “The overall global prevalence of DM is about 4.6%.” 
(Gadsby 2002).  The ADA reported that DM is affecting 15.7 million people in the US, 
comprising almost 6% of the population (Nedra et al. 2000).  While in the UK, it is 
suggested that the prevalence is increased from 3.5 to 4.7% (Gadsby 2002) and this 
figure could increase up to 10% over the age of 75 (Mackinnon 2002). The DM 
epidemic relates particularly to T2DM, and is taking place both in developed and 
developing nations (Zimmet 1999). It is a growing problem in the Middle East, more 
specifically in Saudi Arabia. Epidemiological studies in Saudi Arabia have shown that 
in 1982, the prevalence was 2.5%, and it increased dramatically to 13% in 1996. The 
 4 
 
latest epidemiological survey conducted in Saudi Arabia showed that the prevalence has 
increased to 23.7% (Al-Nozha et al. 2004; Elhadd et al. 2007).  Also, there is a parallel 
increase in GDM along with T2DM and its prevalence may range from 1 to 16% of all 
pregnancies, depending on the type of population and the diagnostic criteria used 
(Jimenez-Moleon et al. 2000). In Saudi Arabia, the overall prevalence is about 12% 
with a significant morbidity and mortality (Ardawi et al. 2000; Elhadd et al. 2007). This 
is significantly higher compared to US where about 135,000 cases of GDM (3 - 8 % of 
all pregnancies) are diagnosed annually (Dabelea et al. 2005).  
 
1.1.2 T2DM in children 
T2DM was considered to be a disease for adults. However, it is now being 
diagnosed earlier in life and the incidence of T2DM in children is also increasing at an 
alarming rate (Rocchini 2002). This may partly be due to a higher incidence of 
childhood obesity owing to changes in lifestyle, diet, and reduction in physical activity 
(Miller et al. 2004). It is becoming the major form of DM in young people in several 
non-white populations, such as Native Americans, Asian and Paciﬁc Islanders, and 
African-Americans, with the highest rates observed among the adolescent (The Writing 
Group for the Search for Diabetes in Youth Study Group 2007). An approximate 
fourfold rise in the incidence of T2DM in 6 to 15 year olds has been shown in Japan, 
and between 8 and 45% of newly presenting children and adolescents in the US have 
T2DM (Alberti et al. 2004). This is not only a serious public health problem for health 
care professionals, it may burden the future generation with significant morbidity and 
mortality at the peak of their working lives and productivity. This is likely to affect the 
workforce of countries across the world. This in turn will add to the economic burden 
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for both developed and low and middle income countries across the globe. (Alberti et al. 
2004).  
 
1.1.3 Factors involved in T2DM epidemics 
The factors involved in the T2DM epidemic are complex. Genetic susceptibility 
of certain ethnic groups, environmental and behavioural factors such as a sedentary 
lifestyle, nutrition and obesity are clearly important risk factors of the prevalence of DM 
(Patel 2003). Furthermore, population growth, ageing, urbanization and other factors 
also contribute to the DM epidemic (Wild et al. 2004). However, the intrauterine 
environment, due to maternal malnutrition (thrifty phenotype hypothesis) (Hales and 
Barker 1992), and genetic controls in the foetus of glucose sensing, insulin secretion 
and insulin resistance (foetal insulin hypothesis) (Hattersley and Tooke 1999) must also 
contribute to the increasing prevalence of childhood obesity as well as T2DM and 
cardiovascular disease (CVD) in adult life (Saravanan and Yajnik 2010). Indeed, there 
is emerging evidence that a cluster of metabolic risk factors are present at birth in the 
offspring born to mothers with a higher metabolic risk (Catalano et al. 2009; Saravanan 
and Yajnik 2010). 
 
1.1.3.1 Thrifty phenotype hypothesis 
The concept of this hypothesis was put forward about 20 years ago after 
reviewing the aetiology of T2DM (Hales and Barker 1992). The thrifty phenotype 
hypothesis proposes that poor foetal nutrition in utero changes glucose-insulin 
metabolism leading to the development of T2DM in adult life. These changes include a 
reduced capacity for insulin secretion and insulin resistance, due to the poor 
development of pancreatic β-cell mass and function, which combined with the effects of 
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obesity, ageing and physical inactivity, are the most important factors in determining 
T2DM (Figure 1.1) (Hales and Barker 2001). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1: Diagram represent the key features of the "thrifty phenotype" hypothesis of 
the aetiology of T2DM (non-insulin-dependent diabetes). It proposes that poor foetal 
nutrition affects the growth of different organs and thus produces permanent changes in 
the structure and function of the body. One of the major long-term consequences of 
inadequate early nutrition is impaired development of the endocrine pancreas. Also 
outlined is the suggestion that the features of Metabolic syndrome may have closely 
related origins in failures of early growth and development. Not shown for the sake of 
simplicity and clarity are the additional possibilities that (i) an early reduction of insulin 
production could have secondary consequences for the growth and development of 
other organs involved in Metabolic syndrome; (ii) infant malnutrition may be involved 
in processes contributing to components of Metabolic syndrome (Hales and Barker 
1992). 
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1.1.3.2 Foetal insulin hypothesis 
The foetal insulin hypothesis offers an alternative explanation for the consistent 
association between impaired foetal growth and insulin resistance during life and the 
link with hypertension and vascular disease (Hattersley and Tooke 1999). It proposes 
that the association between low birth weight and adult insulin resistance is principally 
genetically mediated (Figure 1.2A). The concept is that insulin-mediated foetal growth 
will be affected by foetal genetic factors that regulate either foetal insulin secretion by 
the foetal pancreas or the sensitivity of foetal tissues to the effects of insulin (Hattersley 
and Tooke 1999) (Figure 1.2B).  
 
 
 
 
 
 
                              
 
 
 
                              (A)                                                                 (B) 
Figure 1.2: Foetal insulin hypothesis. (A) shows two alternative explanations for the 
association of small, thin babies with insulin resistance, T2DM, and ischaemic heart 
disease - intrauterine environment and foetal genetics. (B) shows a simplified 
representation of the hypothesis: foetal genetics could lead to defects in glucose 
sensing, insulin secretion, or the response to insulin of insulin-sensitive tissues (insulin 
resistance) thus impaired foetal growth (Hattersley and Tooke 1999). 
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Though, evidence from monogenic disorders supports the foetal insulin 
hypothesis, this affects a relatively small number of people and is therefore an unlikely 
contributor to the epidemic of T2DM and CVD (Saravanan and Yajnik 2010). On the 
contrary, several studies across different populations confirmed that the future 
metabolic risk (T2DM and CVD) is high in people born with low birth weight, 
especially if they become overweight adults (Barker 2004), suggesting this association 
is much more common and therefore unlikely to be due to genetic factors alone 
(Saravanan and Yajnik 2010). ‘Gene-diet’ interaction during foetal development is 
more likely to contribute to the epidemic of T2DM. Several micronutrients and vitamin 
are involved in the metabolic pathways that regulate DNA synthesis and/or repair and 
the expression of genes (Fenech and Ferguson 2001). The deficiency of such nutrients 
may result in impaired enzyme activity, disruption of genomic integrity and alteration 
of DNA methylation. Therefore, gene-diet interactions seem to explain the different 
response to environmental/diet exposure at the molecular level (Friso and Choi 2002). 
Such interaction is likely to ‘programme the foetus’ for the rest of its life. An example 
on such interaction on foetal programming is given in (Figure 1.3). However, the 
factors and the mechanism by which such programming results in low birth weight is 
not clear.  
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Figure 1.3: Demonstrates the feedback loop of the insulin involvement in a number of 
different tissues. During foetal development, these tissues learn to communicate with 
each other. The signalling from the beta cells of the pancreas is via insulin (dotted 
lines). This acts on the liver, muscle and adipose tissue to change levels of glucose in 
the circulation (solid lines). The development of liver, muscle and adipose tissue is 
regulated by gene-nutrient interactions. If the maternal diet is nutritionally imbalanced, 
the development of these tissues will change, thus altering the characteristics of this 
feedback loop. The communication between these organs is complex where any 
changes in just one component can influence the behaviour of the whole system. For 
example, maternal malnutrition may suppress beta cell development resulting in fewer 
foetal beta cells, resulting in reduced insulin release, requiring a corresponding increase 
in insulin sensitivity of the foetal liver, muscle or adipose tissue to maintain glucose 
homeostasis (Maloney and Rees 2005). 
 
 
Understanding ethnic variations could provide us with some explanation to the 
susceptibility to T2DM and CVD. The South Asian population (Indian) is a good 
example for this, where they are known to be at higher risk of these conditions. They 
have a distinctive adverse anthropometric (Figure 1.4) and biochemical profile (Yajnik 
2001; Yajnik and Yudkin 2004) compared to the UK counterparts, which are reflected 
in different patterns of DM. Indian diabetes patients are diagnosed a decade earlier and 
are considerably thinner than their UK counterparts (BMI 23.9 and 28.5 kg/m2, 
respectively). Despite their thinness, they are centrally obese, with a higher waist-hip 
ratio and a higher subscapular-triceps skinfold ratio than their UK counterparts (Yajnik 
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2001). They also develop T2DM and CVD at an earlier age (Yajnik 2001) and have 
worse adverse outcomes (Forouhi et al. 2006; Gunarathne et al. 2008).  
 
 
 
 
 
 
 
                              (A)                                                                   (B) 
Figure 1.4: (A) The characteristics of adverse anthropometry of South Asians with 
newly diagnosed T2DM. Bars above the line indicate higher levels. Insulin resistance 
was calculated from the homeostatic model assessment (HOMA) model. BMI = body 
mass index, Fat % = total body fat content, mid-arm = mid arm circumference, SS/TR = 
subscapular-triceps skinfold thickness ratio, WHR = waist-hip ratio. Retreived from 
(Yajnik 2001) (B) Y-Y paradox: demonstrates the central adiposity and higher body fat 
content of a South Asian compared with a European with the same BMI. (Yajnik and 
Yudkin 2004; Saravanan and Yajnik 2010). 
 
Similar adverse profiles seem to be present at birth (Figure 1.5). Indian babies 
were small, had small abdominal viscera and low muscle mass, but preserved body fat 
(Yajnik et al. 2002; Yajnik et al. 2003). This body composition may persist postnatally 
and predispose the person to an insulin-resistant state suggesting that genetic factors 
that contribute to the higher metabolic risk of South Asians undoubtedly influence body 
size and composition of a developing foetus and may well be due to adverse prenatal or 
intrauterine environment.  
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Figure 1.5: Demonstrates the adverse anthropometry and cardiovascular risk factors of 
South Asian children compared with white Caucasian children. Mean and 95% CI for 
maternal pre-pregnancy weight and height and for birth measurements and cord blood 
concentrations are shown. The white Caucasian group mean is represented by 0 and the 
mean difference for each measurement is shown. All SD scores are negative, suggesting 
that the Indian babies are smaller than the white Caucasian babies (Yajnik et al. 2002). 
 
 
Recent evidence from a well-designed longitudinal observational study suggests 
that micronutrients, especially folic acid and vitamin B12 may play a crucial role and 
could contribute to the epidemic of adiposity and T2DM in India (Yajnik et al. 2008). 
The possible mechanism of this contribution will be discussed later in the chapter.  
 
1.2 Folate  
Folate is used as the generic descriptor for all derivatives of pteroic acid that 
demonstrate vitamin activity in humans. It refers to both the endogenous form of the 
vitamin which can occur naturally in food and the synthetic form - folic acid - found in 
supplements and fortified food. Folic acid differs chemically from folate in that there is 
only one glutamic acid (monoglutamate) attached to the pteridine ring unit and it is the 
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most oxidized and stable form of the vitamin (Figure 1.6). While naturally accruing 
folate contains one to six glutamate molecules (polyglutamates) joined in peptide 
linkage (Bender 2003; Bailey 2004), in most natural foods, the pteridine ring is reduced 
to give either the 7,8-dihydrofolate (DHF) or 5,6,7,8-tetrahydrofolate (THF). In the 
cells, the reduced form of folate conjugates to the polyglutamate chain. Polyglutamates 
have a single type of action in that they can accept so called one-carbon (1-C) units 
from various donors and pass them in various biosynthetic reactions. Thus, in the cells 
folate will be a mixture of tetrahydrofolate (e.g. 10-formyl-, 5,10-methylene- and 5-
methyltetrahydrofolate) depending on which C group attached to them (Scott 1999). 
 
 
 
 
 
 
Figure  1.6: Structure of a folic acid compound. It comprises a bicyclic Pterin ring 
joined by a methylene  bridge to p-Aminobenzoic acid,  which in turn attached via α-
peptide to a single molecule of L-Glutamic acid. Figure obtained from (Ball 2004a). 
 
 
1.2.1 Metabolism of folate 
1.2.1.1 Digestion, absorption and transport of folate 
Folate cannot be synthesized in the body, thus it must be obtained from 
exogenous sources. There are two sources of folate in the intestine: dietary folate and 
folate synthesized by bacteria in the large intestine. The latter source is directly 
absorbed in the colon (Ball 2004a). Before the absorption of dietary folate, the 
polyglutamate chain must be broken down in the brush border of the mucosal cells by 
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the enzyme conjugase (pteroylpolyglutamate hydrolase) and form the monoglutamate, 
which is taken up by a specific carrier in the cell membrane of the small intestine. Most 
of the dietary folate undergoes reduction and methylation within the intestinal mucosa, 
thus the only form entering the human circulation from the intestinal cells is 5-methyl-
tetrahydrofolate monoglutamate (Scott 1999). Approximately two-third of folate in the 
plasma are protein bound. About 10 - 20% of methyl monoglutamate is taken up by the 
liver during the first pass, and the remainder is rapidly cleared by peripheral tissues. The 
majority of 5-methyltetrahydrofolate arriving at the liver from the intestine and taken up 
is unchanged (not demethylated). It enters the enterohepatic cycle where it metabolized 
to polyglutamate derivatives and retained or secreted in the bile to be reabsorbed in the 
small intestine together with food folate before re-entering the circulation. The kidneys 
play a role in conserving body folate by actively reabsorbing folate from the glomerular 
filtrate (Steinberg 1984). 
 
1.2.1.2 Metabolism and excretion   
Before being stored in tissue or used as a coenzyme, folate monoglutamate is 
converted to the polyglutamate form by the enzyme polyglutamate synthetase. When 
released back to the circulation, reconversion to the monoglutamate form is required. 
Folate must be reduced enzymatically and resynthesized to the polyglutamate form to 
function in a single-carbon atom (1-C) transfer reaction (Institute of Medicine 1998a). 
Both folate and vitamin B12 are metabolically interrelated, which may explain why a 
single deficiency of either vitamin leads to the same haematological changes (Institute 
of Medicine 1998a). The mechanism of action will be discussed later in the chapter. 
Except in cases of malabsorption, the body conserves dietary folate efficiently. 
Folate secreted into the bile is reabsorbed in the small intestine; much of the circulating 
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folate binds to plasma proteins and so cannot be filtered in the kidneys; and the free 
circulating folate that is filtered is captured by the folate receptors in the renal tubules 
and reabsorbed into the bloodstream. The result is very little folate loss by faecal or 
urinary excretion (Bender 2003). 
 
1.2.2 Dietary sources and bioavailability 
Dietary folate is mainly found in dark green leafy vegetables and fresh fruits. It 
is also present in liver products. Folic acid is fortified in wheat flour in many countries 
(Center for Disease Control and Prevention 2008) mandatorily, while in many other 
countries voluntary fortification is in practice, in a variety of foods products such as 
breakfast cereals and bread.  
The bioavailability of folate depends on whether the folate is in the 
polyglutamate form (food folate) or in the monoglutamate form (synthetic folic acid). 
All naturally-occurring folates are chemically unstable, which leads to significant loss 
of activities during harvesting, storage, processing, and preparation. About half or 
perhaps three-quarters of initial folate activity may be lost during these processes. In 
contrast, folic acid contains pteridine in unreduced form, so they are very resistant to 
chemical oxidation (Scott 1999). Food folates, unlike folic acid, must undergo 
enzymatic deconjugation in the small intestine before they can be absorbed. Thus, folic 
acid is significantly more bioavailable than food folate (Bailey 2004). Various factors 
may affect the folate bioavailability. For example, organic acids present in many foods, 
such as orange juice and tomato, can inhibit conjugase activity (Wei and Gregory 
1998). This may partly explain why the polyglutamyl folate present in natural food 
sources is less bioavailable than the folic acid present in fortified foods and supplements 
(Cuskelly et al. 1996). When folic acid is consumed as a supplement without food, it is 
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100% bioavailable compared to 85% when it is consumed in food as in fortified 
products (Pfeiffer et al. 1997). Food folate is not more than 50% bioavailable (Bailey 
2004).  
 
1.2.3 Dietary intake of folate 
1.2.3.1 Dietary requirement 
Based on the controlled metabolic study data, the recommended dietary 
allowance (RDA) of folate for an adult aged 19 years or more is 400 μg per day 
(Institute of Medicine 1998a). For pregnant women, approximately 600 μg per day 
folate is adequate to maintain normal folate status, based on erythrocyte (RBC) and 
serum folate concentrations during pregnancy (Bailey 2000). For lactating women, the 
RDA is 500 μg per day based on estimates of the folate intake needed to replace the 
folate secreted in human milk (Bailey 2000). 
 
1.2.3.2 Effects of high intake 
It was believed that there were no adverse effects associated with the 
consumption of excess folate from food (Butterworth and Tamura 1989). However, 
there are several reports suggesting excess folate may cause harm especially certain 
types of cancer (Ulrich 2008). In addition data from the USA, a decade after the 
mandatory folic acid fortification was introduced in 1997, shows that high folate levels 
particularly in the presence of vitamin B12 insufficiency is associated with higher 
homocysteine and methylmalonic acid (MMA) levels (Selhub et al. 2007) and a higher 
incidence of anaemia and cognitive dysfunction in the elderly (Morris et al. 2007).  
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1.3 Vitamin B12 
Vitamin B12 is the generic descriptor for all cobalamin. It is involved in the cell 
metabolisms particularly in the DNA synthesis and regulation and fatty acid synthesis 
and energy production. Vitamin B12 can be converted to either two cobalamin 
coenzymes that are active in human metabolism, namely methylcobalamin and 5-
deoxyadenosylcobalamin. 
Vitamin B12 molecules refer to a group of cobalt-containing compounds 
(corrinoids), that have a lower axial ligand that contains the cobalt-coordinated 
nucleotide (5, 6-dimethylbenzimidazole as a base; Figure 1.7) (Bender 2003). The 
common synthetic form of vitamin B12 is cyanocobalamin. It is the most stable form of 
the vitamin, and is commonly used in pharmaceutical preparation and food 
supplementation (Ball 1998; Scott 1999).  
 
Figure 1.7: Structure of vitamin B12 compounds. Four coordination sites on the central 
cobalt atom are occupied by the nitrogen atoms of the corrin ring, and one by the 
nitrogen of the dimethylbenzimidazole nucleotide. The six coordination sites may be 
occupied by  N- cyanocobalamin  O - hydroxocobalamin   2O- a uocobalamin  
   - methylcobalamin  and 5   deoxyadenosylcobalamin. Figure obtained from (Bender 
2003). 
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In plasma, methylcobalamin accounts approximately 60 – 80% of plasma 
vitamin B12, adenosylcobalamin accounts up to 20% and the reminder mainly 
hydroxycobalamin. The major vitamin found in tissue is adenosylcobalamin, which 
accounts about 70% in the liver, then hydroxycobalamin accounts about 25% and less 
than 5% as methylcobalamin (Bender 2003).  
 
1.3.1 Metabolism of vitamin B12 
1.3.1.1 Digestion and absorption of vitamin B12 
Vitamin B12 digestion and absorption from food in human subjects are complex 
as shown in (Figure 1.8). It requires many processes, and any interruption of one or any 
combinations of these processes could place individuals at risk of developing deficiency 
(Oh and Brown 2003). Very small amounts of free vitamin B12 (between 1 – 5%) can 
be absorbed by passive diffusion across the intestinal mucosa (Andres et al. 2004). This 
explains the mechanism of treating deficiencies associated with pernicious anaemia and 
food-cobalamin malabsorption (Kuzminski et al. 1998; Carmel 2000).  
Once vitamin B12 is absorbed, it binds to transport proteins known as 
transcobalamin I, II, or III (TCI, TCII, or TCIII) and then transported throughout the 
body (Andres et al. 2004). TCI circulates an estimated 80% of vitamin B12. Apparently, 
it does not seem to be involved in cellular uptake of the vitamin. However, it prevents 
circulating vitamin B12 from being filtered by the kidneys (Ball 2004b). TCII is the 
form that delivers vitamin B12 to the tissues through specific receptors. The liver takes 
up to approximately 50% of vitamin B12 and the remaining amount is transported to 
other tissues (Institute of Medicine 1998b).  
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Figure 1.8: The metabolic pathway of vitamin B12 (cobalamin or Cbl) and 
corresponding causes of deficiency. (1) Dietary intake of vitamin B12  enters the 
stomach bound to food protein (P). (2) In the stomach, the acidic environment (pepsin 
and hydrochloric acid (HCL)) facilitates the cleavage of vitamin B12 that is bound to P, 
giving the free form of the vitamin. The released form of vitamin B12 is immediately 
passed to a mixture of glycoprotein such as R-protein (R), which is primarily produced 
by the parietal and salivary cells, to protect vitamin B12 from chemical denaturation in 
the stomach. Intrinsic factor (IF) is also secreted by parietal cells in the stomach, but its 
binding to vitamin B12 is weak in the presence of gastric and salivary R-protein. (3) 
Then, vitamin B12 leaves the stomach and enters the duodenum bound to R-protein and 
accompanied by IF and by vitamin B12-R-protein complex that have been secreted 
from the bile. (4) In the mildly alkaline environment of the jejunum, pancreatic 
enzymes degrade both biliary and dietary vitamin B12-R-protien complexes, releasing 
free vitamin B12. IF is resistant to proteolysis and binds to the released vitamin B12 to 
facilitate its active absorption in the ileum. (5) The IF-B12 complex is carried down 
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until the distal 80 cm of the ileum where it binds to mucosal cell receptors (cubilin), 
then vitamin B12 is bound to transport proteins known as transcobalamin I, II and III 
(TCI, TCII and TCIII). Vitamin B12 is subsequently transported systemically via the 
portal system. (6) Within each cell, the TCII–vitamin B12 complex is taken up by 
means of endocytosis and vitamin B12 is liberated and then converted enzymatically 
into its two coenzyme forms, methylcobalamin and adenosylcobalamin.*Nitrous oxide, 
a general anaesthetic, causes multiple defects in vitamin B12 use, most of which are 
intracellular and clinically relevant only in people who have low or borderline-low 
serum B12 level. Figure obtained from (Andres et al. 2004). 
 
At the cellular level, lysosomal degradation of TCII occurs, resulting in released 
vitamin B12 into cytoplasm in the form of hydroxocobalamin. Hydroxocobalamin is 
either converted to methylcobalamin in the cytoplasm or to adenosylcobalamin in the 
mitochondria (Andres et al. 2004). TCIII is rapidly cleared by the liver. It seems to 
provide a mechanism for returning vitamin B12 from peripheral tissues to the liver, as 
well as for clearance of other corrinoids. These corrinoids are then secreted into the bile, 
in the form of Cbl-R protein complexes (Figure 1.9) (Bender 2003).  
 
 
 
 
 
 
 
 
Figure 1.9: Diagram highlighting the cellular uptake and processing of vitamin B12 
(Cbl). Vitamin B12 (Cbl) is bound to transcobalmin II (TCII). Cbl-TCII enters cells by 
means of TCII receptor-mediated endocytosis. Lysosomal enzymes degrade the TCII, 
resulting in free Cbl. In the mitochondria, Cbl is converted to adenosylcobalamin, a 
coenzyme involved in the conversion of methylmalonyl-CoA to succinyl-CoA. In the 
cytoplasm, Cbl is converted to methylcobalamin, a coenzyme involved in the 
conversion of homocysteine to methionine. MS: methionine synthase, THF: 
tetrahydrofolate, MTHFR: methyltetrahydrofolate, MCM: methylmalonyl CoA mutase. 
Figure obtained from (Dali-Youcef and Andrès 2009).   
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1.3.1.2 Post-absorptive metabolism, storage and excretion 
Unlike the other water-soluble vitamins, the body can efficiently conserve 
vitamin B12. In adults, it stores approximately 2000 - 5000 µg, of which about 80% of 
vitamin B12 is stored in the liver in the form of adenosylcobalamin.  The amount stored 
in the liver increases with age. The remainder is located in muscle, skin, and blood 
plasma. About 2 - 5 µg of vitamin B12 are lost daily through metabolic turnover, 
regardless of the amount stored in the body (Ball 2004b). Only after an injection of 
vitamin B12 and when the circulating vitamin B12 exceeds the protein-binding capacity 
will the excess be excreted in the urine. Thus, the binding with plasma proteins, 
negligible urinary loss and an efficient enterohepatic circulation, together with the slow 
rate of turnover, all explains why strict vegetarians, with normal absorptive capacity, 
take 20 years or more to develop signs of deficiency. People with absorptive 
malfunction develop deficiency signs within 2 - 3 years (Ball 2004b). 
 
1.3.2 Dietary sources and bioavailability 
1.3.2.1 Dietary sources 
Vitamin B12 naturally originates from synthesis by bacteria and other 
microorganisms growing in soil or water, in sewage, and in the rumen and intestinal 
tract of animals. It cannot be made by plants. If there is a small amount detected in 
plants this may be due to microbial contamination from the soil or manure, or due to 
bacterial synthesis in the root modules of certain type of legumes (Ball 2004b). Thus, 
vitamin B12 is provided from any foods of animal origin including fish, meat, poultry, 
eggs, and milk products (Watanabe 2007), or from microbiologically contaminated 
plants. An outstanding dietary source of vitamin B12 is liver, followed by kidney and 
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heart (Ball 2004b). Fortified foods such as breakfast cereals contain crystalline vitamin 
B12 (cyanocobalamin) (Bailey 2004). 
 
1.3.2.2 Bioavailability 
Individuals depend entirely on the dietary intake of vitamin B12. Though 
vitamin B12 can be synthesized in the human colon, it is apparently not absorbed. Thus, 
strict vegetarians may have vitamin B12 insufficiency owing limited amounts ingested 
from the vitamin (Ball 2004b).  
The bioavailability of dietary vitamin B12 is estimated to be about 50% in 
healthy adults with normal gastric function. If a person consumes a large portion of 
food rich in vitamin B12 in a meal, less absorption take place (Institute of Medicine 
1998b). For example, in an intake of 0.5 µg or less, about 70% of available vitamin B12 
is absorbed. At 5.0 µg intake of the vitamin, a mean of 28% is absorbed (range 2 - 
50%), while an intake of 10 µg has a mean of 16% absorption (0 - 34%) of vitamin 
B12. These limits were derived from single oral doses of radioactive vitamin B12 
(Herbert 1987). When large doses of crystalline vitamin B12 (100 µg) are taken, the 
absorption drops to approximately 1% of the dose, and the excess is secreted in the 
urine (Ball 2004b). Different levels of absorption assumed under various conditions are 
presented in Table 1.1. 
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Table 1.1: Assumed vitamin B12 absorption under different conditions. 
Obtained from (Institute of Medicine 1998b) 
Form of vitamin B12 Natural Gastric 
Function (%) 
Pernicious 
Anaemia (%) 
a
 
Naturally occurring  50 0 
Crystalline, low dose (< 5 µg) 60 0 
 rystalline, high dose (≥ 500 µg) 
with water  
1 1 
Crystalline, high dose with food  0.5 ≤ 0.5 
a
 A disorder in which lack of intrinsic factor severely limits the absorption of    
vitamin B12 
 
The approximate percentage absorption of vitamin B12 from a few foods is 
shown in Table 1.2. In normal healthy adults, vitamin B12 in lean mutton (Heyssel et 
al. 1966), chicken meat (Doscherholmen et al. 1978), milk (Russell et al. 2001) and fish 
is efficiently absorbed as a comparable amount of crystalline vitamin B12 (Institute of 
Medicine 1998b). In contrast, vitamin B12 in eggs is poorly absorbed due to the 
presence of a different vitamin B12 binding proteins in egg white and egg yolk (Levine 
and Doscherholmen 1983). The absorption of vitamin B12 from liver is low (Heyssel et 
al. 1966) because of its high content of vitamin B12 (Scott 1997).  
One of the reasons that could explain why a high intake of vitamin B12 does not 
necessarily result in higher absorption is the refractory nature of vitamin B12 absorption 
or on other word the limited capacity of the gastric IF-mediated absorption process 
(Carmel 2008). The absorption of vitamin B12 enters a refractory phase of about 3 h 
after ingestion. Thus, the specific IF-mediated absorption is saturated at certain level. 
An additional dose of vitamin B12 is absorbed normally when given 4 – 6 h after the 
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initial intake (Bor et al. 2004). Approximately only 1 - 1.5 µg per meal can be absorbed 
at any one time of a single dose of vitamin B12 (Herbert 1987).  
 
Table 1.2: Percentage absorption of vitamin B12 from foods 
by healthy adults. Obtained from (Institute of Medicine 1998b) 
Reference Food Absorption (%) 
Heyssel et al., 1966 Mutton 65 
Doscherholmen et al., 1978 Chicken 60 
Russell et al., 2001 Milk 55 - 65 
Doscherholmen et al., 1981 Trout 25 - 47 
Doscherholmen et al., 1975 Eggs 24 - 36 
Heyssel et al., 1966 Liver 11 
 
 
Another important factor that could affect the vitamin B12 bioavailability is 
changing in the type of intestinal flora and/or it’s activity. For example, overgrowth of 
intestinal bacteria, as a result of decrease gastric acidity, leads to a competition for 
uptake of vitamin B12 and thus interferes with vitamin B12 availability (Baik and 
Russell 1999, Wolters et al. 2004). Other factors that stimulate or inhibit growth of 
different types of intestinal flora include poor dietary intake, stress and use of 
medication. Furthermore, alteration in intestinal flora (quantitatively and qualitatively) 
could contribute to a wide range of diseases, including obesity, DM and metabolic 
syndrome (Diamant et al. 2011). Interest has recently been directed towards establishing 
a potential association between intestinal flora and T2DM. T2DM was associated with 
compositional changes in the intestinal microbiota (Larsen et al. 2010). 
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1.3.3 Dietary intake of vitamin B12 
1.3.3.1 Dietary requirement  
The human need for vitamin B12 is extremely small. Based on the 
haematological evidence and serum vitamin B12 values and to ensure normal serum 
concentrations and ade uate stores, the RDA for vitamin B12 is calculated to be 2.4 μg 
per day for adults 19 years or over. Because of the estimated decrease of vitamin B12 
bioavailability in people older than 50 years old, it is advisable to have most of the 
recommended vitamin B12 intake from fortified foods with vitamin B12 or vitamin B12 
supplement (Institute of Medicine 1998b). For pregnant women, the RDA is increased 
to 2.6 μg per day to allow for foetal deposition throughout pregnancy and evidence that 
maternal absorption of the vitamin becomes more efficient during pregnancy. During 
lactating, the RDA is further increased to 2.8 μg per day, based on non-lactating 
women’s re uirements and the amount of vitamin B12 secreted in the milk (Bailey 
2004). 
 
1.3.3.2 Effects of high intake 
Ingested amounts that exceed the limited binding capacity in plasma and tissue 
are excreted unchanged in the urine and faeces (Ball 2004b). Thus, it is believed that 
there are no adverse effects associated with excess vitamin B12 from food or from 
supplements in healthy individuals (Institute of Medicine 1998b; Bailey 2004). 
However, the studies in which excess intakes were reported were not designed to assess 
the adverse effects of the vitamin (Institute of Medicine 1998b; Carmel 2008).  
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1.4 Mechanism of actions of folic acid and vitamin B12 
Folic acid and vitamin B12 are essential nutrients for humans as they are 
necessary for new cell formation and maintenance by participating in several vital 
reactions (Kamen 1997). Folic acid is involved in nucleic acid synthesis, methionine 
regeneration, and in the activation, oxidation and reduction of one-carbon units, referred 
to as 1-C metabolism, required for normal metabolism and regulation (Bailey and 
Gregory 1999). Vitamin B12 is an important co-factor involved in only two enzymatic 
reactions in the cell metabolism; methionine synthase (MS) and methylmalonyl-CoA 
mutase (MCM).  
MS converts homocysteine to methionine and then to S-adenosylmethionine 
(SAMe) in the presence of vitamin B12 (in the form of methylcobalamin) and folic acid 
(in the form of tertrahydrofolate). Lack of MS from vitamin B12 insufficiency will lead 
to decreased synthesis of methionine and 5-tetrahydrofolate (5THF), as well as the 
accumulation of homocysteine and 5-methyl-THF (5MTHF). Less methionine synthesis 
will lead to less SAMe production, which is a common methyl donor required for the 
maintenance of methylation patterns in DNA that determine gene expression (Fenech 
2001). SAMe normally suppresses methylene-THF reductase (MTHFR), thus an 
impaired production of SAMe will reduce this suppression and result in the irreversible 
conversion of 5,10-methylene-THF to 5-methyl-THF. The 5-methyl-THF then becomes 
metabolically trapped owing vitamin B12 insufficiency. Furthermore, the reduction in 
5THF leads to reduced availability of 5,10-methylene-THF, which is needed to convert 
deoxyuridine monophosphate (dUMP) to deoxythymidine monophosphate (dTMP) in 
the presence of thymiylate synthase. Under conditions of folic acid insufficiency, 
dUMP accumulates and as a result uracil is incorporated into DNA instead of thymine 
(Blount et al. 1997). 
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MCM is required for degradation of odd-chain fatty acids and branched-chain 
amino acids, in particular conversion of methylmalonic-CoA (MM-CoA) in the 
presence of vitamin B12 (in the form of adenosylcobalamin) to succinyl-CoA, which is 
an important substrate in the Krebs cycle. MM-CoA is derived from propionyl-CoA, 
which enter the pathway via degradation of several amino acids including methionine 
and beta oxidation of odd-chain fatty acids. While the actions of MS (which happen 
inside the cell cytosol) are dependent on folic acid in addition to vitamin B12, the 
actions of MCM (which occur inside the mitochondria) are dependent only on vitamin 
B12 (Figure 1.10) (Rosenberg 2008).  
SAM-e is the common methyl donor required for methylation reaction including 
methylation of DNA. In addition, the folic acid derivative, 5,10 methylene 
tetrahydrofolate is involved in DNA synthesis and repair (Figure 1.10). Thus, both 
vitamin B12 and folic acid play crucial roles in the genomic stability of human cells by 
preventing chromosomal breakage and hypomethylation of DNA (Fenech 2001) as well 
as being involved in several other critical pathways during development and adult life 
(Saravanan and Yajnik 2010).  
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Figure 1.10: Pathways that involve vitamin B12 and the suggested mechanism of 
increased adiposity and insulin resistance. Vitamin B12 insufficiency traps folic acid as 
5MTHF. This results in reduced synthesis of methionine and SAMe inside the cell 
cytosol. Inside the mitochondria, MM-CoA is converted into MMA, which is a potent 
inhibitor of beta-oxidation (Yajnik et al. 2008; Saravanan and Yajnik 2010). Key: dTmP 
= deoxythymidine monophosphate; dUmP = deoxyuridine monophosphate; TS = 
thymidylate synthase; MTHF = methyl tetrahydrofolate; MTHFR = methylene 
tetrahydrofolate reductase; DHF = dihydrofolate; THF = tetrahydrofolate; MS = 
methionine synthase; SAH = S-adenosylhomocysteine; SAM-e = S-adenosyl 
methionine; R = methyl acceptor; R-CH3 = Methylate compound;  MM-CoA = 
methylmalonyl-CoA; MCM = methylmalonyl-CoA mutase; CPT1 = carnitine 
palmitoyltransferase-1. 
 
 
1.5 Clinical manifestations of folic acid and vitamin B12 insufficiency 
1-C metabolism can be impaired in the absence of folate insufficiency. The 
availability of several nutrients affects the efficiency of folate-mediated 1-C 
metabolism, resulting in the accumulation of various substrates and metabolic 
intermediates which may have negative consequences (Bailey and Gregory 1999). As 
mentioned previously, the enzyme MS catalyzes the vitamin B12–dependent  
conversion of homocysteine and 5-methyl THF to methionine and 5THF (Figure 1.10). 
Because the MTHFR enzyme catalyzed conversion of 5,10-methyl THF to 5-methyl 
THF is essentially irreversible, loss of MS activity due to vitamin B12 insufficiency or 
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genetic mutation results in an accumulation of cellular folate as 5-methyl THF, referred 
to as a folate “methyl trap”. The accumulation of 5-methyl THF depletes the 
concentration of other forms of folate and thereby inhibits nucleo-protein synthesis 
(Herbig et al. 2002), resulting in vitamin B12-responsive megaloblastic anemia (Carmel 
and Karnaze 1985).  Thus, overt deficiency of either vitamin B12 and folate results in 
megaloblastic anaemia as rapid cell division in the bone marrow is impaired, especially 
erythropoiesis, and thus release immature erythrocyte into the circulation (Bender 
2003). 
In addition, methylation is a very important process in protecting nerves myelin. 
One important methylation is that of myelin basic protein. It makes up one-third of 
myelin, the insulation cover on nerves. In the presence of vitamin B12 insufficiency, the 
methylation process is interrupted which leads to demyelination of the nerves, resulting 
in a neuropathy which leads to ataxia, paralysis and if untreated, ultimately death (Scott 
1999). Neuropathy generally begins in the peripheral nerves and progresses to the spinal 
cord and brain (Ball 2004b). Severe vitamin B12 insufficiency results in cognitive 
impairment especially in elderly and rarely subacute combined degeneration of the 
spinal cord (Wilson and Langman 1966; Saravanan and Yajnik 2010). However, overt 
deficiencies of these vitamins are rare and are diagnosed early (Saravanan and Yajnik 
2010). 
Vitamin B12 insufficiency is not rare in populations, especially among vegans 
because the predominant dietary sources of vitamin B12 are meat, poultry, seafood and 
dairy products (Watanabe 2007). Malabsorption is a leading cause of vitamin B12 
insufficiency (Fernández-Bañares et al. 2009), which is common in the elderly people 
(Matthews 1995). About 60 – 70% of elderly people suffer from malabsorption 
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(Fernández-Bañares et al. 2009). If untreated, vitamin B12 insufficiency results in an 
irreversible decline in cognitive function and memory (Malouf et al. 2003).  
Folic acid insufficiency in mothers is one of the major risk factors for NTDs 
(Lumley et al. 2002). It has been assumed that folate-responsive NTDs result from 
impaired maternal and/or foetal folate metabolism, with the affected pathways being 
either dTMP or methionine (SAM) syntheses, and that these metabolic disruptions can 
be resolved by increasing maternal folate status. The suggested mechanisms include 
accumulation of homocysteine, decreased rates of DNA synthesis due to impaired 
dTMP synthesis, and elevations in the SAH/SAM ratio (Stover 2004). Introducing 
periconceptional supplementation with folate and/or multivitamins reduces the NTDs 
risk by 50% (Lumley et al. 2002). This has resulted in mandatory folic acid fortification 
of wheat flour in many countries such as the US. The list of countries that have a 
mandatory folic acid food fortification programme are shown in a figure in Appendix I. 
In the UK, although it is not mandatory, most breakfast cereals have fortification of 
folic acid (Saravanan and Yajnik 2010). However, foetal NTDs continue to affect about 
6 to 12 in every 10,000 pregnancies (Ray et al. 2007). A systematic review of 
previously published data suggests that maternal vitamin B12 insufficiency is an 
independent risk factor for NTDs (Ray and Blom 2003). In addition, it has been 
observed that the risk of NTDs was higher in the presence of low maternal vitamin B12 
in folic acid sufficient individuals (Ray et al. 2007). As of the fortification of various 
foods, folic acid insufficiency is increasingly rare and vitamin B12 insufficiency has 
become the major modifiable risk factor for NTDs (Ray et al. 2007). Several recent 
studies report that vitamin B12 insufficiency is common in infants too (Schulpis et al. 
2004; Jones et al. 2007; Hay et al. 2010; Saravanan and Yajnik 2010). Low maternal 
vitamin B12 levels can result in low levels in the infants with resultant poor brain 
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development (Molloy et al. 2008) and cognitive impairment in children (Bhate et al. 
2008). Furthermore, a combination of both low folate and vitamin B12 is associated 
with abnormal behaviour and development (Black 2008). Another aspect of the 
interrelationship between folate and vitamin B12 is the increased plasma homocysteine 
concentrations as a result of folate and/or vitamin B12 insufficiencies. The possible 
mechanism includes lack of re-methylation of homocysteine to methionine. Though, 
mutations in the enzymes and/or nutritional deficiencies in B-vitamins required for 
homocysteine metabolism can induce hyperhomocysteinemia (Wald et al. 2002).  
 
1.6 Homocysteine, vitamin B12 and metabolic risks in offspring 
Despite folate status being known as major determinant of homocysteine 
concentration in non-folic acid supplemented populations, subgroups within such 
populations may exhibit dependence of homocysteine on vitamin B12 status rather than 
folate (Strain et al. 2004). In a study comparing different habitual diets in free-living 
Australians it was found that meat-eaters have lower homocysteine and higher serum 
vitamin B12 concentrations compared to ovo-lacto vegetarians and vegans. 
Interestingly, ovo-lacto vegetarians have much lower methionine intakes than the 
habitual meat-eaters (Mann et al. 1999). In addition, it has been reported that there are 
higher homocysteine and serum folate levels in Taiwanese vegetarians compared to 
meat-eaters (Hung et al. 2002). Furthermore, in countries implementing folic acid 
fortiﬁcation of flour, vitamin B12 insufficiency has emerged as the most common 
modiﬁable risk factor for hyperhomocysteinemia (Green 2009). Homocysteine is shown 
to be an independent risk factor for CVD, including ischemic heart disease, stroke, and 
peripheral vascular disease (Wald et al. 2002). It is believed that there is a causal 
relationship between hyperhomocysteinemia and atherosclerosis (Zhou and Austin 
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2009). A recent systematic review did not support the effect of vitamin B12 
insufficiency on increasing the risk of CVD in adults (Rafnsson et al. 2010). In addition, 
B-vitamins supplementation in a high risk population did not reduce CVD, despite  
significant homocysteine lowering (Bazzano et al. 2006; Albert et al. 2008). However, 
these results do not rule out the causal link between the B-vitamins and CVD 
(Saravanan and Yajnik 2010). Saravanan and Yajnik listed several factors to support 
this link: “(a) these studies were performed in non-deficient populations; (b) these 
vitamins, especially vitamin B12, may have other effects independent of homocysteine 
and (c) they may play a more crucial role during development rather than during 
adulthood” (Saravanan and Yajnik 2010). Thus, the effect of vitamin B12 insufficiency, 
if any, on the risk of chronic disease such as CVD and DM may occur earlier in life 
(Yajnik et al. 2008; Rafnsson et al. 2010). In fact, homocysteine correlates strongly with 
low birth weight while folic acid has the opposite effect (Yajnik et al. 2008). The folic 
acid (independent effects of vitamin B12), in insufficient states may also cause 
increased MMA resulting in increased lipogenesis due to the inhibition of beta-
oxidation by inhibiting CPT-1, an enzyme that helps in the change of fat to energy 
(Figure 1.10) (Saravanan and Yajnik 2010). Also in the presence of vitamin B12 
insufficiency, methyl folate trap will adversely affect methionine production from 
homocysteine, thus leading to less amino acid production, and therefore potentially 
reducing protein synthesis and lean tissue deposition (Yajnik et al. 2008). Such 
interactions in the intrauterine environment could result in ‘thin-fat’ babies with higher 
body fat and lower muscle mass (Figure 1.11). These babies will in turn have higher 
insulin resistance and therefore be at high risk of CVD in later life (Yajnik et al. 2003; 
Bhargava et al. 2004). Thus, lowering the homocysteine by using vitamin B12 and folic 
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acid during pregnancy is likely to have a significant impact on the metabolic risk of the 
offspring (Saravanan and Yajnik 2010).  
 
 
 
 
 
 
 
 
Figure 1.11: The characteristics phenotype of a South Asian compared to Caucasian 
baby. Compared with UK white babies, Indian babies are small. There is a substantial 
deficit in non-fat soft tissues, while subcutaneous fat was preserved (Yajnik et al. 2003). 
 
1.7 Attentions from folic acid fortification studies  
Since January of 1998, the US Food and Drug Administration has required the 
folic acid fortification of all enriched cereal grain products. The main motivation behind 
fortification is the prevention of the NTDs’ birth. In this regard, the folic acid 
fortification programme has been effective in terms of reducing the incidence of NTDs 
by 20 – 50 % (Honein et al. 2001; De Wals et al. 2007). Parallel to the NTDs’ birth 
reduction, additional benefits have been observed. The prevalence of both low folate 
and high homocysteine has been reduced in the general population (Jacques et al. 1999); 
in addition the epidemiological evidence showed a decline in the rate of stroke mortality 
in the US and Canada which may be related to the folic acid fortification (Yang et al. 
2006).  owever, some concern has been raised. Geometric mean folate concentration 
has increased from    12 to     0 nmol/l (Ganji and Kafai 2006) and some of the serum 
folate was detectable as unmetabolized folic acid (Troen et al. 2006). More important, 
 33 
 
those who were exposed to folic acid fortification and used vitamin supplements were 
consuming an amount exceeding the folate upper tolerable limit of 1 mg/d 
(Choumenkovitch et al. 2002). Folic acid is a synthetic form and not found generally in 
food; a high intake of this unnatural substance could lead to unintended consequences 
affecting at least a part of the population (Miller et al. 2009). 
Before the folic acid fortification programme started, the possibility of an 
increased folic acid intake that might mask haematological signs related to vitamin B12 
insufficiency or even aggravate its neurologic and neuropsychiatric effects was the main 
concern (Morris et al. 2007). However, the adverse effects of excess folic acid intake 
especially in the presence of vitamin B12 insufficiency have only recently been studied. 
After folic acid fortification, data from the National Health and Nutrition Examination 
Survey (N ANES III) reported both a ‘good’ and a ‘not-so-good’ side of folate  
(Morris et al. 2007; Smith 2007). The ‘good news’ is that, in subjects with a normal 
vitamin B12 status, high serum folate was associated with protection against cognitive 
impairment of the elderly. A similar result was reported for Latinos living in California, 
where higher red blood cell folate concentrations after folic acid fortification were 
associated with protection from cognitive impairment and dementia (Ramos et al. 
2005). The ‘not-so-good’ news is that the relation between high serum folate and 
cognitive impairment was reversed in subjects who had a low vitamin B12 status 
(Morris et al. 2007; Smith 2007). Thus, simply we can say that folic acid 
supplementation is not good for everyone. 
In support of the periconceptional supplementation with folic acid, population-
wide fortification of wheat flour achieved similar reductions in NTDs (Lumley et al. 
2002; Saravanan and Yajnik 2010). The prevalence of vitamin B12 insufficiency has 
increased in Canada, especially in the era after folic acid flour fortification. In addition, 
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NTDs attributable to vitamin B12 insufficiency have tripled in the same period (Ray 
and Blom 2003; Ray et al. 2007). The current data suggest that 1 in 20 women in 
Ontario may be vitamin B12 insufficient in the critical period of the embryonic neural 
tube closure. Thus, determining the prevalence of vitamin B12 insufficiency in this 
crucial period may inform future programme designed to lower the risk of NTD (Ray et 
al. 2008). 
In the Pune Maternal Nutrition Study (PMNS), the participants were known to 
be vegetarian and using folic acid as a standard care (500 µg /day) during pregnancy. 
Thus, the majority of pregnant women (> 60%) had low vitamin B12 and only one 
woman had a low folate level. After a follow up, it has been shown that the children 
born to mothers with the combination of ‘high folic acid and low vitamin B12’ had 
higher adiposity and insulin resistance (Figure 1.12) (Yajnik et al. 2008). Thus, an 
intrauterine imbalance between the two related vitamins (vitamin B12 and folate) may 
increase NTDs, increase the risk of disease such DM and CVD in later life, as well as 
increasing the risk of cognitive impairment in the elderly population (Saravanan and 
Yajnik 2010).  
 
 
 
 
 
 
 
 
Figure 1.12: The impact of maternal “high folate and low vitamin B12” in the 
offspring. Insulin resistance in children at 6 years of age in relation to maternal vitamin 
B12 (18 weeks) and erythrocyte folate (28 weeks). Children born to mothers who had 
the lowest vitamin B12 and highest folic acid levels during pregnancy were the most 
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insulin resistant (Yajnik et al. 2008). Insulin resistance was calculated using the fasting 
insulin and glucose concentration (homeostatic model assessment of insulin resistance 
[HOMA-R]). 
 
1.8 Possible mechanisms of “imbalance of vitamin B12/folate” on the 
metabolic risk of offspring  
It is well known that influences linked to early growth and development have an 
important effect on the risk of T2DM and CVD. The intrauterine environment, 
particularly maternal nutrition, can alter the vital development process in utero and 
during infancy and continue if exposed to an adverse environment in childhood and 
adult life (Godfrey and Barker 2000; Barker 2004; Mcmillen and Robinson 2005). 
 owever, until recently the mechanism of specific nutrients on ‘nutrient programming’ 
was not known (Sinclair and Singh 2007; Saravanan and Yajnik 2010). The DNA 
methylation that occurs initially at gametes phase and then at pre-implantation embryos 
highlight the possibility that periconceptional availability of methyl groups might 
influence such programming which leads to several alterations at adult status (Santos 
and Dean 2004). Furthermore, early nutrition can inﬂuence the DNA methylation 
because the mammalian 1-C metabolism, which provides the methyl groups for all 
biological methylation reactions, is highly dependent on dietary methyl donors 
(methionine) and cofactors (vitamin B12 and folate) (Waterland and Jirtle 2004). The 
genome of the pre-implantation mammalian embryo undergoes extensive 
demethylation. The patterns of DNA methylation must then be maintained over many 
rounds of rapid cellular proliferation during foetal and early postnatal development. 
Thus, the availability of dietary methyl donors and cofactors during this critical period 
might influence cell differentiation, development and function, then enhance the 
susceptibility to chronic disease in later life (Waterland and Jirtle 2004). The effects of 
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unbalanced maternal nutrition on the methylation status were studied in animals by 
using diets providing methyl groups which contain both vitamin B12 and folic acid. 
Studies in rodents showed that such diets during pregnancy altered the DNA 
methylation of candidate genes (agouti, peroxisomal proliferator-activated receptor 
(PPAR-α) and glucocorticoid receptor) which in turn affected the regulatory 
mechanisms of these genes throughout the life of these animals (Waterland and Jirtle 
2003; Lillycrop et al. 2005). More recently, the effect of a diet restricting the supply of 
vitamin B12, folate and methionine were investigated in mature female sheep. 
Interestingly, the results showed that lambs born to sheep fed a ‘methyl-deficient’ diet 
had higher adiposity, higher insulin resistance and higher blood pressure (Sinclair et al. 
2007). Thus, the results from animal studies can provide  clear evidence for epigenetic 
alterations of DNA methylation by these nutrients during the periconceptional period. 
Furthermore, evidence from humans in regard to this issue is very limited and only 
comes from the PMNS study . However, the causality from this study cannot be proven 
(this would need intervention studies) and need to be urgently replicated in other 
populations, given the potential huge impact of such intervention (Yajnik et al. 2008; 
Saravanan and Yajnik 2010). As subclinical vitamin B12 insufficiency is not rare (Allen 
2009), many research questions have been raised which need to be considered as to 
whether or not to introduce mandatory vitamin B12 fortification in the population 
(Green 2009). However, given the strong influence on the DNA methylation with 
potential lifelong epigenetic programming, such measures should only be taken after 
careful evaluation of such an intervention (Saravanan and Yajnik 2010). 
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1.9 Thesis aims 
It is well known that T2DM is a growing health problem worldwide. It is now 
being diagnosed earlier in life. Thus, preventing the epidemic of such a disease is a 
huge public health challenge that needs careful long term planning and implementation. 
As discussed previously, ‘gene-diet’ interaction during foetal development is likely to 
contribute to the epidemic of T2DM and CVD. More important, the intrauterine 
imbalance between the two related vitamins, vitamin B12 and folate, altered DNA 
methylation and could programme the foetus for the whole life. Thus, micronutrient 
status during pregnancy is likely to have a significant impact on the metabolic risk of 
the offspring. This thesis will predominately focus on vitamin B12 status during 
pregnancy among Saudi population. This will be shown, firstly, by understanding the 
worldwide prevalence of vitamin B12 insufficiency, particularly in the non-vegetarian 
population. Secondly, by investigating the possible role of maternal vitamin B12 in 
blood, as an independent risk factor, in predicting low birth weight in the offspring. 
Thirdly, by investigating the correlation between dietary intake of vitamin B12 and 
folate and their nutritional biomarker. Finally, by providing prevalence of vitamin B12 
insufficiency among Saudi pregnant women. This will help us to identify the 
importance of maternal vitamin B12 status during the periconceptional period.  
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Chapter 2 
Worldwide prevalence of vitamin B12 insufficiency during pregnancy 
and it’s relation to birth weight 
 
 
Systematic review (A)  
“Worldwide prevalence of vitamin B12 insufficiency during Pregnancy” 
 
Systematic review (B)  
“Does maternal vitamin B12 level independently predict low birth 
weight?” 
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2.1. Introduction 
Pregnant women in developing countries are vulnerable to nutritional deficiencies. This 
is due to the increased nutritional and physiological demands imposed by pregnancy 
involving a growing placenta, foetus and maternal tissue, which could be associated 
with maternal and foetal morbidity (Baker et al. 1975). An average of 20 - 30% of 
pregnant women suffer from a vitamin deficiency. Without supplementation, about 75% 
would show a deficiency of at least one vitamin (Baker et al. 2002). The importance of 
the different micronutrients deficiency may vary depending on regional and cultural 
differences (Bondevik et al. 2001). Thus, there is widespread recognition of the 
importance of adequate maternal nutrition during pregnancy in developing countries 
where profound malnutrition is uncommon (Mathews et al. 1999). The frequencies of 
low birth weight infants, still births, and babies born with congenital disorders are high 
among malnourished mothers (Leader et al. 1981; Pitkin 1981). As nutritional 
requirements are high, the effects of malnutrition can be severe and long-lasting in 
pregnant mothers (Ackurt et al. 1995). Nutritional status during pregnancy is thus 
implicated as a significant contributory factor in maternal and infant morbidity and 
mortality (Kafatos et al. 1989). 
The associations between low birth weight and the risk of later chronic disease 
such as CVD and DM has been strongly addressed by Barker and his colleagues, where 
poor maternal nutrition has been implicated as one of the key “adverse environmental 
influences in utero,” which could lead to compromised foetal growth and adverse long 
term consequences (Barker 2004). Moreover, low birth weight is associated with insulin 
resistance and related condition, including T2DM, but the underlying mechanisms are 
not clear (Levy Marchal and Jaquet 2004). The thrifty phenotype hypothesis proposes 
that foetal malnutrition in utero results in reduced foetal growth and programming of 
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the foetus to be insulin resistant postnatally (Barker 1995). In addition, “Foetal 
programming” is likely to be mediated through DNA methylation which involves B-
vitamins such as folic acid and vitamin B12 in such reactions. This is called epigenetic 
regulation and may provide some clues to the epidemic of T2DM and CVD (Saravanan 
and Yajnik 2010).   
In the presence of folic acid fortification of various foods and the 
recommendation for preconception folic acid supplementation, folate insufficiency has 
become rare in the general population as well as in pregnant women. Indeed, vitamin 
B12 insufficiency has become a potential major modifiable risk factor for metabolic 
diseases as well as neural tube defects (NTDs) (Morris et al. 2007). In fact, 10 years 
after mandatory folic acid fortification in Canada, NTDs due to vitamin B12 
insufficiency have tripled (Ray et al. 2007). In addition, vitamin B12 insufficiency has 
been reported to be common in pregnancy. Approximately 20% of women show a 
physiologic drop in serum vitamin B12 level during pregnancy (Pardo et al. 2000). In 
India, where vitamin B12 insufficiency is common, authors of PMNS provided a strong 
stimulus towards further understanding of the possibly fundamental relationship 
between vitamin B12 insufficiency in mothers and metabolic outcomes in offspring, 
which seriously overlap with the growing global concern about obesity and adiposity 
(Rosenberg 2008). The PMNS study has children with a low mean birth weight; 
children are short and thin but relatively adipose compared to white children, and the 
results showed that children born to mothers with low vitamin B12 but high folate 
concentrations were the most insulin resistant (Yajnik et al. 2008). Thus, vitamin B12 
insufficiency during the periconceptional period, especially in the presence of high folic 
acid levels, may increase NTDs as well as the offspring’s future risk of T2DM and 
CVD (Saravanan and Yajnik 2010). 
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It is perceived that vitamin B12 insufficiency will be rare in populations with a 
high intake of animal protein such as Saudi Arabia. However, the results from the 
National Diet and Nutrition Survey (NDNS) data of the UK adult population showed 
the presence of vitamin B12 insufficiency in 10.5% compared to 2.1% folate 
insufficiency, with an even higher prevalence of 11.8% in women of childbearing age 
(Saravanan et al. 2010a). We therefore aimed to conduct a systematic review trying to 
answer the following questions:  (A) What is the worldwide prevalence of vitamin B12 
insufficiency during pregnancy, particularly in the non-vegetarian population? and (B) 
Does the vitamin B12 level during pregnancy predict low birth weight in the offspring? 
Thus, we identify all relevant observational studies investigating the worldwide 
prevalence of vitamin B12 insufficiency and the possible role of maternal vitamin B12, 
as an independent risk factor, in predicting low birth weight in the offspring.  
 
2.2 Methods  
2.2.1 Study search 
We conducted a comprehensive literature search for publications on vitamin 
B12 during pregnancy in MEDLINE/PUBMED (National Library of Medicine and 
National Institute of Health), and EMBASE (The Excerpta Medica database), Global 
health, CAB (Commonwealth Agricultural Bureau database) and CINAHL (The 
Nursing & Allied Health database). All databases were searched from inception. We 
applied a search strategy based on a combination of keywords and medical subject 
headings (MeSH) (e.g. cobalamin, vitamin B12, vitamin B12 insufficiency, 
methylmalonic acid, holotranscobalamin, homocysteine, pregnancy or pregnant women 
and birth weight). The study search for the two systematic reviews was conducted 
separately by different reviewers and at different times, using slightly different 
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eligibility criteria and search keywords relevant to the aim of the reviews. All search 
results were limited to studies conducted on humans, and published in the English 
language. We also examined the reference lists of key publications for other potential 
citations.  
 
 2.2.2 Study eligibility 
Study eligibility criteria included publications of observational studies 
(longitudinal or cross-sectional studies) on normal adult pregnancy (18 years old or 
more). Studies that were designed specifically to look for NTDs’ birth, or case-control 
studies on low birth weight, studies on adolescent pregnancy, anaemic pregnancy, 
studies on vitamin B12 and early pregnancy loss, or studies designed to look for the 
effect of smoking in vitamin B12 level were excluded. The eligibility criteria for each 
systematic review A and B were specified in (Figure 2.1 and Figure 2.3) respectively. 
Results for some subjects were reported in more than one paper. In these cases, we 
included the papers with the most complete information relevant to the aim of the 
reviews.  
 
2.2.3. Study selection and data extraction 
All initial data searches and screening of titles and abstracts of identified studies 
were independently done for eligibility according to the pre-specified inclusion and 
exclusion criteria by two reviewers. Potentially relevant articles were retrieved and full-
texts were evaluated against the same criteria. Each accepted study was extracted by a 
single reviewer, and a second reviewer independently verified the extracted data. Data 
extraction issues were resolved by consensus. When disagreements could not be 
resolved, a third reviewer was consulted for a final judgement. Data was subsequently 
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extracted onto pre-designed forms by the two reviewers. For each study, we extracted 
information on the study site and population, maternal age, gestational age at blood 
collection, vitamin B12 measurement method, use of supplement prior to blood 
sampling, and results. When the study design was not specified in the article, it was 
assigned according to the type of study design and method used in subject collection 
and agreed by the two reviewers. In addition, Vitamin B12 and folate levels are 
presented in the International System of Units (SI) (pmol/l and nmol/l) respectively. 
When levels in an article were presented in conventional units (e.g. pg/ml for vitamin 
B12 and ng/ml for folate), calculations were made to convert them in to SI units using 
the conversion table for chemical compounds (conventional unit => SI unit: multiply by 
conversion factor; 0.738 and 2.266 for vitamin B12 and folate respectively). 
 
2.2.4. Study quality assessment 
Studies included in the reviews were assessed independently by the two 
reviewers for methodological quality using assessment checklist criteria according to 
the type of study design (cross-sectional or longitudinal observational study design). 
Differences in methodological quality across studies can indicate that the results of 
some studies are more likely to be affected by bias than others. Therefore, the quality of 
a study should be taken into account when the potential causal distribution of risk 
factors is being evaluated. The results were compared and disagreements between the 
reviewers on individual items were resolved by discussion. When disagreements could 
not be resolved, a third party was consulted for a final judgment. 
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2.2.4.1. Longitudinal studies 
An assessment checklist of criteria provided in the NICE guidance for public 
health (National Institute for Health and Clinical Excellence 2009), which was adapted 
from the Tooth et al. checklist criteria of reporting of observational longitudinal studies 
(Tooth et al. 2005) were used. The quality assessment focused on appraising the internal 
(study design and quality) and external (how well it can be applied to the population in 
question) validity of the studies. The criteria reflect design and interpretation aspects 
covering the study rationale and population, recruitment, measurements and biases, data 
analysis, and generalizability of the results. The overall assessment for each article in 
the review was concluded with an evidence statement, as adapted from the Scottish 
Intercollegiate Guidelines Network (SIGN) (www.sign.ac.uk), which reflects the 
strength of the study. The results of the quality assessment were used for descriptive 
purposes to provide an overall evaluation of the studies included in the review. More 
specifically, the overall assessment per paper is based on the number of relevant items 
addressed in each paper. The ranking system used for the overall assessment was 1st 
tertile (< 33% "yes") = few criteria met, 2nd tertile (33% - 66% "yes") = some criteria 
met, and 3rd tertile (> 66% "yes") = most criteria met. However, when comparing 
different papers (e.g. high quality versus low quality), we looked within the overall 
assessment and focus on which specific items (e.g. focusing on the key 10 relevant 
items of internal validity; which are questions 1, 4, 7, 9, 17, 18, 27, 28, 29, and 30 in the 
checklist) were addressed or not since it is unlikely that they are all equal. 
 
2.2.4.2. Cross-sectional studies 
An assessment checklist of criteria for cross-sectional studies provided in 
(Ariens et al. 2000; van der Windt et al. 2000) was used with a slight modification (in 
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some items’ statement) to suit the aim of the present review. The list consisted of 
different items in 5 categories on information, validity and precision (study objective, 
study population, exposure and outcome assessment, and analysis/data presentation).  
Each item was scored as “1” when a study positively provided the information on an 
item, “0” when a study did not provide that information, or “don’t know” (unclear) if 
the paper provided insufficient information on a specific item. Subsequently, total 
quality scores were calculated by counting the number of positively scored items over 
the total number of applicable items. The maximum score given was 8. The studies 
were categorized as either high or low in methodological quality according to their total 
score computed. A high quality study was defined as a study that scored positively on at 
least 75% (≥ 6) of the total methodological quality assessment score. 
 
2.2.5. Study heterogeneity 
Substantial study heterogeneity was observed because of differences in sample 
characteristics, study design (including: gestational age and use of vitamin supplement 
at blood collection) and data analyses performed (including: measurement and 
adjustment for confounding factors). In addition, study heterogeneity arose from 
differences between studies in biological sample characteristics: plasma vs. serum and 
fasting vs. non-fasting, and vitamin B12 assay measurement methods (microbial assay, 
immunoassay, radioimmunoassay, enzyme assay, etc.). 
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2.3 Systematic review (A)  
“Worldwide Prevalence of Vitamin B12 Insufficiency during Pregnancy” 
 
2.3.1. Results  
2.3.1.1. Study characteristics 
A total of 4187 relavent articles were identified in bibographic databases, from 
inception to August 2011, for title and abstract screening. According to the pre-
specified inclusion and exclusion criteria, only 251 articles were selected and initially 
retrieved for further review and inspection. Detailed evaluation of the full text was 
reviewed for 122 articles. Sixty five articles were excluded because of duplicate studies 
or same study population (n = 12), no prevalence of vitamin B12 insufficiency or clear 
vitamin B12 cut-off level was reported (n = 28), or has anaemic subjects (n = 3), studies 
on lactating mother (n = 1), non-pregnant sample (n = 2), reviews (n = 5), small sample 
size (n = 11) or conference papers (n = 3) (Figure 2.1). A total of 57 articles were 
included in the review. The studies have been categorized according to the geographic 
distribution into different continents. In addition to the usual list of continents, 2 
additional categories have been added (Middle Eastern and South Asian countries) as 
previously used (Stabler and Allen 2004), as we believe that countries in these areas 
could share similar dietary habits and food consumption patterns that may affect their 
total nutrients intake and actual levels in the blood. The list and number of studies 
included in each category are as follows: American continent (North American; n = 7 
and Central and South American; n = 6), Australian continent (n = 2), European 
continent (n = 11), African continent (n = 7), Asian continent (n = 7), Middle Eastern 
countries (n = 6), and South Asian countries (n = 11). The methodological overview of 
the studies included in this review are shown depending on each continent from (Table 
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2.1 to Table 2.7). A brief description on the studies included in each continent are given 
as follows. 
 
2.3.1.1.1. American continent 
Thirteen studies, 7 from North American: Canada (Lowenstein et al. 1960; 
House et al. 2000; Ray et al. 2008), USA (Baker et al. 1975; Jacob et al. 1976; Knight et 
al. 1991; Pagán et al. 2002) and 6 from Central and South American: Mexico (Black et 
al. 1994), Latin America (Cook et al. 1971), Venezuela (Garcia-Casal et al. 2005) and 
Brazil (Giugliani et al. 1984; Guerra-Shinohara et al. 2004; Barbosa et al. 2008), were 
included in the review; 3 longitudinal and 10 cross-sectional studies. The number of 
participants ranged from 51 to 10622 pregnant and the mean maternal age ranged from 
25 to 30.5. Only 4 studies reported the use of multivitamins at blood collection (Table 
2.1). 
 
2.3.1.1.2. Australian continent 
Only 2 studies were included in this continent (Whiteside et al. 1968; Cole et al. 
1974). One is a longitudinal study followed the participants at the 3 trimesters and the 
other one is cross-sectional study screened the participants at the third trimester. The 
number of participants ranged from 60 to 147 pregnant (Table 2.2).  
 
2.3.1.1.3. European continent 
Eleven studies from Denmark (Zachau-Christiansen et al. 1962; Milman et al. 
2006), UK (Ball and Giles 1964; Roberts et al. 1973), Scotland (Shields et al. 2011), 
France (Frery et al. 1992), Norway (Bjorke et al. 2001), Netherland (Bruinse and Van 
den Berg 1995), Amesterdam (Goedhart et al. 2011) , Spain (Murphy et al. 2007) and  
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Figure 2.1 Flow diagram of studies included in the systematic review (A). All initial data searches and 
screening of titles and abstracts of identified studies were independently done for eligibility according to the pre-
specified inclusion and exclusion criteria by 2 reviewers – agreement was (97%). 
Inclusion Criteria: 
 Studies on normal adult pregnancy. 
 Studies identify number or % of low 
vitamin B12 level. 
 
Exclusion Criteria 
 No cut-off level identify for low vitamin 
B12 level.  
 Case-control studies that were designed 
to look for LBW. 
 Adolescents’ pregnancy 
 Pregnancy and NTDs or IUGR infants 
 Vitamin B12 and early pregnancy loss. 
 Studies designed to look for the effect of 
smoking on vitamin B12 
 Anaemia. 
 
4187 potentially relevant articles identified in 
bibliographic database  (MEDLINE, EMBASE, 
CAB, Global health, CINAHL) from inception 
to August 2011, for title & abstract screening 
 
251 total articles selected for further review & 
inspection 
 
3936 excluded due to failing to meet 
inclusion & exclusion criteria 
 
122 full text articles retrieved for more 
detailed evaluation 
129 excluded due to failing to meet criteria 
for any topic in full text 
 
57 full text articles included in the review 
and assessed for study quality 
65 excluded : 12 duplicate or same studies 
population, 28 has no B12 prevalence or 
clear cut-off level, 3 has anaemic subjects, 
1 lactating mother sample, 2 non-pregnant 
sample, 5 reviews, 11 small sample size 
and 3 conference papers 
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Table 2.1: Shows the methodological overview of studies included in the review: American continent.  
References Country or city/ 
time period 
Study 
Design 
No. of subjects Period of blood 
collection  
Maternal age 
(years) 
Vitamin B12 
measurement method/ 
blood sample 
B12 supplement 
prior to blood 
sample 
Q/A score 
 
L         CS 
Lowenstein et al., 
1960  
Canada L 345  2nd trimester  
3rdtrimester  
N/R MBA/ Serum  N/R ( - )  
Cook et al., 1971 Latin America 
1968-1970 
CS 899  35 (32-40) ‡ (15-40) N/R N/R  6 
Baker et al., 1975 New Jersey CS 174  Delivery 
Cord 
(20-37) MBA/Serum  Yes (76.4% used 
multivitamin) 
 7 
Jacob et al., 1976  Los Angeles 
1972-1974 
CS 301 Mexican  2nd trimester (n= 257) 25 ± 6 
(15-42) 
MBA/Serum  
 
Yes (20% used 
multivitamin) 
 5 
Giugliani et al., 1984 Brazil CS 51  Delivery (38-42) N/R RIA/Serum Yes (51% )  5 
Knight et al., 1991   
 
Washington DC 
1985-1990 
L 600 14 - 27wks (n=109) 
> 27wks (n=117) 
Delivery (n=101) 
Cord (n=91) 
(16-35) RIA/Fasting serum  Yes (90%used 
multivitamin) 
(+)  
Black et al. ,1994 Mexico 
1985-1987 
CS 85 5-8 months of 
pregnancy 
30.5 ± 7 RA/Fasting serum  N/R  5 
House et al.,  2000  
 
Newfoundland 
1996-1997 
CS 1424  16 wks. 28 (15-47)‡ EIA (IMx B12 
system)/Serum  
N/R  5 
Pagan et al., 2002 USA  
1986-1988 
L 285  18 wks. 
30 wks. 
25.5 
(18-38) 
RBA/Non-fasting 
serum 
N/R (+)  
Guerra-Shinohara et 
al., 2004  
Brazil CS 119  Delivery (37-42wks.) 
Newborn 
25.5 ± 6.7 
(15-44) 
IMx system & Immulite 
kits/ Serum  
N/R  6 
Garcia-Casal et al., 
2005  
Venezuela 
2001- 2002 
CS 1283 1st trimester 
2nd trimester 
3rd trimester 
19-25 (n=571) 
26+ (n=449) 
RIA/Fasting serum  
 
N/R  5 
Ray et al., 2008 Canada 
Jan - July 2007 
CS 10622  1st trimester 29.9 ± 7.1 
(15-46) 
N/R N/R  5 
Barbosa et al., 2008 Brazil 
Apr- May 2001 
CS 275   Delivery (39 ± 1.2) 25.2 ± 6.5 Immulite Kit/Serum No  6 
Values represent are mean ± SD (range), ‡ median (range), MBA = microbiological assay, RIA = radioimmunoassay,  RA = radioassay, EIA = enzyme immunoassay, RBA 
= Radiobinding assay, CS = cross-sectional study, L= longitudinal study, Q/A = quality assessment, quality score for L are: ( - ) = few criteria fulfilled, (+) some criteria 
fulfilled and (++) most criteria fulfilled,  uality score for  S are ≥ 6 = high  uality and < 6 = low  uality,  N/R = not reported. 
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    Table 2.2: Shows the methodological overview of studies included in the review : Australian continent  
References Country or city/ 
time period 
Study 
Design 
Subjects Period of blood 
collection  
Maternal age 
(years) 
Vitamin B12 
measurement method/ 
blood sample 
B12 supplement 
prior to blood 
sample 
Q/A score 
 
L         CS 
Whiteside et al.,  1968  Australia 
 
L 60 pregnant 12 wks. 
26 wks. 
38 wks. 
N/R MBA/Serum  N/R ( - )  
Cole et al., 1974 South Australia CS 147 pregnant 3rd  trimester 
 
23 (15 - 28) MBA/Serum  N/R     3 
Values represent are mean  (range), MBA = microbiological assay, CS = cross-sectional study, L =  longitudinal study, Q/A = quality assessment, quality score for L are: ( - ) 
= few criteria fulfilled, (+) some criteria fulfilled and (++) most criteria fulfilled,  uality score for  S are ≥ 6 = high  uality and < 6 = low  uality, N/R = not reported. 
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Table 2.3: Shows the methodological overview of studies included in the review : European continent  
References Country or city/ 
time period 
Study 
Design  
 
Subjects Period of blood 
collection  
Maternal age 
(years) 
Vitamin B12 
measurement 
method/ blood sample 
B12 supplement 
prior to blood 
sample 
Q/A score 
 
 L       CS 
Zachau-Christiansen 
et al., 1962  
Denmark CS 367 pregnant Delivery 
Cord 
N/R MBA/Serum  N/R  6 
Ball et al., 1964*  Stoke-on-Trent, 
UK. 1957- 1964 
CS 
 
320 pregnant 9 wks. to full term N/R MBA/Serum  N/R  3 
Robert et al., 1973 England 
Feb - July 1971 
L 322 immigrant 
pregnant 
2nd trimester 
3rd trimester 
N/R MBA/Serum  N/R (+)  
Frey et al., 1992  France 
 
CS 
 
188 pregnant 
154 newborn 
Delivery (39.5 ± 1.3) 
Cord  
29.2 ± 5 (19 - 43) RA/ Plasma  N/R  7 
Bruinse et al., 1995*  Netherland L  
 
116 pregnant  
 
16 wks., 28 wks. 
34 wks., delivery 
N/R CPB-assay with 
intrinsic factor /Fasting 
serum  
No (+)  
Bjorke-Monsen et 
al., 2001 
Norway 
1996 – 1997 
CS 
 
169 mothers 
173 newborn 
Delivery [39 - 41] ‡ 
Cord 
 
29 [26-34] ‡ MBA/Serum  36% used  
multivitamin 
 7 
Schulpis et al., 2004  Greek 
1999 – 2002 
CS 
 
1933 pregnant; 
1025 Greeks, 
908 Albanian 
Delivery 
Cord 
Greeks 27.5± 3.4 
Albanian 26.8 ± 2.5 
CIA/ Serum  No  5 
Milman et al., 2006   Denmark 
1995 – 1997 
L 406 pregnant 18 wks. 
32 wks. 
39 wks. 
29.6 ± 4 
 
EIA/Non-fasting 
plasma  
34% used 
multivitamin 
prior to inclusion 
(+)  
Murphy et al., 2007* Spain  L 92 pregnant 8 wks., 20 wks. 
32 wks., Delivery 
cord 
18 – 35 MBA /Serum 27% used 
 multivitamin 
(+)  
Goedhart et al., 2011 Amsterdam 
2003 – 2004 
CS 
 
4389 pregnant 2nd trimester  
(median 13 wks.) 
N/R CIA/Serum  N/R  6 
Shield et al., 2011 Scotland 
2008 – 2009 
CS 190 pregnant 1st trimester  (n = 113) 
3rd trimester (n = 77) 
29 (17 - 42) 
29 (18 - 40) 
N/R/Serum N/R  5 
Values represent are mean ± SD (range), ‡ median [25th – 75th], MBA = microbiological assay, RA = radioassay, EIA = enzyme immunoassay, CIA = Chemiluminescence 
immuneassay, CS = cross-sectional study, L= longitudinal study, Q/A = quality assessment, quality score for L are: ( - ) = few criteria fulfilled, (+) some criteria fulfilled and (++) 
most criteria fulfilled,  uality score for  S are ≥ 6 = high  uality and < 6 = low  uality, N/R = not reported, *provided vitamin B12 insufficiency (%) in total during pregnancy. 
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Greek (Schulpis et al. 2004) were included in the review; 4 longitudinal and 7 
cross-sectional studies (Table 2.3).The number of participants ranged from 92 to 4389 
pregnant and the mean maternal age ranged from 26.8 to 29.6 years old. Only 3 studies 
reported the use of multivitamins at the time of blood collection (Table 2.3).  
 
2.3.1.1.4. African continent 
Seven studies from Nigeria (Osifo and Onifade 1976; Vanderjagt et al. 2007; 
Vanderjagt et al. 2009), Kenya (Brabin et al. 1986), South Africa (Colman et al. 1975), 
Tanzania (Hinderaker et al. 2002) and Ethiopia (Gibson et al. 2008) were included in 
the review; 1 longitudinal and 6 cross-sectional studies. The number of participants 
ranged from 50 to 2547 pregnant and the mean maternal age ranged from 17.7 to 27.8 
years old. Only 1 study reported the use of multivitamins at the time of blood collection 
(Table 2.4). 
 
2.3.1.1.5. Asian continent 
Seven studies from Taiwan (Ho et al. 1987), South Korea (Park et al. 2004), 
China (Ma et al. 2004), Japan (Takimoto et al. 2007), Philippine (Marzan et al. 1971) 
and Thailand (Areekul et al. 1976; Srisupandit et al. 1983) were included in the review; 
1 longitudinal and 6 cross-sectional studies. The number of participants ranged from 92 
to 1163 pregnant and the mean maternal age ranged from 25 to 30.5 years old. Only 1 
study reported the use of multivitamins at the time of blood collection (Table 2.5). 
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Table 2.4: Shows the methodological overview of studies included in the review : African continent 
References Country or city/ 
time period 
Study 
Design 
Subjects Period of blood 
collection  
Maternal 
age (years) 
Vitamin B12 
measurement method/ 
blood sample 
B12 supplement 
prior to blood 
sample 
Q/A score 
 
L        CS 
Colman  et al., 1975 South Africa CS 
 
144 pregnant  3
rd
 trimester 23.5 (16 - 45) RID/Serum  N/R  5 
Osifo et al., 1976  Nigeria 
 
CS 
 
50 mother-infant 
pairs 
Delivery 
Cord 
N/R MBA/ Non-fastingserum  N/R  4 
Barbin et al., 1986  Kenya 
Jan - Apr. 1981 
L  
 
291 pregnant; 
119 primigravida 
172 multigravida 
1st trimester  
2nd trimester  
3rd trimester 
17.7 ± 2.0 
24 ± 5 
RA/Serum  N/R (+)  
Hinderaker et al., 2002 Tanzania 
1995 - 1996 
CS 
 
2547 pregnant; 
155 non-anemic 
Median 5 months Median 25 Magnetic separation 
assay/ Serum  
N/R  6 
Vanderjagat et al., 
2007*  
Nigeria 
Jun - Aug. 2003 
CS 
 
146 pregnant 
 
2nd trimester (n = 59) 
3rd trimester (n = 79) 
26.5 (15 - 45) CIA/ Non-fasting serum  Yes (33% used 
multivitamin) 
 6 
Gibson et al., 2008 Ethiopia 
 
CS 
 
99 pregnant 3rd trimester 27.8 ± 4.6 RA/Non-fasting serum N/R  6 
Vanderjagat et al., 2009  
 
Nigeria CS 
 
98 pregnant 33.7 ± 3.8 wks. 
 
27.4 ± 5.4 CIA/ Non-fasting serum  No  5 
Values represent are mean ± SD (range), MBA = microbiological assay, RA = radioassay, RID = Radioisotope dilution, CIA = Chemiluminescence immuneassay, CS = cross-
sectional study, L= longitudinal study, Q/A = quality assessment, quality score for L are: ( - ) = few criteria fulfilled, (+) some criteria fulfilled and (++) most criteria fulfilled, 
 uality score for  S are ≥ 6 = high  uality and < 6 = low  uality,  N/R = not reported, *provided vitamin B12 insufficiency (%) in total during pregnancy. 
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Table 2.5: Shows the methodological overview of studies included in the review : Asian continent 
References Country/ 
time period 
Study 
Design  
 
Subjects Period of blood 
collection  
Maternal 
age (years) 
Vitamin B12 
measurement method/ 
blood sample 
B12 supplement 
prior to blood 
sample 
Q/A score 
 
 L         CS 
Marzan  et al., 1971 Philippine CS 250 pregnant 2
nd
 trimester 
3rd trimester 
25 
26 
RID/Serum  No  5 
Areekul et al. ,1976*  Thailand CS 
 
216 pregnant; 
169 non-anemic 
1st trimester 
2nd trimester 
3rd trimester 
16 - 42 RAD/ Non-fasting 
serum  
 
N/R  6 
Srisupandit et al., 1983* Thailand CS 
 
568 pregnant 2nd trimester 
3rd trimester 
16 - 30 RID / Serum N/R  6 
Ho et al ., 1987  Taiwan CS 
 
221 Chinese 
pregnant; 198 non-
anemic 
Delivery  
39.5 (32 - 43) 
27.6 (18 - 42) RA/Serum  No  6 
Park et al., 2004  South Korea 
 
CS 
 
92 pregnant 24-28 wks. 
 
30.5 ± 3.7 
(18 - 39) 
RIA/Fasting serum  Yes (39% used 
multivitamin) 
 5 
Ma et al., 2004  
 
China 
1999 - 2000 
CS 
 
1163 pregnant; 512 
non-anemic 
3rd trimester (20 - 35) RIA/Serum  No  6 
Takimoto et al., 2007  Japan 
2001 - 2003 
L  
 
94 pregnant; only 39 
pregnant provide 
blood sample at all 3 
trimesters  
7-14 wks. (n = 51) 
26-29 wks. (n = 77) 
34-36 wks. (n = 82) 
29 ± 4.7 CIA/ Non-fasting 
serum  
N/R (++)  
Values represent are mean ± SD (range), RIA = radioimmunoassay,  RA = radioassay, RID = Radioisotope dilution, RAD = Radioactive dilution, CIA = Chemiluminescence 
immunoassay, CS = cross-sectional study, L= longitudinal study, Q/A = quality assessment, quality score for L are: ( - ) = few criteria fulfilled, (+) some criteria fulfilled and 
(++) most criteria fulfilled,  uality score for  S are ≥ 6 = high  uality and < 6 = low  uality, N/R = not reported, *provided vitamin B12 insufficiency (%) in total during 
pregnancy. 
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2.3.1.1.6. Middle Eastern countries 
Six studies from Turkey (Ackurt et al. 1995; Koc et al. 2006; Ipciglu et al. 2007; 
Haliloglu et al. 2010), Sudan (Abdelrahim et al. 2009) and Egypt (Hussein et al. 2009) 
were included in the review; 2 longitudinal and 4 cross-sectional studies. The number of 
participants ranged from 68 to 279 pregnant and the mean maternal age ranged from 
23.7 to 27 years old. Only 1 study reported the use of multivitamins at the time of blood 
collection (Table 2.6). 
 
2.3.1.1.7. South Asian countries 
Eleven studies from India (Yusufji et al. 1973; Pathak et al. 2007; Yajnik et al. 
2008; Krishnaveni et al. 2009; Katre et al. 2010; Veena et al. 2010), Nepal (Bondevik et 
al. 2001; Jiang et al. 2005) and Bangladesh (Hall et al. 2007; Li et al. 2008; Lindstrom 
et al. 2011) were included in the review; 3 longitudinal and 8 cross-sectional studies. 
The number of participants ranged from 101 to 1165 pregnant and the mean maternal 
age ranged from 22.6 to 27 years old. Only 2 studies reported the use of multivitamins 
at the time of blood collection. (Table 2.7). 
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Table 2.6: Shows the methodological overview of studies included in the review : Middle Eastern countries 
References Country/ 
time period 
Study 
Design 
Subjects Period of blood 
collection  
Maternal 
age 
(years) 
Vitamin B12 
measurement method/ 
blood sample 
B12 supplement 
prior to blood 
sample 
Q/A score 
 
 L        CS 
Ackurt et al., 1995   Turkey 
Feb - Dec 1991 
L 130 pregnant 13-17 wks. (n = 130) 
28-32wks. (n = 88) 
23.7 ± 4 
(16 - 35) 
RA/ Non-fasting plasma  N/R (+)  
Koc et al., 2006  Turkey 
Before 2004 
CS 
 
180 parturient Delivery (38 - 42 wks.) 
Cord 
27 ± 5.8 electrochemiluminiscence 
method/ Non-fasting serum  
19% used 
multivitamins 
 6 
Ipciglu et al., 2007* Turkey CS 
 
186 pregnant 2nd trimester (n = 58) 
3rd trimester (n = 98) 
19 - 35 Microparticles enzyme 
immunoassay/ Fasting 
serum  
N/R  5 
Abdelrahim et al., 
2009  
Sudan 
2007-2008 
CS 
 
279 pregnant; 
55 non-anemic 
Delivery 25.9 ± 6.4 Immunofluorescent assay/ 
Serum  
N/R  6 
Hussein et al., 2009  Egypt 
 
CS 
 
84 mother-
newborn pairs 
Delivery 
Cord 
 
26 ± 0.5 
(16 - 42) 
Automated 
Chemiluminescent/  
Serum  
N/R  6 
Haliloglu et al., 2010* Turkey L 68 pregnant 1st trimester (11 wks.) 
2
nd 
trimester (25 wks.)
 
3rd trimester (32 wks.) 
23 - 31 Iluminescence method/ 
Fasting serum  
No (+)  
Values represent are mean ± SD (range), RA = radioassay, CS = cross-sectional study, L= longitudinal study, Q/A = quality assessment, quality score for L are: ( - ) = few 
criteria fulfilled, (+) some criteria fulfilled and (++) most criteria fulfilled,  uality score for  S are ≥ 6 = high  uality and < 6 = low  uality, N/R = not reported, *provided 
vitamin B12 insufficiency (%) in total during pregnancy. 
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Table 2.7: Shows the methodological overview of studies included in the review : South Asian countries 
References Country/ 
time period 
Study 
Design 
Subjects Period of blood 
collection  
Maternal age 
(years) 
Vitamin B12 
measurement method/ 
blood sample 
B12 supplement 
prior to blood 
sample 
Q/A score 
 
  L        CS 
Yusufji et al., 1973  India 
1966-1968 
CS 
 
1000 pregnant 3rd trimester 25.3 (15 - 35) MBA/ Serum  N/R  6 
Bondevik et al.,  2001  Nepal 
1994-1995 
CS 
 
328 pregnant 18.5 wks.  22.6 (15 - 36) MSA/ Non-fasting 
serum  
No 
 
 7 
Jiang et al., 2005  Nepal 
1998-2001 
CS 
 
1165 pregnant 10.9 ± 4.6 23.6 ± 6.0  
(15 - 45) 
MBA/Serum  No  7 
Pathak et al., 2007  
 
India CS 
 
283 pregnant ≥ 28 wks 
 
22.9 ± 3.3 MBA/Serum  N/R  6 
Hall et al., 2007 Bangladesh 
2004-2005 
CS 
 
101 pregnant Delivery 
Cord 
26 ± 5.3 
(16.7 - 39) 
RIA/Plasma  N/R   5 
Yajnik et al., 2008   Indian 
1994-1996 
L  
 
797 pregnant 18 ± 2 wks.  
28 ± 2 wks. 
21 [19, 2 ]‡ MBA/ Fasting plasma  N/R (++)  
Li et al., 2008  Bangladesh 
Jan. - Dec. 2002 
L 753 pregnant 8 wks. † 
14 wks. 
27 (14 - 44) RA/Plasma  N/R (+)  
Krishnaveni et al., 2009  India 
1997-1998 
CS 
 
774 pregnant;  
35 GDM 
30 ± 2 wks. 
 
N/R MBA/Fasting serum  Yes (30%)  7 
Veena et al., 2010  India 
1997-1998 
CS 
 
830 pregnant 30 ± 2 wks. 23.9 ± 4.2 MBA/Fasting plasma  N/R  7 
Katre et al., 2010  India 
2004-2006 
L 184 pregnant; 
94 rural, 90 urban 
Mean 17 (12 - 22) 
Mean 28 (24 -  0) † 
Mean 34 (32 -  6) † 
22.8 ± 3.7 MBA/Fasting plasma  Yes (45%) (++)  
Lindstrom et al., 2011 Bangladesh 
Jan. - Dec. 2002 
CS 
 
738 pregnant; 523 
non-anemic 
14.5 ± 1.8 26.6 ± 5.9 RIA/Plasma  N/R  7 
Values represent are mean ± SD (range), ‡ median [25th – 75th], MBA = microbiological assay, RIA = radioimmunoassay, RA = radioassay, MSA = Magnatic separation 
assay, CS = cross-sectional study, L= longitudinal study, Q/A = quality assessment,  quality score for L are: ( - ) = few criteria fulfilled, (+) some criteria fulfilled and (++) 
most criteria fulfilled,  uality score for  S are ≥ 6 = high  uality and < 6 = low  uality, N/R = not reported, † B12 insufficiency (%) was not presented at this period. 
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2.3.1.2. Study quality assessment 
The present review included 15 longitudinal and 42 cross-sectional studies. 
According to the type of study design, we used a suitable quality assessment 
checklist, as previously discussed in the Method, to identify the level of 
methodological quality. The last column of the methodological overview tables 
(Tables 2.1 to 2.7) present the total quality score for studies included in the review. 
From the total longitudinal studies included in the review, 3 studies 
(Takimoto et al. 2007; Yajnik et al. 2008; Katre et al. 2010) met most of the quality 
assessment criteria, 10 studies met some and 2 studies (Lowenstein et al. 1960; 
Whiteside et al. 1968) met few of the assessment criteria. Details of the quality 
assessment of these studies are presented in Tables 1 and 2 in Appendix III.  Most 
of the studies reported a clear research question, defined target and study population, 
location, stated eligibility criteria, number of participants at the beginning of the 
study, issues of selection in to the study methods of data collection, type of analyses 
conducted, reported the absolute effect size and related their results back to the target 
population. While issues related to consenting (number of consenters and reasons for 
non-consenting, comparisons of consenters with non-consenters in terms of baseline 
demographic or clinical features) and analysis (loss of follow up, missing data and 
confounders accounted into the analysis) were poorly reported. Other items such as 
reliability and validity of measurement method were both reported only in 
(Lowenstein et al. 1960; Brabin et al. 1986; Murphy et al. 2007), while reliability 
alone was reported in (Knight et al. 1991; Katre et al. 2010) and validity was 
reported only in (Pagán et al. 2002; Takimoto et al. 2007). Furthermore, relative 
effect size was only reported in (Pagán et al. 2002; Takimoto et al. 2007; Katre et al. 
2010). In terms of assessing the bias, no study reported the impact of biases 
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quantitatively; however, only 4 studies reported it qualitatively (Takimoto et al. 
2007; Li et al. 2008; Yajnik et al. 2008; Katre et al. 2010). Finally, issues on the 
generalizability of the results was only discussed in (Ackurt et al. 1995; Milman et 
al. 2006; Yajnik et al. 2008). 
From the total cross-sectional studies included in the review, 60% (n = 25) of 
the included studies scored positively on more than 75% on the quality items in the 
assessment checklist and were rated as a high quality studies. Fifteen studies scored 
between 44% and < 75% and only 2 studies scored 43%, though both were rated as 
low quality studies. Details of the quality assessment of these studies are presented in 
Tables 1 to 7 in Appendix IV. Most of the studies clearly defined their objectives, 
issues related to the study population and outcome measures were also well 
identified, while adjusting the results for possible confounders in the analysis were 
varied and assessed in 14 studies only. Six studies (Ball and Giles 1964; House et al. 
2000; Schulpis et al. 2004; Garcia-Casal et al. 2005; Hall et al. 2007; Ray et al. 
2008) did not assess the outcome measures (serum vitamin B12 and folate) from new 
participants. In addition, the exposure assessment item was not applicable for all the 
included studies according to the aim of the present review.  
 
2.3.1.3. Prevalence of vitamin B12 and folate insufficiency during pregnancy 
Studies in the review used different cut-off values to identify vitamin B12 
and folate insufficiency during pregnancy. About 50% of them used a cut-off value 
of < 148 or  < 150 pmol/l for vitamin B12 insufficiency, while the cut-off value used 
for folate varied between the studies. Furthermore, gestational age at blood 
collection varied from follow up at each trimesters to delivery time. Thus, the 
prevalence of vitamin B12 and folate insufficiency in this review are presented 
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separately for each trimester and delivery. In addition, the studies included in each 
trimester were ordered into continent, then the studies included in each continent 
were ascendingly ordered according to the cut-off level used. The data in this review 
was presented only when the sample size per trimester was ≥ 50. The results from 
each trimester, delivery vs. cord and during pregnancy were given as follows. 
 
2.3.1.3.1. Vitamin B12 and folate status at first trimester 
About 7 studies reported the level of vitamin B12 and folate at the first 
trimester. The overall prevalence of vitamin B12 insufficiency ranged from 0 
(Brabin et al. 1986) to 44.2% (Garcia-Casal et al. 2005). Africa, Australia, Europe, 
and South Asia showed a prevalence of 0, 5, 16 and 28.3% respectively. In addition, 
America showed a prevalence range between 5.2 to 44.2%. Furthermore, the overall 
prevalence of folate insufficiency ranged from about 11 (Jiang et al. 2005) to 39.5% 
(Garcia-Casal et al. 2005). South Asia, Australia and America showed a prevalence 
of 11, 26 and 39.5% respectively, while it was ranged between 25 to 28.6 in Africa 
(Table 2.8). 
 
2.3.1.3.2. Vitamin B12 and folate status at second trimester 
About 21 studies reported the level of vitamin B12 and folate at the second 
trimester. The overall prevalence of vitamin B12 insufficiency was ranged from 
0.35% (Pagán et al. 2002) to 73% (Katre et al. 2010). Australia, and the Middle East 
showed a prevalence of 25 and about 49% respectively. In addition, America, 
Europe, Africa, Asia and South Asia showed a prevalence range between 0.35 to 
58.8%, 15 to 35%, 6.1 to 14.4%, 1.5 to 46.1% and 42 to 73% respectively. The 
overall prevalence of folate insufficiency ranged from 0.2% (Yajnik et al. 2008) to 
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69% (Jacob et al. 1976). Note that Yajnik et al. used RBC folate to assess the folate 
level. The Middle East and Australia showed a prevalence of about 59.7 and 68% 
respectively, while it was ranged between 3.3 and 69% in America, 19.7 and 34% in 
Europe, 13.7 and 31.2% in Africa, 8 and 31% in Asia and 0.2 and 40% in South 
Asia. At the second trimester, the South Asian countries share a similar pattern of 
high serum vitamin B12 and low folate levels compared to other countries. In 
contrast, a study from Newfoundland and Kenya showed the opposite, low vitamin 
B12 insufficiency but high folate levels. Furthermore, Turkey showed high vitamin 
B12 and folate insufficiency (Table 2.9). 
 
2.3.1.3.3. Vitamin B12 and folate status at third trimester 
About 24 studies reported the level of vitamin B12 and folate at the third 
trimester. The overall prevalence of vitamin B12 insufficiency ranged from 0% 
(Brabin et al. 1986) to about 81% (Ackurt et al. 1995). The Middle East showed a 
prevalence of 80.9%, while Asia, Africa, Australia, America, Europe and South Asia 
showed a prevalence range between 0 to 16%, 0 to 23%, 12.3 to 20%, 2.1 to 69.2%, 
42.6 to 60% and 42.5 to 74.1% respectively. In addition, the overall prevalence of 
folate insufficiency was ranged from 0.2% (Yajnik et al. 2008) to 73% (Yusufji et al. 
1973). The Middle East showed a prevalence of 76.4%. In addition, the folate 
insufficiency was ranged between 2 to 43.8% in Africa, 10.1 to 35.5% in America, 
16.9 to 38% in Asia and 0.2 to 73% in South Asia. Similar to the second trimester, 
the South Asian countries had high vitamin B12 insufficiency and low folate levels 
compared to other countries, except in Yusufji et al. study (Yusufji et al. 1973) 
where both vitamin B12 and folate insufficiency were high (Table 2.10).   
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        Table 2.8: Shows the prevalence of vitamin B12 and folate insufficiency of the studies included in the review : at 1
st
 trimester 
Continent Reference Year Country No. of subject 
Serum B12 
cut-off level 
(pmol/l) 
%  of B12  
insufficiency  
Serum folate 
cut-off level  
(nmol/l) 
% of folate 
insufficiency 
Australia Whiteside et al. 1968 Australia 60 < 74 5 < 11.3 26 
America Ray et al. 2008 Canada 
   ≤ 28 days gest. 
   > 28 days gest. 
 
1244 
2490 
 
< 125 
 
5.2  
10.1  
 
N/R 
 
N/R 
 Garcia-Casal et al. 2005 Venezuela 
     19-25yrs 
 
86 
 
< 148 
 
44.2  
 
< 6.8 
 
39.5  
Europe Shield et al. 2011 Scotland 113 < 156  16 N/R N/R 
Africa Barbin et al. 1986 Kenya 
     Primipara  
     Multipara 
 
119 
172 
 
125 – 161 
 
0  
0  
 
< 4.5 
 
28.6  
25.0  
Asia Takimoto et al. 2007 Japan 51 < 148 N/R < 12 N/R 
South Asia Jiang et al. 2005 Nepal B12 data (1158)  
Folate data (1164) 
< 150 28.3  < 6.7 11.1  
N/R = not reported, N/M = not measured in the study, gest. = gestation 
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    Table 2.9: Shows the prevalence of vitamin B12 and folate insufficiency of the studies included in the review : at 2
nd
 trimester 
Continent References 
 
Year Country No. of subjects 
Serum B12 
cut-off level 
(pmol/l) 
%  of B12  
insufficiency 
Serum folate 
cut-off level  
(nmol/l) 
% of folate 
insufficiency 
Australia Whiteside et al. 1968 Australia 60 < 74 25 < 11.3 68 
America Jacob et al. 1976 Los Angeles B12 data (182)  
Folate data (300) 
< 74 
74 – 110 
0.5  
4  
< 6.8 
6.8 - 13.4 
18  
51  
House et al. 2000 Newfoundland 1424 < 130 
130- 160 
25.3  
18.3  
< 6 
6 - 7 
1.9  
1.4  
Knight et al.  1991 Washington DC 108 < 148 7  < 13.6 26  
Lowenstein et al. 1960 Canada 59 < 148 15.2  N/M N/M 
Pagan et al. 2002 USA 285 < 148 0.35  < 11 5 
 Garcia-Casal et al. 2005 Venezuela 
     19-25yrs. 
     26+yrs. 
 
243 
187 
 
<148 
 
58.8  
58.3  
 
< 6.8 
 
41.1  
29.4  
Europe Robert et al. 1973 England 320 < 118 35  < 13.6 34 
 Milman et al. 2006 Denmark 406 < 150 15  N/R N/R 
 Goedhart et al. 2011 Amsterdam B12 data (2921) 
Folate data (2622) 
< 185 20.1 < 19.2 19.7 
Africa Barbin et al. 1986 Kenya 
     Primipara  
     Multipara 
 
119 
172 
 
125 – 161 
 
6.1  
6.1  
 
< 4.5 
 
30 
31.2 
 Hinderaker et al. 2002 Tanzania 153 < 150  14.4 < 4.5 13.7 
Middle East Ackurt et al. 1995 Turkey 130 < 110.7 48.8 ≤ 1 .5 59.7 
Asia Marzan et al. 1971 Philippine 100 < 59 1.5  < 6.8 21 
 
 
Takimoto et al. 2007 Japan 77 < 148 8  < 12 31  
Park et al.   2004 South Korea 89 < 258 46.1 < 6.8 8 
South Asia Yajnik et al. 2008 India 638 < 150 60  < 28 † 0.2 
 Katre et al. 2010 India 163 < 150 73  < 7 1  
 Bondevik et al. 2001 Nepal 328 < 150 49 ≤  4.5 4.5 
 Lindstrom et al. 2011 Bangladesh 523 < 150 42  < 6.8 15  
 Li et al. 2008 Bangladesh 753 <185 60  < 9 40 
        N/R = not reported, N/M = not measured in the study, † RB  folate 
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       Table 2.10: Shows the prevalence of vitamin B12 and folate insufficiency of the studies included in the review : at 3
rd
 trimester 
Continent Reference 
 
Year Country No. of subjects 
Serum B12 
cut-off level 
(pmol/l) 
%  of B12  
insufficiency  
Serum folate 
cut-off level  
(nmol/l) 
% of folate 
insufficiency  
Australia Whiteside et al. 1968 Australia 60 < 74 20 < 11.3 54 
 Cole et al. 1974 South Australia B12 data (130) 
Folate data (136) 
< 148 12.3 <  6.8 26.5 
America Cook et al. 1971 Latin America 899 < 59 15.4 < 6.8 10.1 
 Knight et al.  1991 Washington DC 117 < 148 14  < 13.6 17  
Lowenstein et al. 1960 Canada 252 < 148 19 N/M N/M 
Pagan et al. 2002 USA 285 < 148 2.1 < 11 13 
 Garcia-Casal, et al. 2005 Venezuela 
     19-25yrs 
     26+yrs 
 
234 
204 
 
< 148 
 
69.2  
68.1  
 
< 6.8 
 
35.5  
30.9  
Europe Robert et al. 1973 England 119 < 118 48 < 13.6 N/R 
Milman et al. 2006 Denmark 406 < 150 42.6 N/R N/R 
 Shield et al. 2011 Scotland 77 < 156  60 N/R N/R 
Africa Barbin et al. 1986 Kenya 
     Primipara  
     Multipara 
 
119 
172 
 
125 – 161 
 
6.9 
0  
 
< 4.5 
 
24.1 
31.2 
 Vanderjagat et al.  2009 Nigeria 98 < 148 12.2  < 7.7 3.06 
 Gibson et al. 2008 Ethiopia B12 data (83) 
Folate  data (94) 
< 150 23 < 6.8 2  
 Colman et al. 1975 South Africa B12 data (106) 
Folate data (144) 
< 295 0.9 < 26 † 43.8 
Middle East Ackurt et al.  1995 Turkey 88 < 110.7 80.9 ≤ 1 .5 76.4 
Asia Marzan et al. 1971 Philippine 57 < 59 0  < 6.8 37.5 
 Takimoto et al. 2007 Japan 82 < 148 16  < 12 38  
Ma et al. 2004 China B12 data (512)  
Folate data (573) 
< 148 8.4  < 6.8 16.9  
South Asia 
 
 
Yusufji et al. 1973 India 492 < 103 52 < 13.6 73 
Pathak et al.  2007 India 266 < 148 74.1 < 6.8 26.3  
Yajnik et al. 2008 India 594 < 150 71 < 28 † 0.2 
Veena et al.   2010 India 536 < 150 42.5  < 7 4.1  
Krishnaveni  et al. 2009 India 780 < 150 43  < 7 4.0 
Christain et al. 2006 Nepal 173 < 150 69.9 < 6.8 22.5 
         N/R = not reported, N/M = not measured in the study, † RB  folate 
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2.3.1.3.4. Vitamin B12 and folate status at delivery 
About 15 studies reported the level of vitamin B12 and folate at delivery time; 8 
out of the 15 studies reported vitamin B12 insufficency in both the maternal and cord 
levels. The overall prevalence of maternal vitamin B12 insufficiency  ranged from 1.5% 
(Ho et al. 1987) to 88%  (Schulpis et al. 2004). Asia showed a prevalence of 1.5%, 
while Africa and South Asian showed a prevalence of 40% and about 59% respectively. 
In addition, vitamin B12 insufficiency was ranged between 1.8 and 72% in the Middle 
East, 15 and 88% in Europe and 23 and 75% in America. The overall prevalence of 
maternal folate insufficiency ranged from 0% (Giugliani et al. 1984) to 66.2% (Zachau-
Christiansen et al. 1962). Asia showed a prevalence of 1.5%, while it ranged between 0 
and 36% in America, 2.6 and 66.2% in Europe, and 12 and 47.2% in the Middle East. 
Moreover, the cord vitamin B12 and folate insufficiency were generally lower 
compared to the maternal level. (Table 2.11). 
 
2.3.1.4. Trends of vitamin B12 and folate insufficiency throughout pregnancy 
Thirteen studies reported the level of vitamin B12 and folate at 2 or 3 trimesters 
during pregnancy. The prevalence of vitamin B12 and folate insufficiency at the 3 
trimesters were only available in 3 studies. The trend of vitamin B12 and folate 
insufficiency per trimester varied between different countries as shown in Table 2.12.  
About 12 studies provided evidence of the prevalence of vitamin B12 and folate 
insufficiency generally during pregnancy. The prevalence of vitamin B12 insufficiency 
showed a higher range (0 to 61.3%) compared to folate insufficiency (0 to 36.3%) 
during pregnancy (Table 2.13).  
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    Table 2.11: Shows the prevalence of vitamin B12 and folate insufficiency of the studies included in the review : at delivery 
Continent References Year Country No. of subjects 
Serum B12 
cut-off level 
(pmol/l) 
%  of B12  
insufficiency 
Serum 
Folate cut-
off level  
(nmol/l) 
% of folate 
insufficiency 
 
Mother Cord Mother Cord 
America Baker et al. 1975 New Jersey 174 < 59 23 N/R < 9 36 N/R 
 Guerra-Shinohara et 
al. 
2004 Brazil 119 Mother < 132  
Placenta* < 194 
52.9  49.5* N/R N/R N/R 
 Knight et al. 1991 Washington 
DC 
 Mother/cord 
B12 data (101/99) 
Folate data ( 91/84) 
< 148 8  2  < 13.6 18  4  
 Giugliani et al. 1984 Brazil 51 < 165 21.6  N/M < 3 0 N/M 
 Barbosa et al. 2008 Brazil 275 < 179 75 N/M N/R N/R N/M 
Europe Zachau-Christiansen 
et al.  
1962 Denmark B12 data (365) 
Folate data (349) 
< 147 41.4 12.8 < 6.5 66.2 N/R 
 Frey et al 1992 France 188 < 148 27.6  N/R < 5.6 N/R N/R 
 Bjorke-Monsen et al. 2001 Norway Mother /cord 
(169/173) 
< 150 15  8 N/R N/R N/R 
 Schulpis et al. 2004 Athens 
    Greek  
    Albanian  
 
1025 
908 
< 170 
 
21.4  
88  
 
7.3  
72  
 
< 10.2 
 
2.6  
2.8  
 
0 
1.8  
Africa Osifo et al. 1976 Nigeria 50 < 148 40 20 N/M N/M N/M 
Middle 
East 
Abdelrahim et al. 2009 Sudan 55 < 110.7 1.8  N/M < 15 47.2  N/M 
Koc et al. 2006 Turkey 180 < 118 72  41  < 9.0 12 0 
 Hussein et al. 2009 Egypt 84 < 150 46.4  N/R N/M N/M N/M 
Asia Ho et al. 1987 Taiwan 198 < 125 1.5  N/M < 5.5 1.5  N/M 
South Asia Hall et al. 2007 Bangladesh B12 data (95) 
Folate data (99) 
< 185 58.9 N/R < 6.8 
< 9 
1  
10.1  
N/R 
N/R 
 N/R = not reported, N/M = not measured 
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   Table 2.12: Shows the trend of vitamin B12 and folate insufficiency of the studies included in the review : throughout pregnancy 
References Year Country 
No. of 
subjects 
Serum B12 
cut-off level 
(pmol/l) 
Prevalence of B12 
insufficiency  (%) per 
trimester 
Serum folate 
cut-off level  
(nmol/l) 
Prevalence of folate 
insufficiency (%) per 
trimester 
1st   2nd    3rd   1st   2nd   3rd   
Marzan et al. 1971 Philippine 250 < 60 s 1.5 0 < 6.8 s 21 37.5 
Whiteside et al. 1968 Australia 60 < 74 5 25 20 < 11.3 26  68 54 
Ackurt et al. 1995 Turkey 130 < 110.7 N/M 48.8 80.9 ≤ 1 .5 N/M 59 76.4 
Robert et al. 1973 England 322 < 118 N/M 35 48 < 13.6 N/M 34 N/R 
Barbin et al. 1986 Kenya 
Primipara  
Multipara 
 
119 
172 
 
125 - 161 
 
0 
0 
 
6.1 
6.1 
 
6.9 
0 
 
< 4.5 
 
0 
0 
 
1.5 
3.7 
 
0 
15.6 
Knight et al. 1991 Washington DC 600 < 148 s 7  14 < 13.6 s 26 17 
Lowenstein et al. 1960 Canada 345 < 148 s 15.2  19 N/M s N/M N/M 
Pagan et al. 2002 USA 285 < 148 N/M 0.35 2.1 < 11 N/M 5 13 
Garcia-Casal et al. 2005 Venezuela 
      19-25yrs. 
      26+ yrs. 
 
571 
449 
 
< 148 
 
44.2 
41.9 
 
58.8 
58.3 
 
69.2 
68.1 
 
< 6.8 
 
39.5 
44.2 
 
41.1 
29.4  
 
35.5 
30.9 
Takimoto et al. 2007 Japan 94 < 148 N/R 8 16 < 12 N/R 31 38 
Milman et al. 2006 Denmark 406 < 150 N/M 15 42.6 N/R N/M N/R N/R 
Yajnik et al. 2008 India 797 < 150 N/M 60 71 < 28 † N/M 0.2 0.2 
Shield et al. 2011 Scotland 190 < 156 28.3 N/M 60 N/R N/R N/M N/R 
Values present as % (n), N/R = not reported, N/M = not measured. s = small sample size, †RB  folate. 
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     Table 2.13 shows the vitamin B12 and folate insufficiency of the studies included in the review : generally during  pregnancy 
Reference Year Country No. of subjects Serum B12 
cut-off level 
(pmol/l) 
% of B12  
insufficiency in 
pregnancy 
Serum folate 
cut-off level  
(nmol/l) 
% of folate 
insufficiency in 
pregnancy 
Marzan et al. 1971 Philippine 187 < 59 0.8 < 6.8 24.7 
Black et al. 1994 Mexico 85 < 74 15  < 6.1 0  
Haliloglu et al. 2010 Turkey 68 < 99 0 < 6.8 0 
Srisupandit et al.  1983 Thailand 568 < 110 0 < 6.8 15.5 
Areekul et al. 1976 Thailand B12 data (150) 
Folate data (164) 
< 110 7.3  < 6.8 25.6  
Ipciglu et al. 2007 Turkey 186 < 133 53 N/R N/R 
Ball et al. 1964 UK 320 < 148 33  N/R N/R 
Garcia-Casal et al. 2005 Venezuela 1283 < 148 61.3 < 6.8 36.3  
Vanderjagat et al 2007 Nigeria 146 < 148 9  < 7.7 8.9  
Murphy et al. 2007 Spain 92 < 150 0 N/M N/M  
Shield et al. 2011 Scotland 190 < 156  33.7 N/R N/R 
Bruinse et al. 1995 Netherland 70 < 180 0 N/R  N/R 
       Values present as % (n), N/R = not reported, N/M = not measured
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2.3.2. Discussion 
This is the first systematic review investigating the worldwide prevalence of vitamin 
B12 insufficiency during pregnancy. Generally, the results supported our hypothesis 
that vitamin B12 insufficiency during pregnancy is not rare, even in a non-vegetarian 
populations. According to the assessment checklist criteria used in the present review, 
about half of the included studies were rated as high methodological quality studies; 
therefore it is unlikely that our conclusion is affected by bias from the included studies. 
The results of vitamin B12 insufficiency from generally known non-vegetarian 
population were varied: from 0% in Kenya at the first trimester (Brabin et al. 1986) to 
about 44% at the first trimester from Venezuela (Garcia-Casal et al. 2005), 60% at the 
second trimester from Bangladesh (Li et al. 2008), 81% at the third trimester from 
Turkey (Ackurt et al. 1995) and 88% at delivery time from the Albanian population 
(Schulpis et al. 2004). In addition, using the cut-off value of around < 148 pmol/l 
showed that the average prevalence of vitamin B12 insufficiency at the second trimester 
was 8%, 14%, 15%, and 28% in Asia, Africa, Europe and America respectively (with a 
total average worldwide prevalence of 16% at the second trimester), while at the third 
trimester, it was 12%, 18%, 34% and 43% in Australia and Asia, Africa, America and 
Europe respectively (with a total average worldwide prevalence of 24% at the third 
trimester). The Middle East showed a prevalence of 46% at delivery time. Generally, 
the prevalence of vitamin B12 insufficiency was 9% in Nigeria (Vanderjagt et al. 2007), 
33% in England (Ball and Giles 1964) and Scotland (Shields et al. 2011) and 61% in 
Venezuela (Garcia-Casal et al. 2005) during pregnancy. Similarly, the folate 
insufficiency was observed among the studies included in the review, although, the cut-
off value used to define the folate insufficiency was much varied compared to the 
vitamin B12. 
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Similar to an earlier report, the prevalence of vitamin B12 insufficiency (Stabler 
and Allen 2004) was low on the Asian continent and rated as least prevalent of vitamin 
B12 insufficiency, except in the Park et al. study from South Korea where it showed a 
high prevalence owing to the high cut-off level (< 258 pmol/l) used to define vitamin 
B12 insufficiency (Park et al. 2004). This could be related to the greater use of all forms 
of seafood and invertebrate and reptile animal foods as well as soy products, algae and 
fish sauces compared to other countries (Stabler and Allen 2004). Our review  was 
comprehensive, including all the publications reporting vitamin B12 levels during 
pregnancy including Northern American (US, Canada) and European. As expected, the 
high prevalence of vitamin B12 insufficiency was observed in studies from known 
vegetarian populations such as India and Nepal at both the second and third trimester, 
mostly with high quality on our assessment criteria (see Table 2.7), with an average 
prevalence of about 60%. Furthermore, the combination of low vitamin B12 and high 
folate levels were also observed in these studies, except in Yusufji et al. study where it 
showed high a prevalence of folate insufficiency (73%) (Yusufji et al. 1973). This is 
could be due to the high cut-off value used to define the folate insufficiency (< 13.6 
nmol/l), as well as because this study was published a long time ago before the 
recommendation of the preconception folic acid supplement started. Though such a 
combination is likely to be common mainly in a vegetarian population such as India, the 
prevalence of low vitamin B12 and high folate levels in this review were also observed 
in non-vegetarian population, particularly from American continent such as the studies 
from Newfoundland (43.6% vs. 3.3%) at the second trimester (House et al. 2000), from 
Mexico (15% vs. 0%) at about the third trimester (Black et al. 1994) and from 
Venezuela (61.3% vs. 36.3 %) throughout pregnancy (Garcia-Casal et al. 2005). In a 
subsample of the latter study from Mexico, a higher cut-off level of vitamin B12 
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insufficiency (< 149 pmol/l) was studied and a prevalence of 62% vs. 0% was observed 
(Allen et al. 1995). This could be related to the mandatory folic acid food fortification 
and/or the preconception folic acid supplementation in these countries. Even in 
countries such as the UK, where only voluntary folic acid fortification of cereals exists, 
the combination of low vitamin B12 and high folate levels was also observed in the 
general adult population 10.5% vs. 2.1% (Saravanan et al. 2010a) as well as in pregnant 
women 20% vs. 6% (Saravanan et al. 2010b). Therefore, the presence of maternal low 
vitamin B12 and adequate folate levels is becoming the main concern (Glew et al. 
2006). As previously discussed, folic acid insufficiency is increasingly rare, while the 
prevalence of vitamin B12 insufficiency has increased especially after the introduction 
of mandatory folic acid fortification. In addition, the NTDs attributable to vitamin B12 
insufficiency have tripled (Ray and Blom 2003; Ray et al. 2007). Furthermore, excess 
folic acid intake in the presence of maternal low vitamin B12 could contribute to the 
increased risk of chronic disease such DM and CVD in the offspring (Rosenberg 2008; 
Yajnik et al. 2008). The potential mechanism of the action of such imbalance was 
previously discussed in the Introduction (Chapter 1). Thus to understand the pattern of 
vitamin B12 status during pregnancy before and after the initiation of folic acid 
fortification, an average prevalence of low vitamin B12 from the included studies in the 
review, as well as other studies from Malaysia (0%), Venezuela (0%), Israel (22%), 
New Jersey (10%) and England (20%) (Diez-Ewald and Molina 1972; Ali et al. 1982; 
Pardo et al. 2000; Baker et al. 2002; Saravanan et al. 2010b) respectively, were plotted 
on a world map to demonstrate the presence of maternal vitamin B12 insufficiency, as 
well as to note the change in vitamin B12 level before and after the year 1997 (Figure 
2.2). The trend in wheat flour fortification with folic acid worldwide from 2004 to 2007 
was given in Appendix II). From the present review, vitamin B12 insufficiency before 
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and after the year of fortification ranged from 0 to 23% vs. 10 to 64% in America, 0 to 
41.4% vs. 15 to 88% in Europe, 0.9 to 40% vs. 12.2 to 23% in Africa, 49% vs. 1.8 to 
72% in the Middle East, 0 to 7% vs. 8 to 46% in Asia, and 52% vs. 49 to 60% in South 
Asia. 
In conclusion, this is the first systematic review that investigates the worldwide 
prevalence of vitamin B12 insufficiency during pregnancy. Much heterogeneity in the 
study’s methodology and  uality was observed. Mixed results were identified owing to 
the different cut-off levels used to define vitamin B12 and folate insufficiency. Despite 
the fact that the prevalence of vitamin B12 insufficiency varied between different 
countries, the overall results showed that vitamin B12 insufficiency is not rare during 
pregnancy, particularly in non-vegetarian populations. Moreover, the trend in vitamin 
B12 insufficiency change before and after folic acid fortification was difficult to 
identify owing to the limited number of studies included. However the trend of change 
in America can be observed. 
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Figure 2.2: Shows the prevalence of vitamin B12 insufficiency before & after folic acid fortification in 1997. Studies before 1997 
% in black colour, after 1997 % in brown colour at 1st or 2nd trimester, those with underline at third trimester or delivery 
41% 
22% 
Prevalence of vitamin B12 insufficiency 
Before & after Folic acid fortification (1997)  
8% 
33% 
88% 49% 
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20% 
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2.4 Systematic review (B)  
“Does maternal vitamin B12 level independently predict low birth weight?” 
 
2.4.1. Results  
 
2.4.1.1. Study characteristics 
A total of 189 articles were initially retrieved, along with several other cited 
references. Then, 19 full text articles were reviewed for more a detailed evaluation. Five 
articles were excluded because no mean levels of vitamin B12, folate, and BW 
(Bondevik et al. 2001), and gestational age (Martin et al. 1967) were reported and no 
statistical analysis (e.g. correlation, regression) were done between maternal vitamin 
B12 levels and BW (Glorimar et al. 2004; Milman et al. 2007; Wallace et al. 2008). 
Only 14 articles met the inclusion criteria (Figure 2.3). Details of the study populations 
and methods are presented in Table 2.14. The study population were from Australia 
(Whiteside et al. 1968), USA (Knight et al. 1991; Tamura et al. 1994), UK (Mathews et 
al. 2004; Relton et al. 2005), the Netherlands (Hogeveen et al. 2010), Norway (Hay et 
al. 2010), Turkey (Ackurt et al. 1995), South Africa (Mamabolo et al. 2006), Japan 
(Takimoto et al. 2007; Takimoto et al. 2011), and India (Muthayya et al. 2006b; Yajnik 
et al. 2008; Veena et al. 2010). The type of study design was not stated in (Whiteside et 
al. 1968; Tamura et al. 1994; Relton et al. 2005; Takimoto et al. 2007; Yajnik et al. 
2008), so we assigned their design accordingly depending on the method used for data 
collection in the study. Studies (Whiteside et al. 1968; Relton et al. 2005; Takimoto et 
al. 2007; Yajnik et al. 2008) followed the participants at different times during 
pregnancy, so we assigned a longitudinal type of study design accordingly.
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1991 potentially relevant articles identified in 
bibliographic database  (MEDLINE, Pub Med, 
EMBASE, CAB, Global health) from inception 
to July 2011, for title & abstract screening 
 
189  total article selected for further review & 
inspection 
 
1803 excluded due to failing to meet inclusion & 
exclusion criteria 
 
19  full text articles retrieved for more detailed 
evaluation 
170 excluded due to failing to meet criteria for 
any topic in full text 
 
14 full text articles included in the review and 
assessed for study quality 
5 articles were excluded because no mean 
vitamin B12, folate, birth weight, gestational age 
were mentioned or no statistical analysis (e.g. 
correlation, regression) were done between 
maternal vitamin B12 levels and birth weight. 
Inclusion Criteria: 
 Studies on normal adult pregnant 
women 
 Both mean vitamin B12 and folate 
levels mentioned. 
 Mean birth weight mentioned. 
 
Exclusion Criteria 
 Case-control studies that designed to 
look for LBW. 
 Adolescents’ pregnancy 
 Pregnancy and NTDs’ birth 
 Vitamin B12 and early pregnancy 
loss. 
 Vitamin B12 level measured at 
delivery time only. 
Figure 2.3: Flow diagram of studies included in the systematic review (B). All initial data searches and 
screening of titles and abstracts of identified studies were independently done for eligibility according to the 
pre-specified inclusion and exclusion criteria by 2 reviewers – agreement was (88.6%). 
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In contrary, in (Tamura et al. 1994) the participants were planned to be seen 
once during the study period, so we assigned a cross-sectional type of study 
accordingly. Furthermore, most investigations used a prospective observational study 
design (longitudinal study) where study subjects were followed at different times 
during pregnancy. Four studies followed the participants at three different points 
(first, second, and third trimesters) during pregnancy (Whiteside et al. 1968; 
Muthayya et al. 2006b; Takimoto et al. 2007) as well as delivery (Knight et al. 
1991). Another 3 studies followed the participants at 2 different points (second and 
third trimesters) during pregnancy (Ackurt et al. 1995; Mathews et al. 2004; Yajnik 
et al. 2008). One study measured the vitamin B12 level at the first trimester (Relton 
et al. 2005), 2 studies at the second trimester (Tamura et al. 1994; Hay et al. 2010) 
and 4 studies at the third trimester (Mamabolo et al. 2006; Hogeveen et al. 2010; 
Veena et al. 2010; Takimoto et al. 2011). The mean maternal age at enrolment 
ranged from 23.4 to 34.1 years (Tamura et al. 1994; Ackurt et al. 1995) respectively. 
Only 2 studies used primipara subjects (100%) (Knight et al. 1991; Mathews et al. 
2004). The mean gestational age at delivery ranged from 36.79 to 40.2 weeks 
(Knight et al. 1991; Mathews et al. 2004).  
Most studies determined the vitamin B12 level from blood samples using 
widely available methods such as microbiological assay (Whiteside et al. 1968; 
Yajnik et al. 2008; Hay et al. 2010; Hogeveen et al. 2010; Veena et al. 2010) or 
radioassay methods (Knight et al. 1991; Tamura et al. 1994; Ackurt et al. 1995) or 
enzyme immunoassay (Mathews et al. 2004; Relton et al. 2005) or 
chemiluminescence assay (Takimoto et al. 2007; Takimoto et al. 2011). In addition, 
only 2 studies reported clearly about vitamin B12 supplementation prior to blood 
sampling (Hay et al. 2010; Hogeveen et al. 2010). Some of the studies used iron 
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(Whiteside et al. 1968) and folic acid (Muthayya et al. 2006b; Yajnik et al. 2008) as 
routine practice, while the rest had mixed reported supplementation. 
 
2.4.1.2. Study quality assessment 
 
The NICE checklist criteria was used as discussed in the Method in all 
included studies to obtain comparable levels of methodological quality. The included 
studies differed substantially in the methodological quality (see Appendix V). Six 
studies (Mathews et al. 2004; Muthayya et al. 2006b; Takimoto et al. 2007; Yajnik et 
al. 2008; Hogeveen et al. 2010; Veena et al. 2010) met most of the quality 
assessment criteria, another 6 studies met some (Knight et al. 1991; Ackurt et al. 
1995; Relton et al. 2005; Mamabolo et al. 2006; Hay et al. 2010; Takimoto et al. 
2011), while only 2 studies met few of the assessment criteria (Whiteside et al. 1968; 
Tamura et al. 1994). Most of the studies reported a clear research question, defined 
target and study population, location, stated eligibility criteria, number of 
participants at the beginning of the study, issues of selection in to the study methods 
of data collection, type of analyses conducted, reported the absolute effect size and 
related their results back to the target population. While issues in consenting 
(number of consenters and reasons for non-consenting, comparisons of consenters 
with non-consenters in terms of baseline demographic or clinical features), reliability 
and validity of measurement method and loss to follow up and missing data account 
in to the analysis were poorly reported. The participant was justified only in one 
study (Mathews et al. 2004), while the relative effect size was only reported in the 
(Muthayya et al. 2006b) study. In addition, issues on the generalizability of the 
results was only discussed in (Ackurt et al. 1995; Yajnik et al. 2008) study. 
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Table 2.14: Shows the methodological overview of studies included in the review 
 
 
Country/ 
time period 
 
Subjects 
Age (years) 
Parity 
GA at delivery 
 GA at blood 
collection (n)  
Vitamin B12 
measurement 
method/ 
blood sample 
Use Supplement prior to blood sample 
References Study 
design 
B12 Folic acid Iron & other 
Whiteside et al., 
1968 
Australia 
 
L 60 pregnant N/A 12 wks. 
26 wks. 
38wks. 
MBA / Serum  N/A N/A Yes (as routine practice; 
ferrous sulphate, 200 mg, 
1-3 times per day) 
Knight et al., 
1991 
Washington, 
DC, USA 
1985 - 1990 
L  600 African 
American 
pregnant 
(16 - 35) 
PP 100%  
Group I (> 2500g) 
40.25 ± 0.08,  
Group II (< 2500) 
36.79 ± 0.45 
1 - 13 wks.(22) 
14 - 27 wks. (109) 
> 27 wks. (117) 
Delivery (101) 
RIA / Fasting 
serum  
N/A N/A 90% received iron & 
vitamin supplement 
Tamura et al., 
1994 
 
Birmingham, 
USA 
 
 
CS 76 pregnant 
(60 whites,  
16 black) 
 
N/A 17.1 ± 1.3 wks. 
(15 - 22 wks.) 
RA / Plasma  N/A 83% were taking 
prenatal suppl., 
providing 800-
1000µg folic acid/day 
N/A 
Ackurt et al., 
1995 
Turkey 
Feb - Dec 1991 
L 130 pregnant N/A  
PP 48%  
N/A 
13 - 17 wks. (130) 
28 - 32 wks. (88) 
RA / Non-
fasting 
plasma  
N/A N/A 35.4% were regularly 
taking iron and/or 
multivitamins, 6.1% took 
suppl. on a sporadic basis 
Mathews et al., 
2004  
 
Portsmouth, 
UK 
1994 - 1996 
L 798 pregnant 
(n = 661, 716)* 
25.4 ± 4.9 
PP 100% 
M 40.0 ± 1.4 
F 40.2 ± 1.4 
~ 16 wks. 
~ 28 wks.** 
EIA / Serum  N/A N/A N/A 
Relton et al., 
2005 
Cumbria, UK 
2000 - 2002 
L 998 pregnant; 
only 315 mother-
child pairs 
(n = 504, 683)* 
27.8 ± 5.83 
PP 43% 
N/A 
11.5 ± 5.8 wks. 
 
EIA / Non- 
fasting serum  
N/A N/A N/A 
Muthayya et al., 
2006b 
Bangalore, 
India 
2001 - 2003 
L 377 pregnant 
(n = 136, 139)* 
24.6 ± 4.1 
PP 58.9% 
N/A 
12.9 ± 3.3 wks. 
24.1 ± 2.0 wks. 
33.9 ± 1.2 wks. 
Delivery 
CIA / Fasting 
serum  
N/A Yes (as standard care, 
500µg folic acid) 
Yes (as standard care,  
60 mg iron) 
Data are presented as mean  ± SD (range), * number of the available sample for serum vitamin B12 & folic acid data (n= B12, folic acid), ** No data available on vitamin 
B12 at this time, GA = gestational age, N/A= Not Available, PP = primipara, M = male, F = female, MBA = microbiological assay, RIA = radioimmunoassay, RA = 
Radioassay, EIA = Enzyme immunoassay, CIA = Chemiluminescence assay. 
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    Cont. Table 2.14 
 
References 
Country/ 
time period 
 
Subjects 
Age (years) 
Parity 
GA at delivery 
GA at blood 
collection (n) 
Vitamin B12 
measurement 
method/ blood 
sample 
Use Supplement prior to blood sample 
Study 
design 
B12 Folic acid Iron & other 
Mamabolo et al., 
2006 
South Africa 
1999 - 2000 
L 219 pregnant  
8.8% GDM (1.5% 
GDM, 7.3% IGT) 
25.4 ± 7.0 
1.53 ± 1.86 
N/A 
28 - 36 wks. Immunoassay / 
Fasting serum 
N/A N/A N/A 
Takimoto et al., 
2007 
Tokyo, Japan 
2001 - 2003 
L 94 pregnant, only 39 
pregnant provide 
blood sample at all 3 
trimesters  
29 ± 4.7 
PP 77% 
39.6 ± 1.0 
7 - 14 wks. (51) 
26 - 29 wks. (77) 
34 - 36 wks. (82) 
CIA / Non-
fasting serum  
N/A Only 2 pregnant took 
folic acid at 1st 
trimester & 4 pregnant 
at 2nd trimester 
N/A 
Yajnik et al., 
2008 
Pune, Indian 
1994 - 1996 
L 700 pregnant 
653 children 
(n = 638, 618)* 
Median 21 [19,23] 
PP 31.6%  
N/A 
18 ± 2 wks. (638) 
28 ± 2 wks. (594) 
MBA / Fasting 
plasma  
N/A Yes (as a standard 
care, 500µg folic acid) 
started from 18 wks. 
Gestation 
Yes (as a standard care,  
60 mg iron) started 
from 18 wks. Gestation 
Hogeveen et al., 
2010 
Netherlands 
2002 - 2004 
L 366 pregnant and  
newborn 
33.3 (30.7 - 35.5) 
PP 48% 
39.7 (38.4 - 40.7) 
 
30 - 34 wks. MBA / Non-
fasting plasma  
No 
 
Yes (57%) N/A 
Hay et al.,  
2010 
Oslo, Norway 
Apr - Jun 
1997 
L 149 pregnant 
361 newborn 
29.9 ± 4.4 
PP 49.5% 
40.1 ± 1.2 
17 - 19 wks. 
 
MBA / Plasma  Yes 
 
Yes 
 
N/A 
Veena et al.,  
2010 
Mysore, India 
1997 - 1998 
L 674 pregnant 
536 children 
23.9 ± 4.2 
PP 50.8% 
39.3 ± 1.6 
30 ± 2 wks. MBA / Fasting 
plasma  
N/A N/A 29% women reported 
taking multi-vitamin at 
recruitment phase. 
Takimoto et al., 
2011 
Tokyo, Japan 
2007 - 2008 
L 42 pregnant;14 folic 
acid users vs. 19 
non-folic acid users 
33.1 ± 5 vs.  
32.7 ± 4.1 
PP 87.9% 
N/A 
3rd trimester CIA / Non-
fasting serum  
N/A Yes (14 women; 8 at 
1st trimester and 9 at 
2nd trimester)  
N/A 
Data are presented as mean  ± SD or median [interquartile range], * number of the available sample for serum vitamin B12 & folic acid data (n= B12, folic acid), GA = 
gestational age, N/A = Not Available, PP = primipara, MBA = microbiological assay, CIA = Chemiluminescence assay, IGT= Impaired Glucose Tolerance  
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2.4.1.3. Association between maternal vitamin B12 and BW 
The results of the association between maternal vitamin B12 and BW from the 
studies included in the review are presented in Table 2.15. Only 3 studies showed a 
significant correlation at the second trimester between vitamin B12 and BW.  In one 
study (Whiteside et al. 1968), vitamin B12 showed a positive correlation with BW after 
computing regression equation using iron, vitamin B12 and folate as independent 
variables and BW as dependent variable (p-value not reported). In the other study 
(Muthayya et al. 2006b), a low maternal vitamin B12 concentration through pregnancy 
was independently associated with the increased risk of IUGR after controlling for 
maternal age, parity, maternal education level, and body weight in early pregnancy, and 
after additionally controlling for weight gain in the second trimester. The higher the 
association was found at second trimester (p < 0.001). In contrast, Hay et al. found that 
birth weight was negatively associated with cord vitamin B12 (p = 0.02). In addition, a 
positive association between maternal holoTC and cord B12 (p < 0.0001) was found. 
No statistical correlation were made directly between maternal vitamin B12 and BW in 
this study (Hay et al. 2010). 
 
2.4.1.4. Association between maternal folate and BW 
The results of the association between maternal folate and BW from the studies 
included in the review are presented in Table 2.16. Five studies showed a significant 
positive correlation between folate and BW; at the first trimester (p < 0.001) (Relton et 
al. 2005), at the second trimester (Whiteside et al. 1968; Knight et al. 1991; Mathews et 
al. 2004) (p = n/a, 0.02, and 0.045 respectively) and at the third trimester (p < 0.05) 
(Veena et al. 2010). Only 1 study found a negative association between serum folate and 
BW (p < 0.01) at the third trimester (Takimoto et al. 2011). 
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Table  2.15: Results of the association between vitamin B12 & BW from the studies included in the review 
 
References B12 levels (pmol/l) per 
trimester 
BW (g) Association under study and effect size (per trimester) Variables controlled in 
multivariate analysis 
   1
st
 trimester 2
nd
 trimester 3
rd
 trimester  
Whiteside et al., 1968 1st:  217 
2nd: 127 
3rd: 115.1 
B12 < 73.8,          3250g 
B12 73.8-146.9,    3460g 
B12 ≥ 174,           3630g  
No significant  
association 
 
Positive correlation 
(combined with iron  
& folate), p = n/a 
No significant  
association 
 
Vitamin B12, folate, and 
iron. 
Knight et al., 1991 1st: 337.6 ± 23.9 
2nd: 340 ± 14.8  
3rd: 297 ± 11.4 
Normal       3274.4 ± 26.3 
Low            2159.9 ± 42.6 
No significant  
association 
 
No significant  
association 
 
No significant  
association 
 
Ferritin, folate, vitamin B12, 
and selected CBC data 
Tamura et al., 1994 
 
2nd:: 320 ± 130 3511 ± 536 
(2470 - 4790) 
N/R No significant  
association 
N/R N/A 
Ackurt et al., 1995 2nd: 140.8 ±105 
3rd: 94.6 ± 107.7  
3510 ± 560  N/R p > 0.05 P > 0.05 N/A 
Mathews et al., 2004  
 
2nd: 207.4 [121.8, 379.3]¹ M 3402 ± 489 
F 3285 ± 431 
N/R β = 0.024,  95%  I       
(- 0.22, 0.27),  p = 0.85 
N/A Maternal height, smoking 
Relton et al., 2005 1st: 239.1 ± 97.4 3430 ± 470  β = 0.0 , 95%  I  (- 0.05, 
0.12),  R² 0.001 , p=0.41 
N/R N/R N/A 
Muthayya et al., 2006b 1st : 115, 156, 224 2 
2nd : 113, 149, 210 
3rd : 111, 142, 181 
2400 ± 340 
 
 
 
2850 ± 450 
Adjusted OR (95% CI) 
5.98 (1.72, 20.74) 
P = 0.006 
 
N/A 
Adjusted OR (95% CI) 
9.28 (2.90, 29.68) 
p < 0.001 
 
N/A 
Adjusted OR (95% CI) 
2.81 (1.01, 7.87) 
p = 0.059 
 
N/A 
Maternal age quartile, 
education, parity, baseline 
(1st trimester) weight quartile  
 
N/A 
Mamabolo et al., 2006 3rd: 174.8 ± 76.6 3120 ± 550 N/R N/R No significant 
 Association 
N/A 
Values are mean or mean ± SD (range) or ¹median [5
th
, 95
th
 centile] or ² medians (interquartile range)  or ³median [25
th
 , 75
th
 centile] or ⁴geometric means (95% CI) or ⁵median, 
N/R = not relevant, (N/A, n/a) = not available, FA users = folic acid users, Non-users = non-folic acid users, † Whole blood folate, *RB  folate. 
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Cont. Table 2.15 
 
References B12 levels (pmol/l) per 
trimester 
BW (g) Association under study and effect size (per trimester) Variables controlled in 
multivariate analysis 
1
st
 trimester 2
nd
 trimester 3
rd
 trimester 
Takimoto et al., 2007 1st : 405 ± 146 
2nd : 301 ± 96 
3rd :265 ± 95 
3120 ± 411 Effect size - 1.05, 
p = 0.08 
Effect size - 5.349, 
 p = 0.38 
Effect size 0.776, 
p = 0.44 
Maternal age, pre-pregnancy 
BMI and parity 
Yajnik et al., 2008 2nd : 135 [103, 175]³ 
3rd : 122 [94, 160] 
2665 ± 358 ‡  N/R No significant  
association 
No significant  
Association 
N/A 
Hogeveen et al., 2010 3rd : 179 (134 - 219) 3425 (3075 - 3855) N/R N/R R = - 0.06, P > 0.15 Gestational age, smoking, 
and infant sex. 
Hay et al., 2010 2nd : 282  (269, 295)⁴ 3673 ± 455 N/R Negative association 
between BW and cord 
B12; Partial r = - 0.19,  
P = 0.021. 
Positive association 
between maternal 
holoTC and cord B12; 
Partial r = 0.50,              
P < 0.0001. 
N/R Maternal factors, newborn 
anthropometric data with P< 
0.1 by univariate analyses 
and maternal plasma vitamin 
indexes 
Veena et al., 2010 3rd :162.5 (124, 220)²  2873 ± 454 N/R N/R β = - 0.01,  95% CI         
(- 0.09, 0.06), P > 0.05 
 hild’s sex and current age 
Takimoto et al., 2011 3rd : FA users  
            262.6 ± 106 
       Non-FA users 
            288.8 ± 104.6  
 
2.894 ± 318 
 
3.154 ± 230 
N/R N/R No significant  
Association 
Maternal age, height, pre-
pregnancy BMI, weight gain, 
gestational length, and infant 
sex. 
Values are mean or mean ± SD (range) or ¹median [5th, 95th centile] or ² medians (interquartile range)  or ³median [25th , 75th centile] or ⁴geometric means (95% CI) or ⁵median, 
N/R = not relevant, (N/A, n/a) = not available, FA = folic acid, ‡ BW obtained from (Rao et al. 2001). 
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Table 2.16  Results of the association between folate & BW from the studies included in the review. 
 
References Folate levels (nmol/l) 
per trimester 
BW (g) Association under study and effect size (per trimester) Variables controlled in 
multivariate analysis 
   1
st
 trimester 2
nd
 trimester 3
rd
 trimester  
Whiteside et al., 1968 1st: 25.1 
2nd: 11.8 
3rd:19.0 
Folate < 11.3,      3430g 
Folate ≥ 11. ,       710g  
N/A Positive correlation 
(combined with iron & 
folate) p = n/a 
N/A Vitamin B12, folate, and 
iron. 
Knight et al., 1991 1st: 18.8 ± 2.0† 
2nd: 21.7 ± 1.4† 
3rd:24 ± 2.0† 
Normal    3274.4 ± 26.3 
Low         2159.9 ± 42.6 
No significant  
association 
Positive correlation  
WB folate & BW 
R²  0.21, p < 0.05 
No significant  
Association 
Ferritin, folate, vitamin B12, 
and selected CBC data 
Tamura et al., 1994 
 
2nd: 38  ± 1 3511 ± 536 (2470 - 
4790) 
N/R No significant  
association 
N/R N/A 
Ackurt et al., 1995 2nd:  13.3 ± 5.9 
3rd:  10.4 ± 6.5 
3510 ± 560  N/R p  > 0.05 p > 0.05 N/A 
Mathews et al., 2004  
 
2nd: 19.7 (10.2, 30.6) M 3402 ± 489 
F 3285 ± 431 
N/R Marginally  significant 
correlation 
β = 10. , 95%  I (25.5, 
20.4),  p = 0.045 
N/R Maternal height, smoking 
Relton et al., 2005 1st: 947.2* 3430 ± 470  β = 0.14, 95% CI (0.07, 
0.23), R² 0.021,  p < 0.001 
N/R N/R N/A 
Muthayya et al., 2006b 1st : 518, 745, 1028* ² 
2nd : 634, 888, 1235* 
3rd : 509, 824, 1228* 
2400 ± 340 
 
 
 
2850  ± 450 
Adjusted OR (95% CI) 
1.12 (0.66, 4.48)  
p = 0.25 
 
N/A 
Adjusted OR (95% CI) 
1.17 (0.39, 3.50) 
p = 0.76 
 
N/A 
Adjusted OR (95% CI) 
2.03 (0.46, 8.92) 
p = 0.36 
 
N/A 
Maternal age quartile, 
education, parity, baseline 
(1st trimester) weight quartile  
 
N/A 
Values are mean or mean ± SD or ¹median [5th, 95th centile] or ² median (interquartile range) or ³median [25th , 75th centile] or ⁴geometric means (95% CI), N/R = not relevant, (N/A, n/a) = not 
available, FA users = folic acid users, Non-users = non-folic acid users, † Whole blood folate, *RB  folate 
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Cont. Table 2.16 
 
References Folate levels (nmol/l) 
per trimester 
BW (g) Association under study and effect size (per trimester) Variables controlled in 
multivariate analysis 
1
st
 trimester 2
nd
 trimester 3
rd
 trimester 
Mamabolo et al., 2006 3rd :18.8 ± 11 3120 ± 550 N/R N/R No significant  
Association 
N/A 
Takimoto et al., 2007 1st : 23.2 ± 9.7 
2nd : 19.3 ± 23.8 
3rd :23.1 ± 69.3 
3120 ± 411 Effect size - 2.60,  
p = 0.80 
Effect size - 3.51,  
p = 0.36 
Effect size - 0.12,  
p = 0.87 
Maternal age, pre-pregnancy 
BMI and parity 
Yajnik et al., 2008 2nd : 874 [687, 1.106]* 3 
3rd : 961 [736, 1.269]* 
2665 ± 358 ‡ N/R No significant  
association 
No significant  
Association 
N/A 
Hogeveen et al., 2010 3rd : 9.1 (6.1 - 16.4) 3425 (3075 - 3855) N/R N/R R = - 0.04, p > 0.15 Gestational age, smoking, 
and infant sex. 
Hay et al., 2010 2nd : 7 (7, 8) 4 3673 ± 455 N/R No association between 
BW and cord folate 
 
N/R Maternal factors, newborn 
anthropometric data with P< 
0.1 by univariate analyses 
and maternal plasma vitamin 
indexes 
Veena et al., 2010 3rd : 34.7 ± 19.2  2873 ± 454 N/R N/R β =  .89, 95%  I (0.28, 
7.50), p < 0.05 
 hild’s sex and current age 
Takimoto et al., 2011 3rd : FA users  
                18.3 ± 7.5 
       Non-users 
                13.8 ± 7.7   
 
2.894 ± 318 
 
3.154 ± 230 
N/R N/R β = - 37.1, 95% CI (- 56.8, 
- 17.4), p < 0.01 
Maternal age, height, pre-
pregnancy BMI, weight gain, 
gestational length, and infant 
sex. 
Values are mean or mean ± SD or ¹median [5th, 95th centile] or ² median (interquartile range) or ³median [25th , 75th centile] or ⁴geometric means (95% CI), N/R = not relevant, (N/A, n/a) = not 
available, FA users = folic acid users, Non-users = non-folic acid users, *RBC folate, ‡ BW obtained from (Rao et al. 2001). 
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2.4.2. Discussion 
This is the first systematic review investigating the association between maternal 
vitamin B12 levels in blood and infant birth weight. Generally, the results did not 
support our hypothesis that the maternal vitamin B12 level independently predicts low 
birth weight. Although mixed results were found in the literature in the association 
between maternal vitamin B12 and BW: positive (Whiteside et al. 1968; Muthayya et 
al. 2006b) and negative association (Hay et al. 2010). The only evidence in favour of 
this came from the study by Muthayya et al with good quality on our assessment (see 
Appendix V). This study reported a relationship between low maternal vitamin B12 
status and the incidence of IUGR and of high significance at the second trimester. In 
fact, no statistical association was made between normal BW and maternal vitamin B12 
in this study. However, a sub-sample of 112 pregnant of the same population with mean 
BW (2900 ± 390 g) found that the maternal serum vitamin B12 concentration at each 
trimester increased with increasing BW. Though, these increases in maternal serum B12 
were only significant during the second trimester (p = 0.036) (Muthayya et al. 2006a). 
In addition, Whiteside et al with low quality on our assessment (see Appendix V) found 
a positive association between maternal vitamin B12 and BW particularly at the second 
trimester. This was reported to be mostly from the contribution of serum iron taken 
together with the vitamin B12 and folate which made a significant improvement over 
the results obtained if the serum iron level only was fitted into the regression equation. 
The authors indicated that deficiency of 1 or all the 3 nutrient levels may affect the 
foetus rate of growth in a deficient mother. Although, another study showed that 
maternal serum iron, folate, and vitamin B12 concentrations had no significant 
correlation with foetal BW (Yusufji et al. 1973). In contrast to Muthayya et al. and 
Whiteside et al., Hay et al. with relatively good quality on our assessment (see 
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Appendix V) showed an association in the opposite direction to what we expected: 
birth weight was negatively associated with cord vitamin B12 after controlling of the 
confounding factor, i.e. the heavier babies had the lowest vitamin  B12 status. Our 
expectation came from that vitamin B12 concentration in cord blood shown to be 
significantly higher than, but correlated to levels in the mother, at all trimesters of 
pregnancy (Monsen et al. 2001; Muthayya et al. 2006a). Furthermore, cord serum 
vitamin B12 levels were linearly associated with BW, such that increasing cord levels 
were associated with increasing BW (Muthayya 2009). 
Our results support the belief that increased BW are associated with high folate 
concentrations (Goldenberg et al. 1992). The role of folate in DNA synthesis and cell 
replication suggests that folate can influence foetal growth (Scholl and Johnson 2000). 
The influence of dietary and circulating folate on infant low birth weight was studied in 
832 women from the Camden Study (Scholl et al. 1996). It was reported that both low 
dietary and circulating folate at 28 weeks gestation was associated with a greater risk of 
low birth weight (Scholl et al. 1996). In our review, studies that showed the association 
between folate and BW did not clearly mention a folic acid containing supplement 
during pregnancy, except in the Takimoto et al. study where folic acid supplement users 
were compared with non-users in 33 healthy Japanese pregnancies at the third trimester. 
It was found that higher serum folate due to folic acid supplement with low vitamin B12 
status may affect foetal growth. However, this study used a small sample size (n = 33) 
and the proportion of low birth weight in folic acid users (14.2%) was unexpectedly 
higher compared to their national data (about 9%) (Takimoto et al. 2011). The 
imbalance between maternal vitamin B12 and folate level has been reported in known 
vegetarian populations (Bondevik et al. 2001; Yajnik et al. 2008) and their possible 
contribution to higher risks for chronic diseases has been discussed (Chapter 1). Even 
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though the Yajnik et al. study, with good quality assessment in our review, showed no 
association between maternal vitamin B12 and neonatal size, it allows analysis of the 
relationship between maternal nutritional status and mid- and late pregnancy and 
childhood outcomes at 6 years of age. Children born to mothers with higher erythrocyte 
folate but low serum vitamin B12 during pregnancy had a higher rate of insulin 
resistance and adiposity (Yajnik et al. 2008).  
The present review has several limitations: it included only published English-
languages studies. It is possible that either non-published data or data in other language 
exist which we did not identify. In addition, it included studies that measured vitamin 
B12 at different trimesters during pregnancy. Although, we are aware of several other 
published studies which also measured vitamin B12 level at delivery time only and 
correlated these levels with BW. However, the pattern of vitamin B12 during pregnancy 
decreased before 27
th
 week gestation and after that the levels were almost constant until 
delivery (Carretti et al. 1994). Furthermore, early-mid pregnancy has been found to be a 
time for significant association between BW and both maternal vitamin B12 and folate, 
thus could be a critical period for the foetal programing for development of disease in 
later life (Yajnik et al. 2008).  
In conclusion, the present review has highlighted much heterogeneity in the 
results of available observational studies of the association between maternal vitamin 
B12 and BW. Mixed results were identified. Studies included in the review differ 
substantially in study methodology and quality. Overall, the review did not support our 
hypothesis that low maternal vitamin B12 level independently predicts low birth weight.  
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Chapter 3 
 
Low vitamin B12 level is associated with maternal obesity and higher 
birth weight in GDM 
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3.1 Introduction 
As previously discussed on Chapter 1, the prevalence of DM is increasing dramatically 
worldwide (Shaw et al. 2010). More importantly, T2DM has been reported in adolescents 
and children, particularly in high prevalence populations (Alberti et al. 2004). One 
consequence of this is high incidence of GDM, which affects up to 14% of the pregnant 
population, approximately 135,000 women per year in the US (Jovanovic and Pettitt 2001). 
GDM seems to increase the risk of developing diabetes in the offspring of affected mothers 
(Pettitt et al. 1993). In addition, the intrauterine environment such as birth weight and 
maternal hyperglycaemia may possibly affect the development of T2DM among the young 
(Alberti et al. 2004). A prospective study found that the prevalence of IGT in the children of 
mothers with diabetes during pregnancy increased with time from 1.2% at < 5 years of age 
to 19.3% at 10 –16 years of age. This was compared with 2.5% at 10 –16 years of age in 
control subjects (Silverman et al. 1995). Furthermore, a U-shaped relationship between birth 
weight and risk of T2DM in later life was reported. A study on children aged 6 - 18 years in 
Taiwan showed that the risk of T2DM was lowest in those with a birth weight of 3 - 3.5 kg, 
and was signiﬁcantly increased in those children who had either low (< 2.5 kg) or high (> 
4.0 kg) birth weight, despite adjustment for other factors, including gestational diabetes, 
family history of diabetes, and socioeconomic status (Wei et al. 2003). In Pima India, a 
follow-up study of infants born during 1940 - 72 showed that the prevalence of DM was 
greatest in those with the lowest and highest birth weights. The age-adjusted prevalence for 
BW < 2500 g, 2500 - 4499 g, and ≥ 4500 g were  0%, 17% and  2%, respectively 
(McCance et al. 1994).  
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Thus, the intrauterine environment is a critical period in human life. The 
development of many organs, particularly brain, adipose and muscle tissue, occur during a 
limited time in this period.  The concept is that the environmental exposures in utero during 
certain phases of development will result in permanent changes in the organism (Strauss 
1997). Maternal nutrition during the intrauterine period is a factor that could affect foetal 
development and growth (Godfrey and Barker 2000). Infants exposed to malnutrition in 
early pregnancy are more likely to be obese in later life. Similarly, children exposed to 
hyperglycaemia in utero are also more likely to develop insulin resistance and obesity during 
childhood. The mechanisms underlying these changes are not understood (Strauss 1997).  
The PMNS was the first study in India to investigate the relationship between 
maternal nutrition and offspring risk of T2DM. It is the first to report an association between 
maternal intake (green leafy vegetables, milk, and fruit) and biomarkers (erythrocyte folate 
and serum vitamin C) and infant size at birth (Rao et al. 2001). Also, it reported that low 
vitamin B12 is common while folate insufficiency is rare in the Indian population (Yajnik et 
al. 2006). Further investigation found that low maternal vitamin B12 is related to higher 
incidence of GDM (Krishnaveni et al. 2009), higher adiposity and insulin resistance in 
offspring (Yajnik et al. 2008) and future T2DM in mothers (Krishnaveni et al. 2009). The 
population in the above study is known to be lacto-vegetarian with infrequent meat 
consumption. It is not known whether similar phenomena exist in a non-vegetarian 
population such as the UK population. Therefore, we aimed to study the vitamin B12 status 
in pregnancy and investigate its relationship with maternal BMI, incidence of GDM and BW 
in women with and without GDM. 
3.2 Materials and Methods 
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3.2.1 Study population 
This is a retrospective study of mothers attending the antenatal diabetes and medical 
obstetrics clinics in a district general hospital in Warwickshire, UK between 2005 and 2010. 
Patients attending these clinics are mainly UK Caucasian population. As part of routine 
practice, maternal vitamin B12 and folate levels were checked for most women. Also, it was 
routine for general practitioners and obstetricians to prescribe a folic acid supplement of 400 
µg/day to pregnant women. Any pregnant woman giving birth to live and singleton babies 
were eligible for the study. In addition, ethics approval from the hospital was obtained to 
conduct this study.  
 
3.2.2 Data collection 
A pre-designed questionnaire was used for data collection (see Appendix VI). 
Personal information such as BMI at booking, gravidity and parity, history of pre-eclampsia, 
history of GDM, other obstetrics and medical history, family history of chronic diseases, 
used medication, smoking status and use of alcohol was obtained from the medical notes for 
each woman. Information about folic acid supplements and vitamin B12 injections was also 
obtained, in addition to the delivery information, such as date of delivery; weeks of 
gestation; mode of delivery; sex of the baby and infant weight; length; and head 
circumferences (when available). 
Maternal vitamin B12 and folate levels were collected from the medical notes and 
biochemistry laboratory. From 2005 to 2009, the haematology lab was using the 
immunoassay technique (Beckman Access analyser) to determine the level of serum vitamin 
B12 and folate. For the samples collected between 2009 and 2010 in the hospital, 
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electrochemiluminescence immunoassay and binding assay (Elecsys and cobas e 
immunoassay analysers, Roche Diagnostics, USA) were used to determine the level of 
vitamin B12 and folate respectively. As there is no specific cut-off level for vitamin B12 and 
folate during pregnancy, low vitamin B12 was defined as a concentration of < 150 pmol/l as 
widely used in many studies (Bondevik et al. 2001; Yajnik et al. 2008; Vanderjagt et al. 
2009; Veena et al. 2010; Goedhart et al. 2011) and folate < 9 nmol/l based on the lower limit 
of the normal level used by the hospital lab.  
 
3.2.3 Statistical analysis 
All statistical analyses were performed using the SPSS programme version 18.0 
(SPSS Inc., Chicago, IL, USA). The analysis focused on the assessment of serum vitamin 
B12, serum folate, incidence of GDM and infant BW for a pregnant born singleton, live 
baby. Sociodemographic factors considered in the analysis were age, BMI at booking, 
gravidity, parity, gestational age at delivery and smoking status. The data were expressed in 
mean ± SD or median [interquartile range] unless otherwise stated. Of the overall 
population, 61 did not have vitamin B12 and folate levels checked during the pregnancy, 
therefore 209 (77.4%) were included for purposes of vitamin B12 related analysis. To 
compare the quantitative variables between the groups, Anova table was used, while Chi  
square (ᵡ2) was used to compare the categorical data. The p-value of less than 0.05 was 
considered significant. Stepwise linear regression was used to identify factors that were 
independently associated with low vitamin B12 level.   
 
3.3 Results 
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3.3.1 Study characteristics 
The total number of pregnancies studied is 303. Of which, 17 cases were excluded 
because of incomplete notes, or twin pregnancy or stillbirth. From the 286 pregnancies, 16 
mothers had pre-existing T1DM and T2DM. Of the 270 mothers who met the inclusion 
criteria, 60 of them had a diagnosis of GDM (22.2%). Vitamin B12 and folate levels were 
measured in 171/210 women with a normal pregnancy and 38/60 women with GDM at 
median 24 weeks of gestation (Figure 3.1).  
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1: Gives an overview of the participants included in the study 
 
 
As expected, GDM mothers were older than non-GDM (33.5 vs. 30.5 years, p < 
0.001), had higher BMI (31.0 vs. 26.1, p < 0.0001) and lower gestational age at delivery 
(38.4  vs. 39.5, p < 0.001). Birth weight was not statistically different between the GDM and 
303 pregnant studied 
286 pregnant  
Excluded 17 cases; incomplete 
notes, twin pregnancy, 
stillbirth. 
270 pregnant  
Exclude 16 cases have pre-
existing T1DM and T2DM 
GDM = 60 
  
non-GDM = 210 
  
GDM = 38 
  
non-GDM = 171 
  
Vitamin B12 & folate data 
available on 209 pregnant 
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the non-GDM group (3426.4 ± 426.3 vs. 3407.9 ± 568.8. p = 0.81). Only 14% of the total 
sample were smokers (Table 3.1). 
 
Table 3.1: Characteristics of the pregnant subjects who participated in the study 
 All 
(n = 270) 
GDM 
 (n = 60) 
Non-GDM  
(n = 210) 
P-
value 
Age (years)(years) 31.2 ± 5.84 33.5 ± 4.98 30.5 ± 5.91 < 0.001 
BMI at booking 
(kg/m
2
) 
27.2 ± 6.25 
*(n = 253)  
31.0 ±  6.21 
*(n = 58)  
26.10 ± 5.82
 
 
*(n = 195) 
< 0.001 
Gravidity 2.50 ± 1.41 2.25 ± 1.17 2.58 ± 1.49 0.11 
Parity 1.04 ± 1.07 0.88 ± 0.88 1.09 ± 1.12 0.20 
GA at delivery 39.2 ± 1.63 38.4 ± 1.15 39.5 ± 1.67 < 0.001 
BW (g) 3412.1 ± 539.7 3426.4 ± 426.3 3407.9 ± 568.8
 
 0.82 
Smoking status 
     non-smoker 
     smoker 
 
231 (85.9%) 
38 (14.1%) 
 
52 (86.7%) 
8 (13.3%) 
 
179 (85.6%) 
30 (14.4%) 
 
Vitamin B12 (pmol/l) 143.9 [106.3,191.5] 129.9 [92.9,174] 143.9 [106.3,195.6] 0.26 
      < 150 pmol/l  115 (55%) 
*(n = 209) 
22 (57.9%) 
*(n = 38) 
93 (54.4%) 
*(n = 171) 
 
Folate (nmol/l) 15.9 [10.0, 25.6] 15.2 [10.6, 25.1] 16.1 [10.0, 26.3] 0.77 
     < 9 nmol/l 45 (21.8%) 
*(n = 207) 
9 (24.3%) 
*(n = 37) 
36 (21.3%) 
*(n = 169) 
 
Values presented are mean ± SD or median [IQR] or no. (%),   
* available no. for specific data   
 
 
 
3.3.2. Vitamin B12 and folate status during pregnancy 
Of the total sample, the median [IQR] for vitamin B12 and folate levels were 143.9 
[106.3, 191.5] pmol/l and 15.9 [10.0, 25.6] nmol/l respectively (Table 3.1). At a mean of 24 
weeks gestation, the mean vitamin B12 level was 167.7 pmol/l (Data is not shown). The 
proportion of women with vitamin B12 levels < 150 pmol/l was 115/209 (55%). In addition, 
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approximately 58% of the GDM group had low vitamin B12 compared to the 54% of the 
non-GDM group (Figure 3.2). Moreover, low folate level was higher among the GDM 
group (24%) compared to the non-GDM group (21%) (Table 3.1). 
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Figure 3.2: The proportion of vitamin B12 in the studied sample 
 
The proportion of pregnant women with vitamin B12 < 150 pmol/l and folate < 9 
nmol/l were 35/115 (30.4%), while the proportion of those pregnant with vitamin B12 < 150 
pmol/l and folate > 9 nmol/l were 80/115 (69.6%) (Figure 3.3). A significant proportion of 
the women with vitamin B12 < 150 pmol/l had co-existent folate deficiency compared to 
those with vitamin B12 > 150 pmol/l (30.4% vs. 11.0%, OR 3.54 (95% CI 1.64 - 7.64), p < 
0.001. Mothers with vitamin B12 insufficiency had a folate concentration 9.2 nmol/l less 
than those without insufficiency (p < 0.001). 
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Figure 3.3: Folate status among vitamin B12 sufficient and insufficient mother 
 
3.3.3 Maternal vitamin B12 and BW 
GDM women with low vitamin B12 had an infant 37 g heavier than GDM women 
with normal vitamin B12 levels, although this difference did not reach the significant level 
(p = 0.80) (Table 3.2). 
 
 
Table 3.2: Neonatal BW associated with maternal vitamin B12 levels 
 GDM  
(n = 38) 
Non-GDM         
(n = 171) 
B12 < 150 pmol/l   82  ± 54  
(n = 22) 
  96 ± 55  
(n = 9 ) 
B12 ≥ 150 pmol/l   45 ± 2 1 
(n = 16) 
  69 ± 618 
(n = 78) 
               Values presented are mean ± (SD) standard deviation 
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3.3.4 Maternal association with low vitamin B12 
  ompared to vitamin B12 levels ≥ 150 pmol/l, women with low vitamin B12 (< 
150 pmol/l) were not significantly different in age (31.2 vs. 31.5, p = 0.71) but had a higher 
BMI at booking (28.0 vs. 25.7, β = - 0.171, p = 0.013); controlled for age, smoking, folate 
and presence of GDM (Table 3.3). Women who developed GDM had lower vitamin B12 
level (129.9 vs. 143.9 pmol/L, p = 0.26) though this was not statistically significant (Table 
3.1). Similarly, a non-significant difference was seen in the proportion of women with low 
vitamin B12 developing GDM (19.1 vs. 17%, p = 0.42) (Table 3). GDM mothers with 
vitamin B12 levels below the median had heavier babies (3522 vs. 3211g, p = 0.025). This 
difference persisted even after controlling for folate levels, gestation age at birth, maternal 
age, smoking and BMI at booking ( = - 0.39, p = 0.017). No such difference was seen for 
non-GDM mothers (3421.8 vs. 3345.8g, p = 0.395). 
 
 
 
Table 3.3: Maternal association with low vitamin B12 
 B12  < 150 pmol/l   
(n = 115)      
B12 ≥ 150 pmol/l  
(n = 94)          
Age (years)  1.2 ± 6.0  1.5 ± 5.6 
Pre-pregnancy BMI (kg/m2) 28.0 ± 6.0 † 
*(n = 10 ) 
25.7 ± 6.7† 
*(n = 9 ) 
Prevalence of GDM 22 (19.1%)  16 (17%) 
    Values presented are mean ± (SD) or no. (%), *available no. for BMI data,                                                                             
    †( β = - 0.171, p = 0.013) controlled for age, smoking, folate, and presence of GDM 
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3.4 Discussion 
In this study, we observed a high prevalence of low vitamin B12 and a relatively lower 
prevalence of folate insufficiency in pregnant women attending one general hospital in 
Warwickshire. This result is consistent with the result from the UK population which 
showed higher low vitamin B12 and lower folate insufficiency in early pregnancy compared 
to age-matched control non-pregnant women (20% vs. 4% and 6% vs.13% respectively 
(Saravanan and Yajnik 2010). Earlier studies supported the presence of vitamin B12 
insufficiency during pregnancy in a Caucasian population (Ball and Giles 1964; Frery et al. 
1992; Koebnick et al. 2002; Garcia-Casal et al. 2005; Milman et al. 2006). However, the 
percentage of vitamin B12 insufficiency varied from one study to another. The median folate 
level in this study was within the normal limit. This is likely due to the routine folic acid 
supplement (400µg /day) with the intention of preventing NTDs. Furthermore, folate 
insufficiency was higher among the GDM group compared to the non-GDM group. In 
addition, GDM pregnant women had both lower vitamin B12 and folate levels compared to 
non-GDM pregnant women. However, the difference did not reach significant levels. This is 
consistent with other studies, where vitamin B12 and folate levels were lower in the GDM 
group compared to the control pregnant group (Seghieri et al. 2003; Hassan et al. 2008). The 
proportion of pregnant women with low vitamin B12 and high folate (67%) was higher 
compared to low vitamin B12 and normal/low folate (33.0%). A study in pregnant Greeks 
and Albanian immigrants observed a high prevalence of low vitamin B12 and a lower 
prevalence of folate insufficiency at delivery particularly among the Albanian pregnant 
women (Schulpis et al. 2004).  
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Low vitamin B12 concentration in our study appeared to be associated with maternal 
BMI and a possible higher incidence of GDM after controlling for age, smoking, folate and 
the presence of GDM. This is consistent with the other result, where lower vitamin B12 
levels were associated with higher maternal adiposity and GDM was twice as frequent in 
women with low vitamin B12 compared with normal level (Krishnaveni et al. 2009). 
Moreover, GDM women with low vitamin B12 had heavier babies compared to GDM 
women with normal vitamin B12 levels. However, previous studies observed no significant 
association between maternal vitamin B12 insufficiency and birth size (Yajnik et al. 2005; 
Yajnik et al. 2008).  
As this study has been done in an almost entirely Caucasian population, which is 
generally known to be non-vegetarian, we did not expect to find a high prevalence of 
maternal vitamin B12 insufficiency. However, one possibility could be the increase of 
vegetarianism within the UK, which has become more popular, with the current estimate of 
3% of the population eating a vegetarian diet (The Vegetarian Society 2011). People tend to 
be vegetarian as a good option to be healthy and to avoid metabolic diseases. This diet, 
though, should be well planned, in order to be nutritionally adequate and provide health 
beneﬁts in the prevention and treatment of some diseases (Messina and Burke 1997). 
Another possibility could be the poor of quality food intake, rich in energy but less so in 
micronutrients which could contribute to low vitamin B12 and obesity (Krishnaveni et al. 
2009). High prevalence of low micronutrients among overweight and obese adults has 
previously been observed. This may be as a result of inadequate nutrient intake and/or 
alteration in nutrient absorption or metabolism (Kimmons et al. 2006). This could give some 
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explanation to what we observed in our study, association between maternal vitamin B12 
insufficiency and adiposity.  
In addition, the combination of low vitamin B12 and adequate/high folate 
concentration and its relationship to insulin resistance and prevalence of GDM has been 
previously reported (Krishnaveni et al. 2009). The plausible biochemical reasons why low 
vitamin B12 could increase adiposity and insulin resistance, particularly in the presence of 
adequate/high folate has been discussed in the PMNS study (Yajnik et al. 2008). Vitamin 
B12 insufficiency will trap cellular folate as 5-methyltetrahydrofolate (Scott 1992). This will 
prevent the formation of methionine from homocysteine and thus impair protein synthesis 
and reduce lean tissue deposition. In addition, MM-CoA mutase, for which vitamin B12 acts 
as a cofactor, is required for the degradation of odd-chain fatty acids and branched-chain-
amino acids, in particular the conversion of MM-CoA to succinyl-CoA. In the presence of 
vitamin B12 insufficiency, an accumulation of MMA will occur and may increase 
lipogenesis and insulin resistance (Yajnik et al. 2008). 
The limitation of this study is that it is retrospective and observational study done in 
a selected clinic population (medical obstetric clinic). Therefore, causality cannot be 
ascertained. However, this is the first study to show the possible interaction between low 
vitamin B12 levels, GDM, and their additive influence on BW. Finally, vitamin B12 and 
folate concentrations are difficult to interpret in pregnancy and there is no agreed cut-off 
level for deficiency, thus we assigned the cut-off level based on the previous published 
studies and the lower limit of the normal range from the hospital lab respectively.  
In conclusion, this study showed that vitamin B12 insufficiency is not rare in the UK 
Caucasian population. It is associated with maternal obesity, possible higher incidence of 
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GDM and macrosomia in GDM. Therefore, adequately powered prospective studies are 
urgently needed on the influence of early pregnancy vitamin B12 levels on the risk of GDM 
and neonatal outcomes. 
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Chapter 4 
Validation of a modified  Semi-Food Frequency Questionnaire for use in 
Saudi Arabia 
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4.1 Introduction 
The prevalence of obesity is increasing worldwide and the rate of increase is particularly 
rapid in Saudi Arabia (World Health Organization). Genetic and environmental factors 
such as diet and lifestyle have been the main factors that lead to obesity and related 
metabolic diseases such as DM, hypertension, and cardiovascular diseases. Environmental 
factors are likely to be the major contributors for such a rapid increase as genetic changes 
tend to take longer (Al-Othaimeen et al. 2007).  
Lifestyle, physical activity, food consumption patterns and dietary habits have 
changed markedly during the past few decades. In fact, the Eastern Mediterranean region 
showed an increase in per capita energy and fat intake in all countries. This is probably due 
to the high consumption of foods rich in fats and calories and a sedentary lifestyle which 
may play an important role in the rise in the prevalence of obesity and chronic diseases in 
this region. It is particularly true that there has been a huge shift from traditional foods to 
more westernized foods, which are characterized by high fat, high cholesterol, high sodium 
and low fibre. For instance, the daily per capita fat showed an increase in most countries, 
ranging from 13.65% in the Sudan to 143.3% in Saudi Arabia (Musaiger 2002; Musaiger 
2004). Studying the relationship between food consumption patterns and dietary habits in 
the Saudi population is likely to provide huge insights into understanding the recent rapid 
changes in food habits. 
Food habits and dietary intakes can be studied using different dietary assessment 
methods. The common methods used to assess an individual’s dietary intake are a food 
record, a 24 hours food recall, and a Food Frequency Questionnaire (FFQ). A 24 hours 
food recall or diet record methods are based on foods and amounts actually consumed by 
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an individual on one or more specific days, while an FFQ is based on an individual’s 
perception of the usual intake over a less precisely defined period of time. Thus, a food 
record could estimate an absolute rather than relative intake compared to an FFQ. 
However, they are expensive, time- consuming, and not representative of the usual intake 
as only a few days are assessed. In addition, they need a skilled and trained interviewer and 
a cooperative participant to obtain accurate and complete information (Buzzard 1998; 
Willett 1998). The major strength of the 24 hours food recall method compared with a food 
record is that it does not require literacy, which is an important factor in obtaining a 
representative sample of a population (Buzzard 1998). 
An FFQ is the most commonly used method to assess eating habits and to rank an 
individual’s energy and nutrients intake. It is a preferable dietary assessment tool in many 
epidemiological studies to relate diet and chronic diseases because of its ability to estimate 
a long-term dietary intake. In addition, it is  practical, easy to administer on a large sample 
and relatively inexpensive (Willett et al. 1985; Block et al. 1986). It is recommended that 
an FFQ should be validated in a specific population prior to its wider use in that population 
because of likely differences in diet between populations (Willett and Lenart 1998). 
However, it is impossible to evaluate the validity of an FFQ in the true sense due to lack of 
a “gold standard” method. As Willett and Lenart described, “The validity of one method 
can only be evaluated relative to another method of unknown but supposedly higher 
validity, i.e. only the 'relative validity' can be estimated” (Willett and Lenart 1998). Many 
studies have examined various food frequency methods by comparing the concordance of 
food frequency responses with reference instrument such as multiple 24 hours food recall 
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or diet record to estimate correlations between nutrient intakes measured by the FFQ and 
the actual intake (Thompson and Byers 1994).   
The calculation of the daily intake from an FFQ is normally done in two ways: 
asking the participants to record how often on average they have eaten the food items each 
week/month and to report the usual portion sizes for each food item (known as FFQ);. (e.g. 
How often do you eat white fish? Then how many grams do you have per day?) or to assign 
pre-specified standard portion sizes (known as semi-quantitative FFQ- SFFQ) for each food 
item; (e.g. How often do you have jam/honey on bread?). While the information about 
portion sizes in an FFQ is important in measuring the differences in food intakes, the 
assignment of an overall portion size is recommended to facilitate data collection
 
(Noethlings et al. 2003). Indeed, asking frequency alone provides a good estimate of 
relative consumption (Samet et al. 1984). Results from several studies (Samet et al. 1984; 
Hunter et al. 1988; Noethlings et al. 2003) have shown that omitting separate questions on 
portion size in an SFFQ is preferable, particularly in large epidemiological studies where an 
FFQ should be kept simple and easy to administer. Hunter et al. found that the day-to-day 
variation in portion size, for the same individual, was much larger than the variation in 
portion size between individuals. These results suggest that using standard portion sizes 
instead of an individual’s own-estimate may not necessarily introduce a larger error 
(Hunter et al. 1988). 
In Saudi Arabia, most of the studies conducted used either a one day 24 hours food 
recall (Al-Shoshan 2007a; Al-Shoshan 2007b) or an FFQ that was developed and validated 
in a different population (Abalkhail 1998; Alissa et al. 2007). To our knowledge, there is no 
precedent for developing an FFQ that suits a Saudi population, apart from one study which 
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used an SFFQ to specifically measure the intake of vitamin A with its relevant biomarker 
(Alissa et al. 2005) and hence was only validated for vitamin A. 
This study has been aimed at modifying and developing an SFFQ that was validated 
in a different population to suit a Saudi population. The performance of the modified SFFQ 
is then validated in a pilot study by comparing daily nutrient intake obtained from the 
frequency questionnaires (SFFQ and FFQ) with those derived from three days of 24 hour 
food recall (24 h FR). 
 
4.2 Materials and methods 
4.2.1 Study population 
This study was carried out in a group of volunteer women from members working 
in the UDC as well as living in Riyadh city in the Kingdom of Saudi Arabia (KSA) in 
2008-2009. A total of 46 apparently healthy, aged between 18 and 45 years, non-smoking 
Saudi women, without any significant medical problems nor taking any medication, 
participated in this pilot study. Permission was obtained from the UDC to conduct this pilot 
study on their staff with institutional research ethics committee approval. Consent was 
obtained from all the participants. 
In order to have a socio-demographic characteristics overview on the collected 
sample, information on education level, occupation, total family monthly income, use of 
dietary supplements, and level of physical activity during work and leisure time were 
collected by using a standardized self-administered questionnaire. Participants’ height and 
weight were measured by a trained dietician to calculate participants’ basal metabolic rate 
(BMR). 
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4.2.2 Dietary assessment tools 
The dietary information was obtained from the participants by a qualified dietician 
in order to assess their intake of different macro- and micronutrients by using two main 
methods. All dietary methods were always obtained in the same order for all participants. 
The difference between the dietary assessment methods used in the study is shown in Table 
4.1. 
 
4.2.2.1 First: Food Frequency Questionnaire 
The Food Frequency Questionnaire used is a validated food intake questionnaire - 
DIETQ000037 (Tunuviel Software 2001-2007) with a few modifications made to suit the 
Saudi food dietary intake.  These modification were: additional food items added to the 
questionnaire from traditional Saudi dishes as well as other commonly used food items 
(Appendix VII). Food items not used in Saudi Arabia were deleted (such as pork, ham, 
alcoholic beverages, etc.). The final modified questionnaire included 112 questions about 
different food items, which is comparable to the usual size of the FFQs (ranging between 
100 and 150 food items)
 
(Willett 1994).  
The modified Food Frequency Questionnaire then was used to ask the participant to 
record how often on average they had eaten the individual food items each week over the 
previous months. Nine possible answers were given for each item namely:  once to seven 
times per week, every two to three weeks (fortnight (F)), or rarely– never (R) (see 
example). Each food item was assigned a portion size employing commonly used units 
where possible (for example, a slice of bread or a teaspoon of sugar or a slice of cheese) or 
by using average portion sizes from a previous study of weighed records, this is known as a 
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Semi-Food Frequency Questionnaire (SFFQ). In addition, questions on the types of 
cooking oils and fats used were included.  
 
Example of types of questions asked 
How often do you eat the following bread?  
White  bread                                                                  7  6  5  4  3  2  1  F  R  
How many slices do you have per day?                           ...............................  
What is the usual size of slice?   
       1. Large 
       2. Medium 
       3. Small 
How often do you eat the following meats and meat dishes?  
Beef: roast, steak, stewed, burgers, lasagna, Bolognese, curry 
                                                                                      7  6  5  4  3  2  1  F  R 
Lamb: roast, chops, stewed, curry                                7  6  5  4  3  2  1  F  R 
Liver, kidney or heart                                                   7  6  5  4  3  2  1  F  R 
Do you usually eat the fat on meat?                              Yes / No 
 
 
To evaluate the portion sizes used in the SFFQ, participants were also asked to 
report the usual amount consumed for each food item; this is known as a Food Frequency 
Questionnaire (FFQ). A Food Photographic Atlas was used to standardize the data 
collection from the participants (Nelson et al. 1997). The Food Photographic Atlas 
contained coloured pictures of eight different portion sizes (Figure 4.1) of foods commonly 
eaten in Saudi Arabia. Also, food models and household measurements were used in order 
to assess the portion size of some of the local food used in Saudi Arabia. 
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Figure 4.1: Shows an example of the  different portion size for rice  
used in the Food Photographic Atlas 
 
 
4.2.2.2 Second: 24 hours Food Recall (24 h FR) 
This was assessed on three non-consecutive days (two weekdays and one weekend day) 
with a minimum gap of four days between them and within two weeks. The first 24 h FR 
was collected during the first visit and after the frequency questionnaire, while the second 
and third 24 h FR were collected through phone call on two separate days. All subjects 
were asked to provide telephone numbers and it was emphasised to them that they would 
be contacted after an appropriate period of time. The date was not specified; as such 
knowledge might have changed the eating habits of some of the participants. The foods 
were recalled chronologically from the previous day. The dietician asked the participants 
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what they had eaten in the previous 24 h from the first food eaten in the morning to the last 
food eaten before breakfast on the day of the interview. The Food Photographic Atlas and 
household measurements were also used to estimate the food portion sizes. At the end of 
each interview the foods were summarized for the respondent.  
 
Table 4.1: Shows the difference between dietary assessment methods used in the 
study 
 SFFQ FFQ 24 h FR 
Same Food Frequency Questionnaire √ √ - 
Assign a pre-specified standard portion size for each 
food item 
√ - - 
Each participant reports the portion size consumed  - √ √ 
Food Photographic Atlas & household measures used 
to report the portion size consumed 
- √ √ 
UK food composition table used to analyse the 
nutrients intake 
√ √ √ 
 
 
4.2.3 Analysis of food consumption data 
The daily intakes of energy and nutrients obtained from the SFFQ and FFQ were 
then analysed using the Q-Builder Software nutrition analysis program (Version 2). This 
includes an up-to-date food composition database with the nutrient contents of 
approximately 5000 foods and a database of portion sizes for 3800 foods. The nutritional 
analysis of Q-Builder is based on the UK food composition tables
 
(McCance 1991). 
Information on food consumption collected by the SFFQ and FFQ are converted by Q-
  111 
Builder into a list of foods and weights, to generate mean daily food and nutrient intakes. 
The approximate daily intake was calculated by multiplying the weekly frequency of 
consumption of a food by the nutrient content of a portion size. 
In addition, daily intake was estimated from the average of the three 24 h FR   by 
using the Tunuviel Software WISP Food Intake Nutritional Analysis System (Version 3). 
Like the Q-Builder program, it is based on the UK food composition tables (see above).
 
WISP is a nutritional analysis program that enables the user to conduct a broad nutritional 
analysis. A wide range of food items was included in the analysis program, but where an 
exact food was not found, a similar food was substituted or a recipe of that food was 
analysed taking cooking methods into account. 
 
4.2.4 Statistical analysis 
All statistical analyses were performed using SPSS version 18.0 (SPSS Inc., Chicago, IL, 
USA). Medians and 25 - 75
th
 percentile of absolute intakes for energy, macro- and 
micronutrients were calculated and compared between the SFFQ, FFQ, and the 24 h FRs. 
The energy and nutrients were not normally distributed. Therefore, the Spearman 
correlation coefficient test across different methods (SFFQ vs. 24 h FR, SFFQ vs. FFQ, and 
FFQ vs. 24 h FR) was used to determine the strength of the relationship for nutrient intakes 
between the dietary assessment methods. In addition, all correlations were adjusted for total 
energy intake to remove variation due to energy and thus allow a reasonable estimate of a 
true correlation. As suggested by Willett et al. the adjustment was done by replacing 
nutrient intake values with their respective residuals from a regression model with nutrient 
intake as the dependent variable and total energy intake as the independent variable (Willett 
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et al. 1985). In addition, the GraphPad Prism5 software statistics program was used to 
assess agreement between the different dietary assessment methods. Agreement was 
expressed by 95% limits of agreement (LOAs), as recommended by Bland-Altman, where 
the difference between two methods was plotted against the average (known as bias) 
(Martin Bland and Altman 1986). Finally, to examine the degree of energy under- or over-
reporting between different methods, we calculated the ratio of reported energy intake (EI) 
to calculate the basal metabolic rate (BMR). The EI/BMR ratio of 1.35 has been suggested 
as the lower cut-off for reasonable habitual energy intake (Goldberg et al. 1991). The BMR 
was calculated by using the equation for prediction of basal metabolic rate identified by the 
World Health Organization for women aged 30-60 years: [8.7 × weight (kg)] – [25 × height 
(m)] + 865 as previously used (Wirfält et al. 1998).      
 
4.3 Results 
4.3.1 Study characteristics 
Of the 46 women who agreed to participate in this pilot study, 41 (89%) completed 
the SFFQ, FFQ and three days 24 h FR. Five participants were excluded from the analysis 
because they did not complete the three days 24 h FR. The characteristics of the 
participants are described in Table 4.2. The mean age (SD) was 28.2 (6.6) and the mean 
BMI (SD) was 24.2 (4.6). The majority of the participants had a university education 
(78.1%), are working (60.9%), and with a high annual income more than 10000 Saudi 
Riyals (~ 37500$) (78.0%). They are moderately active during their work (46.3%) and 
leisure time (46.3%). 
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Table 4.2: Shows the characteristics of women who participated in 
the study (n = 41) 
Age (years)* 28.2 (6.6) 
Height (cm)* 158.3 (6.05) 
Weight (kg)* 60.7 (12.5) 
BMI (kg/m²)* 24.2 (4.6) 
Education level   
     Illiterate 2 4.9% 
     Primary 1 2.4% 
     Secondary 6 14.6% 
     Graduate 30 73.2% 
     Postgraduate 2 4.9% 
Occupation   
     Not working 8 19.5% 
     Student  8 19.5% 
     Employee 24 58.5% 
     Others 1 2.4% 
Monthly income (SR)   
     1000-2999 3 7.3% 
     3000-5999 3 7.3% 
     6000-10000 3 7.3% 
     > 10000 32 78.0% 
PAL during work   
     Not-active (such as office worker) 12 29.3% 
     Moderately active (such as teacher) 19 46.3% 
     Very active (such as worker) 2 4.9% 
PAL during leisure time   
     Not-active (such as sitting, watching TV) 20 48.8% 
     Moderately active (such as walking) 19 46.3% 
     Very active (such as exercising) 2 4.9% 
Data represent as N and % or *mean (SD) 
SR- Saudi Riyals, PAL- Physical Activity Level 
 
4.3.2 Comparison of medians 
The results of the comparison of estimated energy and nutrients intake derived from 
the different dietary assessment methods are shown in Table 4.3. Of the daily median [25-
75
th
 percentile] energy intake, median fat intake were 34%  [31-36.5], 34% [31-38], 35.4% 
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[29.8-41.3], median protein intake were 16% [15-18], 14% [12.5-15], 13% [11.4-16.5] and 
median CHO intake 49% [46-52.5], 52% [47.5-56], 51.5% [45.5-56.9] by SFFQ, FFQ & 
24h FR respectively (data not shown). The SFFQ estimated a higher total energy intake 
compared to the 24 h FR and FFQ (2234 [1695-2699], 1570 [1243-1880], and1347 [1052-
1771] kcal respectively). 
 
Table 4.3: Compares the estimated energy and nutrients median intake of different dietary 
assessment methods 
 
  SFFQ   FFQ   24 h FR 
Nutrient Median 
25 - 75
th
 
percentile  Median 
25 - 75
th
 
percentile  Median 
25 - 75
th
 
percentile 
Energy (kcal)  2234 1695 - 2699  1347 1052 - 1771  1570 1243 - 1880 
Protein  (g)  85.4 67.6 - 107.8  46.0 35.2 - 58.7  52.5 42.7 - 61.7 
Fat  (g)  77.3 56.6 - 106.9  49.8 34.1 - 67.6  60.0 44.2 - 73.4 
Saturated fat  (g) 30.5 23.1 - 42.1  23.8 17.0 - 31.4  20.4 14.1 - 26.8 
Monounsaturated fat (g)  26.9 20.7 - 33.6  15.2 10.5 - 21.6  19.8 12.2 - 24.3 
Polyunsaturated fat (g)  10.2 8.0 - 15.2  5.7 3.6 - 8.2  7.8 6.2 - 10.7 
Cholesterol (mg)  282 226 - 356  158 123.5 - 199  153 108.5 - 217 
Carbohydrate (g)  292.5 205.7 - 359.9  188.6 137.8 - 246.5  201.2 156.2 - 258.5 
Fibre (g)  17.7 14 - 23.9  9.3 6.6 - 13.4  12.5 9.2 - 15 
Sodium (mg)  2123 1458 - 2453  1359 1008 - 1861  1664 1401 - 1994 
Calcium (mg) 1007 800 - 1294  894 721 - 1277  593 428 - 807 
Iron (mg)  9.2 7.2 - 11.5  5.9 4.2 - 6.9  7.8 6.3 - 10.3 
Copper (mg) 1.25 1 - 1.7  0.56 0.4 - 0.75  0.90 0.7 - 1.3 
Zinc (mg)  10.1 8.2 - 13  5.7 4.5 - 7.8  6.3 5.4 - 7.6 
Selenium (µg)  64 52.5 - 78  26 17.5 - 34  33 25 - 41 
Retinol (µg)  466 272 - 1137.5  237 180.5 - 323  197 160.5 - 260 
Vitamin D (µg) 1.6 1.1 - 3  0.5 0.4 - 0.85  0.96 0.5 - 1.4 
Vitamin E (mg)  5.8 4.3 - 7.4  3.1 2.1 - 4.9  5.8 4.2 - 7 
Thiamin (mg)  1.3 0.9 - 1.5  0.8 0.5 - 1  0.86 0.7 - 1 
Vitamin B6 (mg)  1.4 1.2 - 1.8  0.8 0.6 - 1  0.9 0.7 - 1.1 
Vitamin B12 (µg) 6.5 4.7 - 8.2  4.0 3.2 - 5.1  2.2 1.4 - 3.8 
Folate (µg)  251 202 - 305  149 109 - 212  137 121 - 172 
Vitamin C (mg)  95 55 - 122   59 31 - 91   58 27 - 86 
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4.3.3 Comparison of correlation coefficients 
The results of unadjusted and energy-adjusted correlations between energy, macro 
and micronutrients intake derived from the three assessment methods are shown in Table 
4.4. In general, the correlations of individual nutrients between the two FFQ were strong. 
However, the correlation between the FFQs and 24 h FR were weak (SFFQ vs. FFQ: 0.84), 
(SFFQ vs. 24 h FR: 0.31), and (FFQ vs. 24 h FR: 0.24). 
 
4.3.3.1 Correlation coefficients of macronutrients 
The energy un-adjusted correlations between the SFFQ and FFQ for macronutrients 
were high; fat (r = 0.87, P < 0.001), carbohydrate (r = 0.86, P < 0.001) and protein (r = 
0.79, P < 0.001). In contrast, they were weak between the SFFQ and 24 h FR, and FFQ and 
24 h FR (Table 4.4). 
 
4.3.3.2 Correlation coefficients of micronutrients 
Similar to macronutrients, the correlations for the micronutrients intake were higher 
between the SFFQ and FFQ than to 24 h FR. They ranged between r = 0.96 (P <0.001) for 
calcium to r = 0.40 (P = 0.01) for retinol. However, some micronutrients showed stronger 
correlations between the SFFQ and 24 h FR (for example: vitamin C, vitamin D, sodium 
and calcium) and between the FFQ and 24 h FR (for example: vitamin C, vitamin E and 
calcium) ( Table 4.4).   
The energy-adjustment correlation coefficient showed similar if not stronger 
associations between the three assessment methods (Table 4.4). 
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Table 4.4: Shows the Spearman correlation coefficient between different dietary assessment methods 
 
  Energy-unadjusted correlation  Energy-adjusted correlation 
Nutrient 
SFFQ vs.  
FFQ  
SFFQ vs.  
24 h FR 
FFQ vs.  
24 h FR  
SFFQ vs. 
FFQ   
SFFQ vs.  
24 h FR 
FFQ vs.  
24 h FR 
Energy (kcal) 0.86**  0.38* 0.33*      
Protein (g) 0.79**  0.32* 0.24  0.86**  0.38* 0.34* 
Fat (g)  0.87**  0.43** 0.33*  0.86**  0.38* 0.32* 
Saturated fat (g) 0.86**  0.42** 0.35*  0.86**  0.38* 0.32* 
Monounsaturated fat (g) 0.82**  0.40** 0.28  0.86**  0.37* 0.32 
Polyunsaturated fat (g) 0.83**  0.31 0.13  0.87**  0.37* 0.33* 
Cholesterol (mg) 0.86**  0.48** 0.33*  0.86**  0.33* 0.30 
Carbohydrate (g) 0.86**  0.26 0.30  0.87**  0.37* 0.33* 
Fibre (g) 0.81**  0.25 0.22  0.86**  0.40** 0.36* 
Sodium (mg) 0.85**  0.40** 0.26  0.86**  0.36* 0.33* 
Calcium (mg) 0.96**  0.33* 0.31*  0.86**  0.35* 0.31* 
Iron (mg) 0.86**  0.08 0.08  0.86**  0.39* 0.34* 
Copper (mg) 0.59**  0.25 -0.08  0.87**  0.41** 0.38* 
Zinc (mg) 0.81**  0.18 0.15  0.86**  0.39* 0.34* 
Selenium (µg) 0.66**  -0.04 -0.21  0.87**  -0.16 -0.10 
Retinol (µg) 0.40**  0.10 -0.04  0.87**  0.48** 0.44** 
Vitamin D (µg) 0.50**  0.52** 0.26  0.86**  0.43** 0.35* 
Vitamin E (mg) 0.81**  0.40* 0.31*  0.86**  0.38* 0.34* 
Thiamin (mg) 0.86**  0.29 0.17  0.86**  0.36* 0.33* 
Vitamin B6 (mg) 0.84**  0.27 0.19  0.86**  0.37* 0.33* 
Vitamin B12 (µg) 0.62**  0.22 0.13  0.86**  0.46** 0.43** 
Folate (µg) 0.84**  0.28 0.17  0.86**  0.35* 0.31 
Vitamin C (mg) 0.93**  0.55** 0.44**  0.84**  0.30* 0.25 
*   correlation is significant at 0.05 level (2 tailed) 
** correlation is significant at 0.01 level (2 tailed) 
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4.3.4 Level of agreement 
The level of agreement between methods was used to determine whether two 
methods agreed sufficiently well for them to be used interchangeably. The level of 
agreement is based on the median difference of two methods (bias) and plotted against 
the average (Martin Bland and Altman 1986). The level of agreement of the estimated 
energy and nutrient intakes derived from the three dietary assessment methods are 
shown in (Table 4.5). It shows that the SFFQ estimated a higher energy intake by 
38.7%  and 49.5% compared to the 24 h FR and FFQ, respectively. In contrast, the FFQ 
estimated a lower mean energy intake by 15.3% compared to the 24 h FR. 
The overall agreement between nutrient intake measured by the SFFQ, 24 h FR   
and FFQ was assessed using Bland-Altman plots. The 95% limits of agreement, which 
is the median difference plus or minus 1.96 SD, would show how far the median by the 
two methods was likely to be for most individuals. The two methods will agree if the 
difference equals to zero. Our results from the Bland-Altman plots confirmed the higher 
intake estimation of the SFFQ across the range of intake except for vitamin E (vs. 24 h 
FR). Figure 4.2 gives examples of the level of agreement on the Bland-Altman plots. 
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Table 4.5: Shows the level of agreement of estimated energy and nutrients median intake between 
different dietary assessment methods 
Nutrient   
% bias †  
  
Limits of Agreements (LOAs) 
Low High Low High Low High 
SFFQ vs.    
24 h FR 
SFFQ 
vs. FFQ 
FFQ vs. 
24 h FR 
SFFQ vs. 
 24 h FR 
SFFQ vs.  
FFQ 
FFQ vs.  
24 h FR 
Energy (kcal)  38.7 49.5 -15.3  -808.1 2114 98.3 1416 -1435 1227 
Protein (g)  53.7 59.9 -13.2  -17.4 87.4 10.8 64.6 -48.8 43.4 
Fat (g)   27.7 43.3 -18.6  -42.4 87.9 -1.8 56.5 -62.2 53.1 
Saturated fat (g)  40.5 24.7 15.4  -15.03 40.9 -5.4 20.03 -19.6 30.8 
Monounsaturated fat (g)  34.4 55.6 -26.3  -12.6 30.6 -0.34 21.1 -22 19.3 
Polyunsaturated fat (g)  30.4 56.6 -31.1  -10.8 18.3 -1.5 12.2 -14.6 11.4 
Cholesterol (mg)  65.3 56.4 3.2  -96.9 344.2 6.4 239 -208.5 210.4 
Carbohydrate (g)  40.1 43.2 -6.5  -137 310.6 -9.4 193 -219.7 209.6 
Fiber (g)  39.5 62.2 -29.3  -6.95 20.8 1.9 14.85 -13.2 10.3 
Sodium (mg)  26.7 43.9 -20.2  -1237 2171 -263.7 1513 -1801 1485 
Calcium (mg)  49.8 11.9 40.5  -296.6 1098 -127 245.3 -376.2 1086 
Iron (mg)  18.3 43.7 -27.7  -9.04 11.4 0.77 6.29 -11.8 7.1 
Copper (mg)  38.7 76.2 -46.6  -3.86 3.99 -0.19 1.75 -4.5 3.1 
Zinc (mg)  51.6 55.7 -10  -10.65 3.05 -6.38 6.65 -7.4 -0.5 
Selenium (µg)  75.6 84.4 -23.7  -26.75 94.05 2.57 76.41 -51.2 39.5 
Retinol (µg)  89.7 65.1 18.4  -5537 5470 -897.3 1967 -5978 4841 
Vitamin D (µg)  62.7 104.8 -63  -1.45 3.89 -1.34 4.35 -1.6 0.97 
Vitamin E (mg)  0 60.7 -60.7  -5.79 6.94 -1.3 6.4 -7.2 3.2 
Thiamine (mg)  44.6 47.6 -7.2  -0.48 1.3 0.06 0.89 -0.9 0.8 
Vitamin B6 (mg)  48.4 54.5 -11.7  -0.4 1.7 0.13 1.29 -1 0.9 
Vitamin B12 (µg)  101.6 47.6 58.1  -20.9 25.2 -2.99 8.84 -23.7 22.2 
Folate (µg)  63.7 51 8.4  -38.4 256.6 29.60 166.50 -140.2 162.2 
Vitamin C (mg)   52.3 46.7 1.7   -143.8 177.5 -9.99 62.86 -180.3 161.1 
% bias - difference of two medians estimated from the two assessment methods divided by the average 
LOAs -  the two methods will agree if the median difference is equal to zero 
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Figure 4.2: Bland-Altman plots (different of two dietary assessment methods against 
the average) and  95% limits of agreement - LOA (broken lines) (A) for vitamin C 
between the FFQ vs. the 24 h FR and (B) for vitamin E between the SFFQ vs. the 24 h 
FR. 
 
 
4.3.5 Under-reporting of energy 
To ensure that the dietary assessment methods used in this study estimated the 
habitual energy intake from the participants, we examined the EI/BMR ratios of the 
three dietary assessment methods. The mean ratios were 1.65, 1.16 and 1.00 for the 
SFFQ, 24 h FR, and FFQ respectively. The EI/BMR ratio of 1.35 is suggested to be the 
lower cut-off limit for reasonable energy intake. Thus, the FFQ and 24 h FR estimated 
lower energy and nutrients intake. 
 
4.4 Discussion 
In this study, we evaluated the performance of a modified SFFQ by comparing the daily 
nutrient intake obtained from the FFQs with those derived from the three days 24 h FR. 
As there is no approved nutritional database available in Saudi Arabia, we used a 
nutritional analysis software program that was developed in the UK. This was chosen 
for several reasons; firstly, it provides comprehensive information on the nutrient 
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content of approximately 5000 foods, including levels of fat, sodium, fibre, and 
carbohydrates, vitamins and minerals. Secondly, it includes foods used by many 
immigrants, such as South Asian and Arabs (for example Tabulla, Hummus, Falafel, 
Kebbab, Samosa, biryiani rice). Thirdly, a high level of agreement has been confirmed 
between the British and American food composition table (Kushi 1994; Garcia et al. 
2003). Finally, it is well established and many studies have been published using the 
same nutrition analysis program to assess dietary intake (Hill et al. 2004; Magee et al. 
2005; Broadfield et al. 2007; Harrington et al. 2008).  
Our results showed firstly, that the SFFQ generally has a higher energy and 
nutrient estimate compared to the 24 h FR. The mean EI/BMR ratios indicated that the 
24 h FR was under-reporting habitual energy intake compared to the SFFQ. For the EI 
to be representative of habitual or average dietary intake, it must be greater than 1.35 × 
BMR. The 1.35 indicates the lowest physical activity level for any healthy individuals 
and values less than 1.35 cannot represent habitual intake (Goldberg et al. 1991; 
Goldberg and Black 1998). For women between 30 - 60 years of age with light, 
moderate and heavy levels of physical activity, the EI/BMR ratio is estimated to be 1.4, 
1.65 and 1.95, respectively (Goldberg and Black 1998). As our study participants were 
moderately active, an EI/BMR ratio of 1.65 estimated by an SFFQ seems more 
appropriate than a 24 h FR. 
The recommended dietary allowance of energy intake for Saudi adult women 
with BMI 22.1 has been estimated to be 2100 kcal per day (Khan and Al-Kanhal 1998). 
Based on this estimate, the total energy intake for our sample with a mean BMI of 24.2 
should be approximately 2299 kcal. This also supports that our modified SFFQ could 
reflect the right food consumption pattern among the Saudi population compared to 24 h 
FR. Furthermore, the SFFQ show a high consumption of fat (35% of total energy). This 
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probably reflects the current trend in Saudi Arabia where there is an increasing fat 
intake and a decreasing carbohydrate intake since the 1960s (Stephen et al. 1995). In 
addition, this is also supported by the recent national nutrition survey of the 
representative population of Saudi Arabia which showed that the percentage of energy 
from carbohydrates decreased from 75% to 43% and from fat increased from 10% to 
42% between the years 1971 and 1992. Protein intake increased from 49 g to 114 g/day, 
while fat intake increased from 34 g to 144 g/day during the same period (Al-
Othaimeen et al. 2004). All of the above points support that our modified SFFQ with a 
pre-specified standard portion size gives a good dietary intake estimation particularly 
for energy and macronutrients intake and its’ results correspond to the national 
estimates.  
The lower estimation of the FFQ and 24 h FR could be due to inaccurate self-
reported portion size a deliberate underestimation of the actual dietary intake by the 
participants. Because the degree of under-reporting increases with intake, individuals 
tend to report intakes that are closer to perceived norms than to actual intake (Schoeller 
1990). As previously reviewed (Macdiarmid and Blundell 1998), the under-reporting is 
higher among women than men. This has been linked to the increased prevalence of 
weight consciousness and thus dietary restraint in this group (Hill and Davies 2001). 
This could be true as our study participants were well-educated women. On the other 
hand, it could also be due to the limitation of the 24 h FR as only three days of 24 h FR 
were used in our study. It has been shown that the correlations for most nutrients 
increase with an increasing number of recalls (Block and Hartman 1989).  
Secondly, the correlations between the two Food Frequency Questionnaires 
were overall more similar to each other than between the frequency questionnaires and 
recall. This is supported by other studies (Block et al. 1990; TjøNneland et al. 1992; 
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Noethlings et al. 2003), where the same questionnaires, asking about portion size (FFQ) 
or applying standard portion sizes (SFFQ) showed a good correlation. 
Thirdly, despite the fact that the FFQ was not different from the 24 h FR in the 
median energy, macro- and some of the micronutrients intake, they generally had a 
weaker correlation compared to other methods. In addition, the FFQ tends to have a 
limited agreement with the 24 h FR for many nutrients except vitamin C and 
cholesterol, for which there was very good agreement with 1.7% and 3.2% bias, and 
LOA (-180.3, 161.1) and LOA (-208.5, 210.4) respectively. Interestingly, the SFFQ vs. 
24 h FR had a good correlation in terms of total fat, saturated fat, monounsaturated fat, 
and cholesterol, as well as vitamin C and D intake, compared to the FFQ vs. 24 h FR. 
More importantly, energy-adjusted correlation tends to be better between the SFFQ vs. 
24 h FR compared to the FFQ vs. 24 h FR, particularly for retinol, vitamin B12, copper, 
fibre, vitamin C, and folate. Vitamin E has 0% bias between the SFFQ vs. 24 h FR. This 
supports the use of our SFFQ when a particular nutrient intake is to be tested. 
Finally, our pilot study has several limitations; first it uses < 50 years old women 
only. Thus the overall impression in dietary estimate is biased towards this younger 
female group. Secondly, eating patterns may differ from men to women, even though a 
prior study suggested that major eating patterns apply to both men and women (Slattery 
et al. 1998). Another limitation is the small sample size, which may have affected our 
results by having a wider confidence interval. However, this is a pilot study and the 
SFFQ needs to be replicated and validated on a large group of people from different 
parts of Saudi Arabia 
In conclusion, the SFFQ that has been used in this study gave useful estimates of 
energy and some nutrient intakes and appears to be a valid tool in comparison to a 24 h 
FR. Further studies are needed to evaluate such frequency questionnaires through 
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comparing the dietary intake versus actual levels in the blood to give accurate validity, 
particularly for the relevant micronutrients, in order to understand the diet-disease 
relationship among this population. 
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Chapter 5 
Does the estimated dietary intake of vitamin B12 and folate correlate 
with actual blood levels in the Saudi population? 
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5.1 Introduction 
The Middle Eastern region is experiencing an epidemic of T2DM. It is ranked second in 
the world for the prevalence of T2DM  (Shaw et al. 2010a). More specifically, Saudi 
Arabia has shown a rapid increase in the prevalence of DM from 2.5% in 1982 to 23.7% 
in 2000 (Al-Nozha et al. 2004; Elhadd et al. 2007). In addition, nutrition-related chronic 
diseases are a growing epidemic and of major concern in this region (Musaiger 2004; 
Al-Othaimeen et al. 2007; Elhadd et al. 2007). Rapid urbanization has shifted the 
population’s dietary habits from traditional foods to more westernized foods, this is 
believed to contribute to the increasing prevalence of obesity and chronic diseases 
(Musaiger 2000; Musaiger 2004). The Saudi population has variable dietary patterns 
that are influenced mainly by cultural factors. However, urbanization and 
westernization have not only changed the lifestyle but also dietary behaviours. There 
are no recent studies that systematically studied the general dietary patterns or specific 
nutrients that may be contributing to the diabetes epidemic to understand the diet-
disease relationship in this population. However, dietary intakes are complicated and 
difficult to measure even under optimal conditions (Willett 1998). 
With the growing interest in understanding the role of vitamin B12 and folate in 
disease processes such as obesity and DM, particularly during pregnancy, it is important 
to be able to assess dietary intake of these vitamins in epidemiological studies. Accurate 
and objective estimates of the intake are necessary in order to assess any effects of 
nutritional status in those studies. As mentioned in the previous chapter (Chapter 4), 
FFQ are the method of choice for many epidemiological studies to relate diet and 
chronic diseases because of its ability to estimate long-term dietary intake (Willett et al. 
1985; Block et al. 1986). FFQ has been validated and compared with different dietary 
assessment method (known as reference method), all of which may be susceptible to 
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measurement errors (Bolton-Smith et al. 1991), i.e. the same factors that affect the 
reference method may also affect the FFQ resulting in over- or under-reporting. It 
suggested that at least two additional measurements are necessary to determine the 
validity of the FFQ method, for instance, nutritional biomarkers and multiple 24 h FR 
(Kaaks 1997). The advantage of using nutritional biomarkers is that this method is not 
influenced by factors related to under or over reporting (Verkleij-Hagoort et al. 2006). 
In addition, the potential sources of random error occurring with biomarkers are 
different from those of dietary questionnaire measurement methods; therefore, errors 
are independent between the two measurements (Kaaks 1997). The triangular approach 
to such validation known as the ‘method of triads’ uses the correlations between each of 
the three measurement methods (FFQ, 24 h FR and nutrition biomarkers) to obtain a 
 uantitative estimate of the  uestionnaire’s validity coefficient (VC) (Kaaks 1997). 
Ocke and Kaaks described this method in further detail. The method of triads assumes 
that the correlations between the three methods are explained by the fact that all are 
positively linearly related to unknown true long term intake and that their random errors 
are mutually independent (Ocke and Kaaks 1997). Although the method of triads was 
introduced and described several years ago, few dietary validation studies have applied 
it in their method (McNaughton et al. 2004). The traditional method of validation using 
a dietary assessment method such as FFQ vs. biomarker has been widely applied by 
many studies (McNaughton et al. 2004) and only a few studies have interpreted their 
results with respect to the VC using the method of triads (Ocke and Kaaks 1997; 
Kabagambe et al. 2001; McNaughton et al. 2004; Andersen et al. 2005; Verkleij-
Hagoort et al. 2006).  
Although suitable markers are not available for many nutrients, serum values for 
several vitamins are reported to reflect dietary intake in controlled studies (Willett et al. 
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1983). A few biochemical markers are known to provide a valid reference measurement 
of absolute daily intake (Kaaks 1997) such as 24 h urinary nitrogen excretion; as a valid 
reference measurement for protein intake (Bingham and Cummings 1985). 
Unfortunately, the correlation between questionnaire measurements of nutrient intake 
and many biomarkers is relatively weak, with values < 0.40. This could be related to the 
variability in individuals’ absorption, availability and metabolism of the vitamins, 
which can be important sources of random variations in the biomarker, unrelated to true 
dietary intake (Kaaks 1997). Among the Saudi population, a correlation of nutrient 
intake and its relevant biomarker was previously reported with correlation of (r = 0.13, 
p < 0.05) between dietary and serum vitamin A,( r = - 0.06 , P > 0.05) vitamin E (Alissa 
et al. 2005) and (r = 0.136, P < 0.05) iron (Alissa et al. 2007). No such correlation was 
reported between dietary and serum vitamin B12.  
Therefore, the present study aimed to investigate the vitamin B12 and folate 
intake measured by different dietary assessment methods with corresponding nutritional 
biomarkers among the Saudi pregnant population. This is particularly useful as the 
bioavailability of both vitamins is likely to be influenced by cooking methods (e.g. over 
cooking can reduce the bioavailability of folate) and improving hygiene or refrigeration 
(e.g. hygiene, vacuum packing and refrigeration of meat products are likely to kill the 
microorganisms that are essential for the vitamin B12 synthesis in them). 
 
5.2 Materials and methods 
5.2.1 Study population  
The study population consisted of Saudi pregnant women attending the antenatal 
clinics at University hospitals in Riyadh city, KSA. Women aged 20 to 40 years, non-
smokers, with pre-pregnancy BMI > 18 and < 35 kg/m², without any significant medical 
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problems nor taking any medication were eligible for the study. Women were excluded 
if they were on multivitamins or known cases of anemia or had any nutrition related 
pre-existing medical condition such as coeliac disease, known DM or have any liver, 
cardiac or kidney disease. As a routine practice, general practitioners and obstetricians 
at the hospitals were prescribing a folic acid supplement of 500 µg/day in the first 
trimester and fefol tablets (iron and folic acid) 200 mg/day afterwards for all pregnant 
women attending the clinic.  
 
5.2.2 Ethical approval 
The College of Medicine Research Ethics Committee (CMRC) at the College of 
Medicine, and King Khalid University Hospital in Riyadh approved the study protocol. 
The written informed consent was obtained from every participant. 
 
5.2.3 Data collection  
The data collection was carried out between 2009 and 2010. Data was collected 
as follows: between 12
th 
- 14
th
, between 24
th
 - 28
th
 and between 35
th
 - 37
th
 weeks of 
gestation. Pregnant women taking part in the data collection at the first and/or second 
trimesters were asked to be followed up at the next visit. Only 23 pregnant were seen at 
the three visits, 6 pregnant at first and second trimesters and 11 pregnant at second and 
third trimesters. Sociodemographic and anthropometric data was collected using a pre-
designed questionnaire. The data collected included maternal age, education level, 
occupation, total family income, gravidity and parity. In addition, gestational age and 
maternal weight prior to or at the beginning of gestation were obtained from the 
patients’ medical records.  eight and weight were measured using an appropriate 
international standard scale (Digital Person Scale, ADAM Equipment Inc., USA). A 
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research nurse interviewed the participants, explained the study protocol, obtained the 
consent form and prepared for blood sampling. 
 
5.2.4 Dietary assessment tools 
The dietary information was obtained from the participants by a trained dietician 
in order to assess their intake of different macro- & micronutrients by using two main 
methods: FFQ and 24 h FR. All dietary methods were always obtained in the same 
order for all participants. The details of the dietary assessment methods used and 
analysis of food consumption data were described in Chapter 4.  
 
5.2.5 Blood sampling and laboratory analysis  
During the whole study period, blood samples were collected three times (at the 
first, second and third trimester) after an overnight fast for the measurement of serum 
vitamin B12 and folate. Serum samples were separated from whole blood collected in 
the plain tube after standing for 20 - 30 minutes, then centrifuged in 3500 rmp for 15 
minutes Serum aliquots were then kept in the ice-box for about 4 - 6 hours, then later 
transferred and stored in - 80° fridge. At the end of the study, all samples were shipped 
in dry ice boxes from the research lab at the UDC, Riyadh, KSA to the Clinical 
Sciences Research labs at the University of Warwick, Coventry, UK after signing the 
academic human material transfer agreement between the parties and stored until 
measurements. Serum vitamin B12 and folate were measured by 
electrochemiluminescence immunoassay and binding assay (Elecsys and cobas e 
immunoassay analyzers, Roche Diagnostics, USA) respectively. In the laboratory, 
quality controls were tested once per day. Serum vitamin B12 inter-assay CVs were 
6.0%, 2.3% and 4.4%  at 142.4, 554.2 and 693.7 pmol/l respectively, while serum folate 
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were 7.4% and 6.1% at 7.7 and 21.3 nmol/l respectively. From the total blood samples 
collected, 3 and 7 samples were insufficient for vitamin B12 and folate assays 
respectively. The overview of the study’s procedure is shown in Figure 5.1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1 Overview of the study’s procedure 
 
 
5.2.6 Statistical analysis 
All statistical analyses were performed using the SPSS version 18.0 (SPSS Inc., 
Chicago, IL, USA). Medians and 25
th
 - 75
th
 percentile of absolute intakes for energy, 
macronutrients, vitamin B12 and folate from the different dietary assessment methods 
1. Consent form 3. Extracting the blood 
5. Taking the diet history 4. Preparing the blood samples 
2. Data collection 
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(SFFQ, FFQ, and 24 h FR) were estimated and compared at different trimesters. The 
estimated vitamin B12 intake from SFFQ and 24 h FR and serum vitamin B12 were not 
normally distributed, thus log transformation was performed on those variables and 
used for further statistical analysis. Pearson correlation coefficient tests across different 
assessment methods (SFFQ vs. 24 h FR, SFFQ vs. FFQ, and FFQ vs. 24 h FR) were 
used to determine the strength of the relationship for nutrient intakes between the 
dietary assessment methods. Nutrients correlations were adjusted for total energy intake 
to remove variation due to energy and thus allow a reasonable estimate of a true 
correlation as described in Chapter 4. In addition, partial correlation coefficients 
adjusted for age, BMI and estimated energy intake were calculated for the association 
between estimated vitamin B12 and folate intake from different dietary method and its 
actual level in blood.  
The method of triads was used to calculate the VC between those estimated 
from the SFFQ, FFQ, 24 h FR and the biomarker measures and the unknown true intake 
as shown in Figure 5.2. This was interpreted as the upper limit of the VC whereas the 
correlation between the biomarker and the dietary assessment method (SFFQ, FFQ and 
24 h FR) was interpreted as the lower limit of the VC. The existence of negative 
correlation and high random variation in the sample correlation could cause VCs to be 
inestimable or > 1, a condition referred to as Heywood case. Heywood case occurs if 
the product of two correlation coefficients is much higher than the third correlation 
(Ocke and Kaaks 1997).  
Vitamin B 12 insufficiency was defined as concentration of < 150 pmol/l as 
previously used (Bondevik et al. 2001; Yajnik et al. 2008; Vanderjagt et al. 2009; 
Veena et al. 2010; Goedhart et al. 2011). The proportional of pregnant women who had 
a serum vitamin B12 level below or above the cut-off value were compared with the 
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estimated vitamin B12 intake below and above the recommended level (2.6 µg/d) 
(Institute of Medicine 1998b; Bailey 2004). 
 
 
 
 
 
 
 
 
 
Figure 5.2: Graphical representation of the method of triads (Kaaks 1997; Andersen et 
al. 2005). T = unknown true dietary intake, Q = estimated intake from SFFQ or FFQ, R 
= estimated intake from 24 h FR, M = measurement of biomarker, r = correlation and 
VC = validity coefficient. In this study, the rQR were estimated by Pearson correlation 
coefficient and rQM and rRM as Partial correlation coefficient. 
 
5.3 Results 
5.3.1 Study characteristics 
A total of 72 randomly selected pregnant women participated in this study with 
a mean age ± SD of 30.3 ± 5.5, BMI 27.4 ± 5.5 and parity 2.68 ± 2.5. About 40% had 
high school and university level of education, only 8.4% were working and with a 
moderate monthly income  about 6289 ±  907 Saudi Riyals (  2 584 ). The general 
characteristics and nutritional biomarkers of the pregnant participants at different 
trimesters are shown in Table 5.1. Serum vitamin B12 level was at lower levels, while 
serum folate was at higher levels in the pregnant at different trimesters (first trimester 
QT  
RT  
MT  
VCQT 
rRM 
rQM rQR 
M R 
Q 
 
T 
VCMT VCRT 
 133 
 
162, second trimester 138.9 and third trimester 137.8) and (first trimester 30.1, second 
trimester 25.6, and third trimester 22.7) respectively (Table 5.1). On the 23 pregnant 
women who completed the 3 visits, a significant decline in serum vitamin B12 from the 
first trimester to the second and third trimester (p < 0.001) were observed, while the 
level was constant between second and third trimester. Furthermore, serum folate was 
constant from the first to second trimester then after the level decreased but it did not 
reach the significant level (Table 5.2). 
 
5.3.2 Median intake of different dietary assessment methods during pregnancy 
The estimated energy, macronutrients (protein, fat and carbohydrate), dietary 
fibre, vitamin B12 and folate derived from the different dietary assessment methods are 
shown in (Table 5.3, Table 5.4 and Table 5.5). Table 5.3 shows the median daily 
estimate derived from the SFFQ during pregnancy. There is a slight decrease in the total 
energy intake as pregnancy advances. Protein, fat, vitamin B12 and folate intake were 
increased from the first to second trimester, then decreased from the second to third 
trimester. While carbohydrate was slightly decreased from the first to second trimester, 
then increased from the second to third trimester. Fibre intake was almost the same 
throughout pregnancy. During pregnancy, vitamin B12 and folate median intake 
estimate were 5.8 µg and 232.5 µg respectively. Table 5.4 shows the median daily 
estimate derived from the 24 h FR during pregnancy. Of the 40 pregnant women seen at 
the first trimester, 6 did not complete the 3 days FR and of the 60 at the second 
trimester, 4 did not complete the 3 days FR.   
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Table 5.1: General characteristics and nutritional biomarkers of the participants in the study 
 
Nutrient 
Pregnant (n = 134) 
1st trimester      (n = 40) 2nd trimester  (n = 60) 3rd trimester    (n = 34) 
Age (years) 29.4 ± 5.2 30.6 ± 5.4 31.03 ± 5.3 
Education level 
     Primary 
     Secondary 
     High school 
     University 
30.0  (12) 
30.0  (12) 
27.5  (11) 
12.5  (5) 
28.3   (17) 
30.0   (18) 
18.3   (11) 
23.3   (14) 
26.5   (9) 
29.4   (10) 
23.5   (8) 
20.6   (7) 
Occupation 
     Not working 
     Student 
     Working 
97.5 (39) 
- 
2.5   (1) 
88.3   (53) 
1.7     (1) 
10.1   (6) 
94.1   (32) 
- 
5.9     (2) 
Monthly family income (SR) 5854 ± 3824  6544 ± 4176 6568 ± 4283 
Parity 2.61 ± 2.4 2.76 ± 2.6 3.26 ± 2.7 
BMI (kg/m
2
)  27.4 ± 5.6 27.4 ± 5.5 28.9 ± 6.2 
Gestational age (wks.) 12.6 ± 0.73 25.9 ± 1.5 35.5 ± 0.74 
Pregnancy weight (kg) 67.9 ± 15.7 72.1 ± 13.4 75.6 ± 15.5 
Serum vitamin B12 (pmol/l) 
162 [129.1, 209.2] 
(n = 38)     
138.9 [110.6, 168.8] 
(n=59)     
137.8 [ 117.2, 172.9] † 
(n = 33)      
Serum Folate (nmol/l) 
30.1 [27.3, 33.3]  
(n = 38)    
25.6 [19.7, 33.3] 
(n = 55)     
22.7 [18.2, 33.1] † 
(n = 33)  
Values present are mean ± SD, % (n) or median [25
th
, 75
th
 centile], † significant decline (p < 0.05) from 1st to 3rd 
trimester 
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Table 5.2:  The change in serum vitamin B12 and folate throughout pregnancy in the 23 pregnant completed the 3 visits 
 
Characteristic 
Pregnant (n = 23) 
1st trimester     2nd trimester  3rd trimester    
Gestational age (wks.) 12.6 ± 0.73 25.1 ± 1.1 35.3 ± 0.54 
Pregnancy weight (kg) 68.4 ± 15.9 71.3 ± 13.4 73.8 ± 15.5 
Serum vitamin B12 (pmol/l) 164 [129.1, 201.7]  1 0.2 [105.1, 159.4] ‡ 1 1 [ 117.2, 172.9] † 
Serum Folate (nmol/l) 28.94 [25.6, 32.6]  28.91 [23.04, 34.03]  23.4 [18.5, 33.9]  
Values present are mean ± SD or median [25
th
, 75
th
 centile], significant decline ‡ p < 0.001 between 1st & 2nd 
trimester, † p < 0.001 between 1st & 3rd trimester 
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Compared to the SFFQ, 24 h FR had similar total energy (1937 vs. 1837, p = 
0.38), CHO (251 vs. 252, p = 0.85) and fat (71 vs. 70, p = 0.21) estimated intake. 
However, estimated protein intake was lower (76 vs. 64, p < 0.001). It also shows that 
there was a slight decrease in energy, carbohydrate and vitamin B12 intake from the 
first to second trimester, but increase from the second to third trimester. In addition, 
protein intake increased, while fat intake decreased during pregnancy. Fibre intake was 
almost the same throughout pregnancy. During pregnancy, vitamin B12 and folate 
median intake estimate was 2.4 µg and 162 µg respectively. Table 5.5 shows the 
median daily estimate derived from the FFQ during pregnancy. Compared to the SFFQ 
and 24 h FR, FFQ estimated lower median intake for most nutrients, except for vitamin 
B12 intake where it was lowest by the 24 h FR. 
 
5.3.3 Correlation coefficient between different dietary assessment methods  
The results of unadjusted and energy-adjusted correlation between energy, 
macronutrients, vitamin B12 and folate intakes derived from the three dietary 
assessment methods in pregnancy are shown in Table 5.6. Similar to the result of the 
nutrients correlation of the pilot study (see Chapter 4), the correlations between the two 
frequency questionnaires (SFFQ vs. FFQ) were higher compared to the other dietary 
assessment methods. In the present study, only carbohydrate showed a weak correlation 
between SFFQ vs. 24 h FR; however, the energy-adjustment correlation improved the 
correlation between these methods. In addition, vitamin B12 intake showed weaker 
correlation between SFFQ vs. FFQ and FFQ vs. 24 h FR (r = 0.59, p < 0.001 and r = 
0.31, p < 0.001 respectively), however the energy-adjustment correlation improved 
vitamin B12 correlation between those methods ( r = 0.70, p < 0.001 and  r = 0.37, p < 
0.001 respectively). 
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Table 5.3: Comparison of estimated energy and nutrients intake by the SFFQ during pregnancy 
Nutrient 
Pregnancy (n = 134) 
Total pregnant 
(n = 134) 
1st trimester       
(n = 40) 
2nd trimester      
(n = 60) 
3rd trimester      
( = 34) 
Energy (kcal) 2013 [1560, 2463] 1925 [1592, 2275] 1915 [1505, 2077]     1937 [1574, 2321] 
Protein (g) 77 [62.3, 96.1] 78 [60.8, 89] 76 [57.7, 84.1] 76.3 [61.4, 89.1] 
Fat (g)  71 [54.3, 102.8] 74 [58.3, 90.2] 65 [52.9, 93.5]     71 [56.9, 93.2] 
Carbohydrate (g) 269 [189.8, 318.9] 234 [201.4, 289] 248 [223.8, 277.3]     251 [200, 299] 
Fibre (g) 18 [13.8, 21.9] 18 [13.7, 21.2] 17.4 [14.2, 20.4] 18 [13.9, 21.4] 
Vitamin B12 (µg) 2.1 [1.6, 5.6] 6.3 [4.4, 8.4] 4.9 [3.9, 7.0]     5.8 [4.2, 8.0] 
Folate (µg) 134 [7.6, 230] 231 [188, 278.5] 228 [181, 263]   232.5 [188, 278] 
Values are median [25
th
, 75
th
 centile] 
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Table 5.4 Comparison of estimated energy and nutrients intake by the 24 h FR during pregnancy  
Nutrient 
Pregnancy (n = 121) 
Total pregnant 
(n = 121) 
1st trimester       
(n = 34) 
2nd trimester      
(n = 56) 
3rd trimester      
(n = 31) 
Energy (kcal) 1851 [1580, 2067]     1778 [1472.5, 2252]     1873 [1540, 2230]     1837 [1534, 2154] 
Protein (g) 57.3 [44.8, 80.2]     66.5 [49.9, 83]     69 [58.6, 84.5]     64.3 [50.9, 80.6] 
Fat (g)  69 [54.1, 80.6]     67 [50.8, 90.7]     65 [49.3, 86.2]     70 [49.7, 85.4] 
Carbohydrate (g) 245 [222, 269]     241 [196, 293] 265 [238, 292]     252 [210, 286.4] 
Fibre (g) 12.5 [9.2, 15.7] 12.6 [9.9, 17.3] 13.1 [10.8, 20.5] 13 [9.9, 17.3] 
Vitamin B12 (µg) 2.6 [1.3, 3.3]     2.0 [1.2, 3.9]     2.5 [1.0, 3.2]     2.4 [1.2, 3.3] 
Folate (µg) 153 [118, 192]     168.5 [128, 198.5] 167 [145, 222]   162 [134, 204] 
     Values are median [25
th
, 75
th
 centile] 
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Table 5.5: Comparison of estimated energy and nutrients intake by the FFQ during pregnancy 
Nutrient 
Pregnancy (n = 134) 
Total pregnant 
(n = 134) 
1st trimester 
(n = 40) 
2nd trimester 
(n = 60) 
3rd trimester      
(n = 34) 
Energy (kcal) 1302 [994, 1667] 1170 [1020, 1470] 1272 [862, 1533] 1264 [982, 1559] 
Protein (g) 43 [32, 55] 40.4 [32, 51] 44 [34.5, 55.5] 42.7 [32, 53] 
Fat (g)  47 [34, 58] 48 [33, 57] 43 [31.4, 57] 46.9 [33, 58] 
Carbohydrate (g) 184 [139, 238] 169 [130, 207] 173 [123, 225] 174 [131, 220] 
Fibre (g) 9.0 [6.4, 13] 9.1 [6.7, 12.6] 9.5 [7, 11.5] 9.1 [6.7, 12.6] 
Vitamin B12 (µg) 3.6 [3, 5] 3.6 [3.1, 4.4] 4.0 [2.7, 4.8] 3.7 [3.1, 4.5] 
Folate (µg) 145 [103, 175.5] 128 [103, 152.5] 167 [145, 222] 130 [99, 164] 
         Values present are median [25
th
, 75
th
 centile] 
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Table 5.6: Pearson correlation coefficient between different dietary assessment methods 
  Energy-unadjusted correlation  Energy-adjusted correlation 
Nutrient 
SFFQ vs.  
FFQ  
SFFQ vs.  
24 h FR 
FFQ vs.  
24 h FR  
SFFQ vs. 
FFQ   
SFFQ vs.  
24 h FR 
FFQ vs.  
24 h FR 
Energy (kcal) 0.81**  0.27** 0.42**      
Protein (g) 0.73**  0.30** 0.39**  0.81**  0.26** 0.41** 
Fat (g)  0.76**  0.33** 0.40**  0.81**  0.26** 0.41** 
Carbohydrate (g) 0.73**  0.15 0.34**  0.81**  0.27** 0.42** 
Fibre (g) 0.71**  0.25** 0.37**  0.81**  0.27** 0.41** 
Vitamin B12 (µg) 0.59**  0.31** 0.31**  0.70**  0.24** 0.37** 
Folate (µg) 0.77**  0.32** 0.43**  0.81**  0.26** 0.41** 
** correlation is significant at 0.01 level (2 tailed) 
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5.3.4 The validity coefficient (VC) for vitamin B12 and folate using the method of 
triads 
The correlation between different dietary assessment methods and biomarkers 
were used to calculate the validity coefficient for SFFQ and FFQ using the method of 
triads approach and the results are shown in (Table 5.7) and (Table 5.8) respectively 
along with the 95% CIs. Table 5.7 shows that the correlation between both vitamin B12 
and folate estimated intake from SFFQ and 24 h FR vs. biomarker level were weak 
(vitamin B12: rQM = 0.12, rRM = 0.16 and folate: rQM = 0.19, rRM = 0.03 respectively) 
adjusted for age, BMI and estimated energy intake. However, vitamin B12 VC was 
higher between biomarker and the unknown true intake (MT = 0.49) followed by SFFQ 
(QT  = 0.40), and 24 h FR (RT = 0.35). In addition, Table 5.8 shows that the correlation 
between vitamin B12 intake estimated from FFQ vs. serum level was negative, thus the 
VC cannot be estimated. In contrast, relatively good correlation between folate intake 
estimated from FFQ vs. biomarker level was obtained (rQM = 0.31, p < 0.01) compared 
to the 24 h FR. Moreover, folate VC was higher between biomarker and the unknown 
true intake (MT = 0.64) followed by 24 h FR (RT = 0.56), and FFQ (QT  = 0.17).  
 
5.3.5 Serum vitamin B12 insufficiency and estimated intake below and above the 
recommended dietary intake (RDI) level during pregnancy 
 
From the total pregnant sample (n=133), 50.8% (n= 67) had vitamin B12 < 150 pmol/l. 
The proportion of pregnant women who had serum vitamin B12 level < 150 pmol/l 
versus estimated vitamin B12 intake below and above the recommended dietary (RDI) 
level (2.6 µg/d) is presented in (Figure 5.2). The proportion of pregnant women with 
serum vitamin B12 < 150 pmol/l and dietary vitamin B12 intake < 2.6 µg/day were 6/66 
(9%), 10/66 (15.2%) and 39/60 (65%) in SFFQ, FFQ and 24 h FR respectively. In 
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contrast, the proportion of those pregnant with serum vitamin B12 < 150 pmol/l and 
dietary vitamin B12 intake ≥ 2.6 µg/d were 60/66 (91%), 56/66 (84.8%) and 21/60 
(35%) in SFFQ, FFQ and 24 h FR respectively. 
 
 
 
Figure 5.3: Proportion of pregnant women had serum vitamin B12 level < 150 pmol/l 
vs. estimated intake below and above the RDI during pregnancy.  
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               Table 5.7 Validity coefficients (VC) for vitamin B12 and folate estimated by SFFQ, 24 h FR and serum vitamin B12 and  
     folate levels using the method of triads 
 Correlation coefficient (r)  Validity coefficient (VC)  Range for the VC § 
  SFFQ  24 h FR  Biomarker     
 rQM† rRM† rQR ‡  QT  RT  MT  QT RT MT 
Vitamin B12 0.12 0.16 0.24**  0.40  0.35  0.49  0.12 - 0.40 0.16 - 0.35 0.12 - 0.49 
Folate 0.19* 0.03 0.26**  0.17  0.44  0.51  0.17 - 0.19 0.03 - 0.44 0.19 - 0.51 
   T = unknown true dietary intake, Q = SFFQ, R = 24 h FR, M = biomarker (serum level), † Partial correlation adjusted for  
   age, BMI and estimated energy intake, ‡ energy-adjusted correlation, *correlation is significant at 0.05 level, **correlation  
   is significant at 0.01 level, § The lower limit is rQM for the SFFQ and the biomarker and rRM for the 24 h FR and the upper  
   limit is calculated by the method of triads.  
 
 
 
 
 
 
 
 
 
 
 
  
1
4
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    Table 5.8 : Validity coefficients (VC) for vitamin B12 and folate estimated by FFQ, 24 h FR and serum vitamin B12 and  
    folate levels during pregnancy using the method of triads 
 Correlation coefficient (r)  Validity coefficient (VC)  Range for the VC § 
  FFQ  24 h FR  Biomarker     
 rQM† rRM† rQR ‡  QT  RT  MT  QT RT MT 
Vitamin B12 - 0.03 0.16 0.37**  -  -  -  - - - 
Folate 0.31** 0.03 0.41**  0.17  0.56  0.64  0.17 - 0.31 0.03 - 0.56 0.31 - 0.64 
   T = unknown true dietary intake, Q = FFQ, R = 24 h FR, M = biomarker (serum level), † Partial correlation adjusted for age,  
   BMI and estimated energy intake, ‡ energy-adjusted correlation, **correlation is significant at 0.01 level, § The lower limit  
   is rQM for the FFQ and the biomarker and rRM for the 24 h FR and the upper limit is calculated by the method of triads.  
  VC for vitamin B12 cannot be estimated because of the presence of negative correlation. 
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5.4 Discussion 
In this study, we compared the dietary vitamin B12 and folate intake estimated by the 
FFQs and 24 h FR with the corresponding nutritional biomarker among the Saudi 
pregnant population. Firstly, our results on dietary assessment were comparable to what 
has been shown in the pilot study (Chapter 4), where SFFQ generally has a higher 
energy and nutrient estimate compared to the 24 h FR and FFQ. In fact, the present 
study showed that FFQ estimated lower mean energy intake by 42% and 37% compared 
to the SFFQ and 24 h FR respectively, whereas the SFFQ and 24 h FR provided a 
relatively similar energy estimate with a mean difference of 5.3% among the pregnant 
women. Furthermore, the energy and carbohydrate intakes estimated by both SFFQ and 
24 h FR were similar to what has been reported on 1771 Saudi pregnant women, with a 
mean intake of 1811 kcal and 251 g respectively (Al-Shoshan 2007a). A higher mean 
vitamin B12 intake level in the SFFQ versus the 24 h FR were also previously observed 
(Forsythe and Gage 1994) (4.7 vs. 2.8, p < 0.05). The fluctuation on the intake during 
pregnancy could be related to the change in appetite/food habit accompanying the 
pregnancy state.  
Secondly, The correlation coefficients between the SFFQ and 24 h FR for 
energy, fat and (energy-adjusted correlation) carbohydrate were comparable to a 
previous study (Mouratidou et al. 2006). Despite the differences in estimated protein 
intake between the SFFQ and 24 h FR, they had a relatively good correlation (r = 0.34, 
p < 0.001) compared to the other study (Mouratidou et al. 2006). The energy-adjusted 
correlation coefficient for all macronutrients were higher than the other study (Baer et 
al. 2005). In addition, our results of the correlation coefficient between the SFFQ and 
24 h FR for vitamin B12 was higher compared to the other studies (Wei et al. 1999; 
Mouratidou et al. 2006) (r = 0.03 and – 0.09 respectively), while for folate, it was 
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higher to the other (Mouratidou et al. 2006) (r = 0.29). Moreover, the validity of 
different dietary assessment methods for micronutrient intake in pregnant women were 
reviewed and found that the correlation coefficient between SFFQ with a reference 
method of short-term or long-term intake for vitamin B12 ranged between 0.03 to 0.44, 
while for folate ranged between 0.29 to 0.57 (Ortiz-Andrellucchi et al. 2009), which 
supported our results.  
Thirdly, the results did not show any correlation between dietary intake and 
serum levels in both vitamin B12 and folate. Only weak correlation has been shown 
between FFQs and serum folate. As previously reviewed (Ortiz-Andrellucchi et al. 
2009), no study correlated vitamin B12 intake and serum level during pregnancy. 
However, in women of reproductive age, a slightly comparable result for vitamin B12 
correlation between SFFQ and serum was reported (Green et al. 1998; Verkleij-Hagoort 
et al. 2006) (r = 0.19 and 0.21 respectively).  In studies examining folate levels, only 
one study showed a weak correlation between folate intake and serum level (Brantsæter 
et al. 2007). In the latter study, folate intake was estimated from both food and 
supplementation. In general, it was observed that, micronutrient biomarker did not add 
any more certainty in terms of dietary intake method reliability during pregnancy 
(Ortiz-Andrellucchi et al. 2009). Unlike most validation studies, in which data from 
FFQ and one reference method are available, the present study also estimated vitamin 
B12 and folate intake by using three assessment measures (FFQs, 24 h FR and 
biomarker) known as the method of triads. Even though the correlations between the 
methods were low, vitamin B12 VC for the SFFQ was relatively good and similar to the 
biomarker compared to folate VC, suggesting that the SFFQ is a valid tool particularly 
when assessing vitamin B12 intake. Unlike the previous study (Verkleij-Hagoort et al. 
2006), no Heywood case (VC > 1) was shown for vitamin B12. Heywood case reflects 
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either the presence of random sampling fluctuation between sample correlations or one 
or more of the model assumptions was violated, i.e. the VCs are biased (overestimation 
for the questionnaire and reference method and underestimation for the biomarker) 
(Ocke and Kaaks 1997). However, a negative correlation was obtained between FFQ 
and biomarker, thus VC could not be estimated, which is also a type of Heywood case. 
This could support the underestimation of the FFQ compared to the SFFQ method. 
Fourthly, serum vitamin B12 during pregnancy was at the lower level. In 
addition, it decreased from the first to the second trimester. Unlike other studies (Knight 
et al. 1991; Ackurt et al. 1995; Miliman et al. 2006; Takimoto et al. 2007), serum 
vitamin B12 showed a constant level between the second and third trimester. This is 
supported by Carretti et al. were the pattern of vitamin B12 decreased before the 27
th
 
week gestation and after that the levels were almost constant (Carretti et al. 1994). 
Fifthly, even though adequate or a high estimated vitamin B12 intake was 
observed compared to the RDI level, particularly from FFQs, low serum vitamin B12 
was present in about half of the sample. Furthermore, the proportion of pregnant women 
with adequate estimated intake and low serum vitamin B12 (< 150 pmol/l) was high 
compared to those with high serum vitamin B12 (91 vs. 9% and 84.8 vs. 15.2% for 
SFFQ and FFQ respectively) and vice versa for 24 h FR (35 vs. 65%). The difference in 
the FFQs and 24 h FR estimation of vitamin B12 can be explained by under-reporting in 
the 24 h FR for this vitamin (Harrison et al. 2000; Johansson et al. 2001). The possible 
factors that could contribute to this are (1) the improving hygiene, refrigeration and 
prolong cooking of meat products among the general population which is likely to kill 
the microbes that are essential for the vitamin B12 synthesis in the meat and (2) the 
methods used to estimate the dietary vitamin B12 (from the food composition tables) 
could be inaccurate and overestimate the intakes, as they are old and developed in the 
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1970s (Church 2006). As the hygiene is inversely linked to vitamin B12 bioavailability 
(Ball 2004b) this could very well be the reason for such over estimation. Studies 
looking at the bioavailability and nutrient content of different food products are 
therefore urgently required. In addition, the present results support the need to revise the 
RDI levels for micronutrients. The current RDI for micronutrients have been derived 
from levels known to prevent deficiency diseases such as anaemia (Fenech 2001). 
However, micronutrients, particularly vitamin B12 and folate, play a crucial role in the 
genomic stability of human cells by preventing chromosomal breakage and 
hypomethylation of DNA (Fenech 2001), as well as being involved in several other 
critical pathways during development and adult life (Saravanan and Yajnik 2010). 
Vitamin B12 and folate supplementation in controlled studies showed that DNA 
damage can be minimized when plasma vitamin B12 is > 300 pmol/l and folate is > 34 
nmol/l. These concentration can only be achieved at intake levels in excess of the 
current RDI (Fenech et al. 1998; Fenech 2002). 
In conclusion, this is the first study to examine the correlation between dietary 
vitamin B12 and folate intake and its nutritional biomarker among Saudi pregnant 
women using the method of triads. This study supported our pilot study that the 
modified SFFQ used in the study gave useful estimates of energy and some nutrients 
intake in pregnancy, and could be suitable for the investigation of associations between 
nutrition, health and disease in the future studies among Saudi population. However, 
further studies on a larger scale population are also needed to assess dietary vitamin 
B12 and its actual level in blood. 
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Chapter 6 
 
Maternal vitamin B12 and folate status among Saudi population 
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6.1 Introduction 
Vitamin B12 is an essential nutrient in cell metabolism; particularly in DNA synthesis 
as well as for homocysteine (Hcy) metabolism. It is an important co-factor for 2 
enzymatic reactions: methionine synthase (MS) which converts Hcy to methionine in 
the presence of vitamin B12 and folic acid and methylmalonyl-CoA mutase (MCM) 
which is required for the conversion of MM-CoA to Succinyl-CoA in the presence of 
vitamin B12 (Saravanan and Yajnik 2010). Vitamin B12 in nature is produced by 
bacteria and other microorganisms and it is only found in foods of animal sources and 
vegetables contaminated with vitamin B12-synthesized bacteria (Ball 2004b). 
Nutritional insufficiency of vitamin B12 may cause a variety of disorders including 
anaemia, megaloblastosis and neurological disease (Baik and Russell 1999; Bender 
2003), all of which could theoretically be linked to the block in Hcy re-methylation or 
the resulting hyperhomocysteinemia (Scott 1999; Selhub et al. 2007).  
During pregnancy, women have increased an physiological need for this vitamin 
(Milman et al. 2006). This is to meet the increased demand for rapid cell proliferation 
that occurs in the developing embryo, foetus, neonate and pregnant women (Hussein et 
al. 2009). An average of 20 - 30% of pregnant women have been reported to suffer from 
a vitamin deficiency (Baker et al. 2002). Furthermore, frequencies of low birth weight 
infants, still births, and babies born with congenital disorders are high among mothers 
suffering from malnutrition (Leader et al. 1981; Pitkin 1981). As nutritional 
requirements are high, the effects of malnutrition can be severe and long-lasting in 
pregnant mothers (Ackurt et al. 1995). Thus, adequate dietary intake of vitamin B12 is 
required. As previously discussed in Chapter 1, inadequate vitamin B12 status has been 
reported to be associated with a significantly increased risk for NTDs (Suarez et al. 
2003; Molloy et al. 2008). Even after the era of folic acid fortification started, the risk 
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for NTDs tripled in the presence of low maternal vitamin B12 (Ray and Blom 2003; 
Ray et al. 2007). So, the recent concern is the potential role of folic acid to mask or 
exacerbate vitamin B12 insufficiency (Miller et al. 2009). Furthermore, Hcy and related 
B-vitamins like vitamin B12 and folate have been shown to play a crucial role in foetal 
nutrition, growth and development (Hoet and Hanson 1999; Molloy et al. 2009). It has 
been found that high total Hcy and low B-vitamin concentrations are associated with 
birth defects and common pregnancy complications, such as preeclampsia and recurrent 
early pregnancy loss (Aubard et al. 2000; Nelen et al. 2000; Vollset et al. 2000; Refsum 
2001). Recently, the imbalance between the two vitamins (vitamin B12 and folate) has 
been one of the main areas of interest by researchers furthering understanding of the 
effect of these vitamins on human health. It has been reported that the combination of 
low maternal vitamin B12 and adequate/high folate concentration could increase 
adiposity and insulin resistance in the offspring (Yajnik et al. 2008) as well as insulin 
resistance and prevalence of GDM in the mother (Krishnaveni et al. 2009). In addition 
the interaction between serum folate and vitamin B12 status was examined in older 
people from US National Health and Nutrition Examination Survey (NHANES) 
between 1999 - 2002. It was reported that cognitive impairment and anaemia were 
higher among those with low vitamin B12 and high folate compared with low vitamin 
B12 and adequate folate levels (Morris et al. 2007). In a follow-up study using the 
NHANES (before and after folic acid fortification) data, the combination of low serum 
vitamin B12 and high serum folate was also associated with higher Hcy and MMA 
(Selhub et al. 2007). More recently, a cross-sectional study from the Sacramento Area 
Latino Study on Ageing (SALSA) provided an important confirmation of the metabolic 
association, but not the worse cognitive impairment (Carmel 2009; Miller et al. 2009). 
A separate study in an elderly UK population reported no evidence of metabolic, 
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cognitive, or anaemia association of such combination (low vitamin B12 and high folate 
levels) in the setting of voluntary fortification (Clarke et al. 2008). The interaction 
between folate and vitamin B12 status imply that in vitamin B12 insufficiency, high 
folate status is associated with the impaired activity of the 2 vitamin B12 dependent 
enzymes, MS and MCM (Selhub et al. 2007; Selhub et al. 2009). 
As maternal vitamin B12 stores in women eating a mixed diet are approximately 
3000 µg and the vitamin requirement of the foetus is approximately 50 µg, it may be 
assumed that the event of a single pregnancy has minimal impact on maternal stores 
(Koebnick et al. 2002; Schulpis et al. 2004). However, vitamin B12 insufficiency occurs 
in 10 - 28% of women with uncomplicated pregnancies (Pardo et al. 2000; Schulpis et 
al. 2004; Takimoto et al. 2007). As previously reviewed in Chapter 2, vitamin B12 
insufficiency is not rare during pregnancy and it varied between different countries. In a 
vegetarian population, such as in India and Nepal, vitamin B12 insufficiency was 
common with an average prevalence of 50 - 60% (Bondevik et al. 2001; Pathak et al. 
2007; Yajnik et al. 2008; Katre et al. 2010). In the Middle East (the area of our interest), 
it showed an average prevalence of 49 and 51% at the second and third trimester 
respectively (Ackurt et al. 1995; Pardo et al. 2000). Vitamin B12 status has not 
previously been studied in pregnant Saudi women, particularly in the presence of 
mandatory wheat flour fortification with folic acid (150µg/100g) in the KSA (Food 
Safety Authority of Ireland 2006; Safdar et al. 2007). Therefore, we aimed to 
investigate the vitamin B12 and folate status among Saudi pregnancies and estimate the 
frequency of vitamin B12 and folate insufficiency at the second trimester compared to a 
control group of healthy non-pregnant Saudi women. Furthermore, identify the factors 
that independently predict vitamin B12 insufficiency during pregnancy. We also 
examined the interaction between serum vitamin B12, folate and Hcy levels. 
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6.2 Materials and methods 
6.2.1 Study population  
A total of 394 healthy women: 186 pregnant and 208 non-pregnant control 
women living in Riyadh, KSA participated in the present study. Subjects were randomly 
selected from women attending the antenatal clinics and other primary health clinics 
from 4 primary health care centres and the Prince Salman Bin Abdulaziz Hospital in the  
western health sector in Riyadh city. Subjects who agreed to participate were asked to 
fast before their visit to be enrolled in the study. Women aged 18 - 40 years, non-
smokers, with pre-pregnancy BMI > 17 and < 37 kg/m², without any significant medical 
problems and not taking any medication were eligible for the study. Women were 
excluded if they were anaemic, on multivitamins or had any nutrition related pre-
existing medical condition such as coeliac disease, known DM or had any liver, cardiac 
or kidney disease. As a routine practice, general practitioners and obstetricians at the 
hospitals were prescribing a folic acid supplement of 500 µg/day in the first trimester 
and fefol (iron and folic acid) tablets 200 mg/day afterwards for all pregnant women 
attending the clinic.  
 
6.2.2 Ethical approval 
The Research Ethics Committee at Prince Salman Bin Abdulaziz Hospital, and 
the General Directorate of Health Affairs at the Ministry of Health in Riyadh approved 
the study protocol. The written informed consent was obtained from every participant. 
 
6.2.3 Data collection  
The data collection was carried out from May 2009 to December 2010. Data from 
pregnant women was collected at the second trimester; between 16 - 28 weeks gestation. 
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Sociodemographic and anthropometric data was collected. The gestational age and 
maternal weight prior to or at the beginning of gestation were obtained from the patient’s 
medical record. Height and pregnancy weight were measured using the appropriate 
international standard scale (Digital Person Scale, ADAM Equipment Inc., USA). Blood 
pressure was determined with a mercury Sphygmomanometer while participants were in a 
sitting position after being allowed 15 minutes’ rest. A research nurse interviewed the 
participants, explained the study protocol, obtained the consent form and prepared them for 
blood sampling.  
According to the Ministry of Health Protocol for GDM screening, pregnant women 
with a high risk of developing GDM and between 24 - 28 weeks of gestation should have a 
75-gm OGTT (Oral Glucose Tolerance Test) to confirm the presence of DM during 
pregnancy. Pregnant women who meet W O criteria for DM (fasting glucose ≥ 7.0 
mmol/l or 2 h glucose ≥ 11.1 mmol/l) or impaired glucose tolerance (IGT) (2 h glucose ≥ 
7.8 mmol/l and non-diabetes) are classified as having GDM (WHO Consultation 1999; 
Clarke et al. 2008). From a total of 82 pregnant women who had this test, only 10 (12.2%) 
pregnant women were diagnosed as having GDM. In the present study, GDM women were 
used to evaluate and compare the different biomarker levels with the normal pregnant and 
non-pregnant control women.  
 
6.2.4 Blood samples and laboratory analysis  
Fasting blood samples were collected around 8:00 am from the pregnant and 
non-pregnant control women for the measurement of serum vitamin B12, folate, and 
homocystiene. Serum samples were separated from whole blood collected in the plain 
tube after standing for 20 - 30 minutes, then centrifuged in 3500 rmp for 15 minutes. 
Serum aliquots were then kept in the ice-box for about 4 - 6 hours, then later transferred 
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and stored in a - 80° fridge. At the end of the study, all samples were shipped in dry ice 
boxes from the research lab at the UDC, Riyadh, KSA to the Clinical Sciences Research 
labs at the University of Warwick, Coventry, UK after signing the academic human 
material transfer agreement between the parties, and stored until measurements. Serum 
vitamin B12 and folate were measured using the same techniques as mentioned in the 
previous chapter (see Chapter 5). Serum Hcy was measured by ion-paired reversed-
phase HPLC (high-performance liquid chromatography) with electrochemical detection 
as described in Martin et al. (Martin et al. 1999). Hcy analyses were performed in a 
serum sample. Hcy in serum or plasma is shown to be stable for a few days at room 
temperature (Ueland et al. 1993); but our samples were prepared in less than an hour 
and immediately kept on ice. In addition, no significant difference was found comparing 
Hcy in the serum and plasma samples using the HPLC analyser (Church 2006).  
Imprecision data indicated intra-assay coefficients variations (CVs) were 2.2% at mean 
concentration 7 µM  (n = 20) and 2.4% at 20 µM (n = 20), while the inter-assay CVs 
were 8.6% at mean concentration 8.5 µM (n = 8) and 6.8% at 25 µM (n = 8). The 
reference intervals (for individuals aged 20 - 74 years) was 4.6 - 14.2 µmol/L. 
 
6.2.4 Statistical analysis 
All statistical analyses were performed using the SPSS version 18.0 (SPSS Inc., 
Chicago, IL, USA). The data was expressed as mean ± SD or median [interquartile 
range]. Means were compared using independent t-test. The p-value of less than 0.05 
was considered significant. As there is no specific serum cut-off for pregnancy, the cut-
off levels used to define vitamin B12 and folate insufficiency were similar to what has 
been illustrated in the previous chapters (see Chapter 3 and 5). The cut-off levels for 
defining elevated homocysteine level during pregnancy was varied and ranged between 
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> 6.71(Hogeveen et al. 2010) to ≥ 15.42 (Park et al. 2004). However, the cut-off level of 
> 10 umol/l was used in the present study as previously defined (Yajnik et al. 2008; 
Katre et al. 2010). Pearson correlation coefficient was used to determine the strength of 
the relationship between serum vitamin B12, folate and Hcy among pregnant and non-
pregnant control women. Scatter plots were used to present this association through the 
regression line after removing the extreme outliers as described in (Williams 2011). 
Stepwise linear regression analysis was used to identify factors that were independently 
associated with serum vitamin B12 levels during pregnancy. Maternal age, BMI, 
gestational age, weight gain during pregnancy and serum folate and Hcy levels were 
used as independent variables. In addition, logistic regression analysis was used to 
assess the influence of maternal serum vitamin B12 (as a dichotomous variable) on birth 
weight.  The proportion of women who had a serum vitamin B12 below or above the 
cut-off level value was compared with the normal folate level. Geometric mean (95% 
CI) circulating Hcy for serum folate categories (tertiles) was estimated according to 
serum vitamin B12 cut-off levels.  
 
6.3 Results 
6.3.1 Study characteristics 
A total of 394 randomly selected women participated in this study: 186 pregnant 
(10 had GDM and 176 normal pregnancy) and 208 control non-pregnant women. As 
expected, GDM pregnant women were older with a mean age of 35.5 ± 5.0 years and 
heavier with a mean BMI of 29.8 ± 6.7 kg/m2 compared with normal pregnant and non-
pregnant women with mean age of 28.45 ± 5.4 and 27.3 ± 5.4 years and mean BMI of 
26.4 ± 5.23 and 25.01 ± 3.4 kg/m2 respectively. The mean gestational age and weight 
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gain during pregnancy in GDM and normal pregnancy were 25.8 ± 1.6 weeks and 3.9 ± 
3.7 kg and 22.8 ± 4.1 weeks and 4.8 ± 5.1 kg respectively. The general characteristics of 
the pregnant and non-pregnant control women are shown in (Table 6.1).  
 
6.3.2 Study biomarkers results 
The biomarkers results of the pregnant and non-pregnant control participants in 
the study are shown in Table 6.2. This shows that GDM women had lower serum 
vitamin B12 and higher serum folate compared to the normal pregnant (median vitamin 
B12 125.5 vs. 144.4, p = 0.45 and folate 24.9 vs. 21.4, p = 0.256) and non-pregnant 
control women (median vitamin B12 125.5 vs. 237.7, p < 0.001 and folate 24.9 vs. 17.9, 
p = 0.001).  
Similarly, normal pregnant women had significant lower serum vitamin B12 
(median 144.4 vs. 237.7, p < 0.001) and higher serum folate (median 21.4 vs. 17.9, p < 
0.001) compared to the non-pregnant control women. Of the GDM, normal pregnant 
and non-pregnant women, 70%, 54% and 12.5% had a vitamin B12 concentration 
below the cut-off level (150 pmol/l) while 0%, 3% and 4% had folate concentration 
below the cut-off level (9 nmol/l) respectively. Interestingly, normal pregnant women 
had lower serum Hcy compared to the GDM and non-pregnant women (median 4.45 vs. 
5.4, p = 0.099 and 7.2, p < 0.001 respectively). About 13% of non-pregnant women had 
a Hcy level more than 10 umol/l compared to 0% and 1.7% in GDM and pregnant 
women respectively. 
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Table 6.1 General characteristics of the participants in the study 
 GDM 
(n = 10) 
Normal pregnant  
(n = 176) 
Control  
(n = 208) 
Age (years) 35.5 ± 5.0  28.45 ± 5.4 (156) * 27.  ± 5.4 ††  
Weight (kg) 69.0 ± 13.5  64.0 ± 13.2 (156) 62.1 ± 9.6 † 
Height (cm) 153.6 ± 5.3  156.2 ± 6.97 (162) 157.6 ± 6.4  
BMI (Kg/m
2
) 29.8 ± 6.7  26.4 ± 5.23 (156) 25.01 ±  .4 ‡ 
Systolic BP 107.8 ± 11.0  106.7 ± 10.2 (160) 111.4 ± 9.6 (195) ‡‡ 
Diastolic BP 67.9 ± 6.6  67.5 ± 8.9 (160) 72.4 ± 6.1 (195) † ‡‡ 
Weight gain in 
pregnancy (kg) 
3.9 ± 3.7  4.8 ± 5.1 (151) - 
Gestational age (wks.) 25.8 ± 1.6 (9)  22.8 ± 4.1 (153) * - 
Values present are mean ± SD, (n), BP = blood pressure, * p < 0.001 between GDM vs. 
normal pregnant, † p < 0.05 or †† p < 0.001 between GDM vs. control, ‡ p < 0.05 or ‡‡ 
p < 0.001 between normal pregnancy vs. control. 
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Table 6.2 Biomarkers results of the participants in the study  
 GDM  
(n = 10) 
Pregnant  
(n = 176) 
Control  
(n = 208) 
Serum Hcy (umol/l) 
Median [25th, 75th centile] 
Mean ± SD 
Range 
> 10 umol/l, % (n) 
(n = 10) 
5.4 [4.9, 5.7] 
5.  ± 1.07 † 
3.6 - 7.3 
0 (0) 
(n = 176) 
4.45 [3.5, 5.4] 
4.6 ± 1.65 * 
1.5 - 10.96 
1.7 (3) 
(n = 207) 
7.2 [6.0, 8.8] 
7.6 ± 2.53  
2.9 - 18.2 
13 (27) 
Serum vitamin B12 (pmol/l) 
Median [25th, 75th centile] 
Mean ± SD 
Range 
< 150 pmol/l, % (n) 
(n = 10) 
125.5 [94.6, 181.5]  
148.1 ± 72.2 † 
74.7 - 313.8 
70 (7) 
(n = 174) 
144.4 [112.8, 182.5]  
162 ± 117.6 * 
54.2 - 1476 
54 (94) 
(n = 201) 
237.7 [183.2, 312.9]  
264.2 ± 122.2 
87.4 - 814 
12.4 (25) 
Serum folate (nmol/l) 
Median [25th, 75th centile] 
Mean ± SD 
Range 
< 9 nmol/l, % (n) 
(n = 9) 
24.9 [22.5, 26.1] 
25.0 ±  .8 † 
20.4 - 32.6 
0 (0) 
 (n = 171)  
21.4 [16.1, 29.7] 
23.2 ± 9.3 * 
7.6 - 45.3 
1.8 (3) 
(n = 197) 
17.9 [14.1, 20.8] 
18.7 ± 6.75  
6.8 - 45.3 
2.0 (4) 
Values present are mean ± SD or median [25
th
, 75
th
 centile], * p < 0.001 between 
normal pregnant vs. control, † p ≤ 0.001 between GDM vs. control. 
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The distribution of serum vitamin B12, folate and Hcy levels among normal pregnant 
and non-pregnant women are shown in a histogram in Figure 6.1, 6.2 and 6.3 
respectively. 
A.      B.  
Figure 6.1: Frequency distribution of serum vitamin B12 levels among A. pregnant (n 
= 174) and B. non-pregnant control (n = 201) women. 
 
 
 
A.     B.  
 
Figure 6.2: Frequency distribution of serum folate levels among A. pregnant (n = 171) 
and B. non-pregnant control (n = 197) women. 
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   A.     B. 
Figure 6.3: Frequency distribution of serum Hcy levels among A. pregnant (n = 176) 
and B. non-pregnant control (n = 207) women. 
 
 
6.3.3 Variables associated with serum vitamin B12 and folate insufficiency 
A Pearson correlation coefficient and scatter plots were used to describe the 
variables associated with vitamin B12 and folate insufficiency. A Significant negative 
association with Hcy was obtained for both serum vitamin B12; r = - 0.27 , p < 0.001, 
and folate; r = - 0.19, p = 0.007 in the non-pregnant control women. No association was 
found between serum vitamin B12 or folate and Hcy levels in normal pregnant women 
(see Figure 6.4 and 6.5).  
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A.                                                                   B. 
 
 
 
 
 
 
 
 
 
 
Figure 6.4: Scatter plots show regression – serum vitamin B12 vs. Hcy levels A. 
pregnant B. non-pregnant control women after removing extreme outlier. The med line 
shows the mean value and outer lines the 95% CI. 
 
 
      A.              B.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.5: Scatter plots show regression – serum folate vs. Hcy levels A. pregnant B. 
non-pregnant control women after removing extreme outlier. The med line shows the 
mean value and outer lines the 95% CI. 
 
In addition, stepwise linear regression analysis was used to predict factors that 
were independently associated with serum vitamin B12 insufficiency in pregnancy. It 
β = - 0.011 , p = 0.15  β = - 0.266 , p < 0.001  
β =  0.027 , p = 0.7   β = - 0.192 , p = 0.007  
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was found that BMI was the strong negative predictor of serum vitamin B12 during 
normal pregnancy (standardized β (95%  I) - 0.210 (- 13.03, - 1.24), p = 0.02) using 
maternal age, gravidity, parity, BMI, gestational age, weight gain during pregnancy, 
serum Hcy and folate levels as independent variables. Pregnant women with low 
vitamin B12 levels had a mean BMI of 27.2 ± 5.3 compared to 25.4 ± 5.0 in those with 
normal levels. Figure 6.6 shows the comparison scatter plots of the association between 
serum vitamin B12 and BMI in both pregnant and non-pregnant women.  
   A.          B.  
 
 
 
 
 
 
 
 
 
 
Figure 6.6: Scatter plots show regression – serum vitamin B12 vs. BMI A. pregnant B. 
non-pregnant control women after removing extreme outliers. The med line shows the 
mean value and outer lines the 95% CI. 
 
Furthermore, a birth weight measure was available for only 45 normal pregnant 
women; mean 3.02 ± 0.5 (range 1.3 - 3.8) kg. So we studied the possible association 
between maternal serum vitamin B12 and birth weight. No significant association 
between low vitamin B12 and birth weight was found in normal pregnant women (OR 
0.288, 95% CI (0.072 - 1.146), β = - 1.245, p = 0.07). However, pregnant women with 
low vitamin B12 levels had a slightly higher mean birth weight 3.20 ± 0.3 compared to 
those with normal levels 2.90 ± 0.6.      
β = - 0.219 , p = 0.006  β = - 0.115 , p = 0.10  
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6.3.4 Serum vitamin B12, folate and Hcy 
As shown in Table 6.2, about half of the Saudi pregnant women had low serum 
vitamin B12 compared to 12% in the non-pregnant control women. Furthermore, it was 
observed that the proportion of pregnant women with low vitamin B12 and normal 
folate levels was higher (55.4%) compared to the control women (13%) (Figure 6.7). 
 
 
Figure 6.7: The proportion of pregnant and non-pregnant control women with (low 
vitamin B12 + normal folate levels) and (normal vitamin B12 + normal folate levels). 
 
To understand the interaction between serum vitamin B12, folate and their 
functional biomarker Hcy during the pregnancy and non-pregnancy state, serum Hcy 
levels were compared against different folate categories and vitamin B12 cut-off levels 
(Table 6.4). Hcy levels were higher in all categories in vitamin B12 insufficient control 
women compared to those with normal vitamin B12 levels. However, such differences 
were not seen in pregnant women. In addition, we did not observe any increase in Hcy 
levels with increasing folate categories in the vitamin B12 insufficient group in both 
pregnant and non-pregnant women. 
  
 
 
 
 
Table 6.3 Hcy concentration by serum vitamin B12 and serum folate categories.  
 
 
Pregnant 
Geometric mean Hcy   
 
Control 
Geometric mean Hcy   
Serum folate 
nmol/l 
Serum vitamin B12 pmol/l  Serum vitamin B12 pmol/l 
< 150 ≥ 150 p-value  < 150 ≥ 150 p-value 
5.9 4.4 (3.9 - 5.1) (24) 4.3 (3.8 - 5.0) (20) 0.82  10.2 (7.8 - 13.3) (9) 7.4 (6.9 - 7.9) (68) 0.002 
8.3 4.3 (3.6 - 5.2) (22) 4.1 (3.4 - 5.0) (23) 0.75  9.02 (7.6 - 10.8) (9) 7.2 (6.7 - 7.7) (69) 0.03 
13.3 4.6 (4.1 - 5.1) (48) 4.2 (3.7 - 4.7) (34) 0.21  7.0 (5.4 - 9.1) (7) 5.9 (5.3 - 6.6) (34) 0.19 
        Values presented are geometric mean (95% CI) (n). Serum folate values are category medians  
 
 
 
1
6
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6.4 Discussion 
This study has examined the vitamin B12 and folate status among Saudi pregnant and 
non-pregnant control women. It has observed firstly that vitamin B12 insufficiency is 
more common than folate insufficiency in Saudi women, particularly during pregnancy. 
This is consistent with the results from other studies, from both known vegetarian and 
non-vegetarian populations which examined serum vitamin B12 and folate levels at the 
Second trimester, using approximately similar cut-off levels such as the studies from 
India: 60% vs. 0.2%, n = 638 (Yajnik et al. 2008) and 73% vs. 1%, n = 163 (Katre et al. 
2010), Nepal: 49% vs. 4.5%, n = 328  (Bondevik et al. 2001), Newfoundland:    44% vs. 
3%, n = 1424 (House et al. 2000) and UK: 20% vs. 6%, n = 200 (Saravanan et al. 
2010b). The median folate level at 16 - 28 wks. gestation was significantly higher 
compared to non-pregnant control women. Furthermore, more pregnant women had a 
serum folate above the level of 43 nmol/l compared to non-pregnant women (4.7% vs. 
1.5%, p = 0.08). This is likely due to the folic acid supplementation practice during 
pregnancy. The median level of vitamin B12 in our study population was similar to 
what was observed in a recent study of a Caucasian population where the median 
vitamin B12 level in pregnant women (between 16 - 18 wks. gestation, mean age 27 
yrs.) was significantly lower compared to age-matched control non-pregnant women 
(19 .4 vs. 267.9 pmol/l, p ≤ 0.001) respectively. The prevalence of vitamin B12 
insufficiency (< 141 pmol/l) in that population was 20 vs. 4% respectively (Saravanan 
et al. 2010b). In addition, our results in non-pregnant control women were slightly 
comparable to a previous study on 784 Saudi healthy non-pregnant women (between 20 
- 69 yrs.) which showed that mean vitamin B12 and  folate levels were 292 ± 102 
pmol/l and 14.4 ± 5.26 nmol/l respectively (Ardawi et al. 2002). However, the serum 
folate level was higher in another study with a mean of 33.1 ± 13.6 nmol/l (Al-Assaf et 
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al. 2007). In a country such as Saudi Arabia, a wide range of food is easily available to 
women during pregnancy (Al-Shoshan 2007a); thus it is expected that women have an 
adequate nutrient status during this period. However, despite the adequate vitamin B12 
intake that has previously been observed in (Al-Shoshan 2007a) and (Chapter 5) 
compared to the recommended level, more than half of the Saudi pregnant women were 
found to be vitamin B12 insufficient compared to 12% non-pregnant women. 
Furthermore, the combination of low serum vitamin B12 and adequate serum folate 
levels was higher in the pregnant compared to the non-pregnant women. This could be 
owing to the increased metabolic utilization of vitamin B12 during pregnancy, 
especially in the presence of higher folate levels (Saravanan et al. 2010b). The results 
have also found that GDM women had even lower vitamin B12 and higher folate. This 
result is consistent with a result from previous studies (Seghieri et al. 2003; Guven et al. 
2006). 
Secondly, Hcy levels can be increased as a result of either inadequate vitamin 
B12 or folate status during pregnancy (Molloy et al. 2008). However, in the present 
study, we did not find any association between Hcy and vitamin B12 or folate during 
normal pregnancy. In fact, the Hcy level was lower in the pregnant compared to the 
non-pregnant control women. The presence of low Hcy concentrations during normal 
pregnancy has been confirmed by many investigations (Kang et al. 1986; Andersson et 
al. 1992; Holmes 2003). In addition, 30 - 60% lower in Hcy concentrations were found 
in pregnant compared to non-pregnant women (Ueland and Vollset 2004), and the 
lowest values were observed in the Second trimester (Andersson et al. 1992; Walker et 
al. 1999; Murphy et al. 2002; Ueland and Vollset 2004). In contrast, elevated Hcy was 
present in 13% of non-pregnant control women. The Hcy level was slightly comparable 
to a previous study on Saudi women with a mean of 8.5 ± 2.7 umol/l (Ardawi et al. 
 168 
  
2002). Note that their study sample were older compared to the present study sample. 
Furthermore, Hcy concentration was inversely associated with vitamin B12 and folate 
in non-pregnant control women. Thus, it is suggested that folic acid supplementation 
could have an impact in Hcy concentrations during pregnancy, resulting in higher folate 
and lower Hcy concentrations in pregnancy compared to the non-pregnant control 
women (Walker et al. 1999). However, in a longitudinal study, Hcy reduction was not 
explained by folic acid supplementation during pregnancy (Murphy et al. 2002). Other 
studies in non-pregnant subjects demonstrated the relationship between vitamin 
supplementation - containing folic acid and vitamin B12 - and Hcy reduction (Ubbink et 
al. 1993; Ubbink et al. 1994). Other possible factors that could contribute to a low Hcy 
concentration during pregnancy are the physiological effect of pregnancy (Murphy et al. 
2002; Holmes 2003) as well as foetus uptake of the Hcy (Andersson et al. 1992; 
Malinow et al. 1998; Holmes 2003). 
Thirdly, vitamin B12 insufficiency in our study appeared to be associated with 
BMI among pregnant women. This is consistent with other results from Mysore in 
India, where lower serum vitamin B12 levels during pregnancy were associated with 
maternal adiposity compared to normal levels (Krishnaveni et al. 2009). Similarly, the 
results from the Caucasian population (see Chapter 3) showed a similar association 
between vitamin B12 insufficiency and maternal BMI during pregnancy. This in turn 
leads to 2 possible interpretations for this association: one could be that vitamin B12 
insufficiency promotes adiposity or adiposity/obesity lowers serum vitamin B12 
(Krishnaveni et al. 2009). A high prevalence of low micronutrients levels in overweight 
and obese individuals has previously been reported (Kimmons et al. 2006; Mahabir et 
al. 2008; Krishnaveni et al. 2009). This may be as a result of inadequate nutrient intake 
and/or an alteration in nutrient absorption or metabolism (Kimmons et al. 2006; 
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Krishnaveni et al. 2009). Both low serum vitamin B12 and adiposity may be as a result 
of poor quality dietary intake (food rich in energy but less so in micronutrients) 
(Krishnaveni et al. 2009). However, if this explained the association between vitamin 
B12 insufficiency and adiposity, we would expect to have a similar association in the 
non-pregnant control women. 
Fourthly, as previously mentioned the effect of the combination of both low 
vitamin B12 and elevated folate on the increased Hcy level before and after the 
mandatory folic acid fortification (NHANES III and NHANES 1999-2002 respectively) 
in the US (Selhub et al. 2007) and in Mexico (SALSA) (Miller et al. 2009) has been 
reported. However, the present study was first to demonstrate such interaction among 
both Saudi pregnant and non-pregnant women. The results showed a different pattern 
between the 2 groups. The non-pregnant women had a similar trend to what was 
presented in the NHANES III survey, where geometric mean Hcy decreased across 
increasing serum folate categories reaching the significant level among women with 
high vitamin B12 levels. Unlike the NHANES 1999-2002 and SALSA surveys, non-
pregnant women did not have higher Hcy with higher folate and low vitamin B12 
categories. On the contrary, geometric mean Hcy was not different across different 
folate categories and vitamin B12 cut-off levels in the pregnant women. However, we 
observed a slight increase in geometric mean Hcy among the highest folate category 
and low vitamin B12 compared to high vitamin B12 levels. The difference in our results 
compared to the NHANES 1999 - 2002 and SALSA studies could be explained by the 
fact that the present study used younger people and a female sample only and the folate 
levels were ranged within normal reference intervals with a maximum level of 45.3 
nmol/l.     
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Finally, this is the first investigation to study the vitamin B12 and folate status 
during pregnancy among the Saudi population. However, it is cross-sectional in design 
and so it is not possible to describe a cause and effect relation between vitamin B12 
insufficiency and adequate/high serum folate. Moreover, vitamin B12, folate and Hcy 
concentrations are difficult to interpret in pregnancy and there is no agreed cut-off 
levels for deficiency, so we assigned the cut-off level based on previous published 
studies. 
In conclusion, this study showed that at least half of the Saudi pregnant women 
had vitamin B12 insufficiency and more pronounced compared to folate insufficiency. 
Furthermore, vitamin B12 insufficiency was associated with maternal obesity during 
pregnancy. Therefore, well-planned prospective studies are needed to investigate the 
influence of vitamin B12 insufficiency in early pregnancy and the risk of diabetes in 
mother and offspring.  
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Chapter 7 
Discussion 
 
 
 
 
 
 
 
 
 
 172 
  
7.1 Discussion 
It is well known that influences linked to early growth and development have an 
important effect on the risk of T2DM and CVD. The intrauterine environment, 
particularly maternal nutrition, can alter the vital development process in utero. 
Therefore, if the foetus is exposed to an adverse intrauterine environment, it can be 
“programmed” to develop diseases in childhood and adult life (Godfrey and Barker 
2000; Barker 2004; Mcmillen and Robinson 2005), including metabolic disorders. 
Thus, such “gene-diet and gene-environment” interactions, particularly through DNA 
methylation, during foetal development could be an important contributor to the 
epidemic of T2DM (Fenech 2001). However, the exact mechanism of such an 
interaction is not clear. There is some evidence that 1-C metabolism involving key 
vitamins such as vitamin B12 and folate could play an important role in pregnancy and 
the metabolic risk of the offspring (Yajnik et al. 2008). In particular, the intrauterine 
imbalance between these two vitamins (low vitamin B12 and high folate) might play a 
crucial role in foetal programming, which seriously overlap with the growing global 
concern about obesity and adiposity (Rosenberg 2008). In a separate study from India, 
low maternal vitamin B12 in the presence of a high folate level was also related to a 
higher incidence of GDM, higher adiposity and future T2DM in mothers (Krishnaveni 
et al. 2009). Whether such imbalance is common in other parts of the world, in 
particular in the region of our interest where metabolic disorders are the highest in the 
world (Saudi Arabia) is not known. This thesis therefore focused on the prevalence of 
vitamin B12 insufficiency during pregnancy, across the world and in particular in Saudi 
Arabia, in order to identify the potential contribution of maternal vitamin B12 status 
during pregnancy and the associated metabolic risk. 
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In the first part of the thesis, we aimed to understand the worldwide pattern of 
vitamin B12 insufficiency, particularly in the non-vegetarian population. This was done 
by doing a systematic review to identify all relevant observational studies in the 
literature investigating the prevalence of vitamin B12 insufficiency during pregnancy. 
Vitamin B12 insufficiency was demonstrated in the different continents and countries, 
and the emerging data clearly identified that, despite the fact that the prevalence of 
vitamin B12 insufficiency varied between different countries, vitamin B12 insufficiency 
is not rare during pregnancy, even in non-vegetarian populations. Generally the Middle 
Eastern region, which ranked second in the world for the prevalence of T2DM (Shaw et 
al. 2010), showed an average prevalence of about 50% during pregnancy which could 
support the possible role of vitamin B12 insufficiency and increased risk of T2DM in 
this region. No previous studies on a prevalence of vitamin B12 insufficiency from 
Saudi Arabia, the area of our interest, were identified in our review. This reflects the 
need to understand the pattern of maternal vitamin B12 insufficiency in Saudi Arabia.  
As expected, the maternal imbalance between vitamin B12 and folate levels 
were observed in vegetarian populations; however, a similar pattern was also observed 
in some studies from known non-vegetarian populations as well. The maternal 
imbalance between the two related nutrients, as previously discussed, is becoming the 
main concern (Glew et al. 2006), particularly after the mandatory folic acid fortification 
era started in 1997. In Canada, folic acid insufficiency is increasingly rare, while the 
prevalence of vitamin B12 insufficiency has increased. In addition, the NTDs related to 
vitamin B12 insufficiency have tripled in the same period (Ray and Blom 2003; Ray et 
al. 2007). Thus, an average prevalence of vitamin B12 insufficiency from the included 
studies in the review were plotted on a world map in order to understand the pattern of 
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maternal vitamin B12 status before and after the initiation of folic acid fortification in 
1997. The trend of change in America can be clearly observed.  
In addition, children from PMNS were short and thin but relatively adipose, and 
those born to mothers with low vitamin B12 but high folate concentrations were the 
most insulin resistant (Yajnik et al. 2008). Therefore, the thesis also investigated the 
possible role of maternal vitamin B12 insufficiency, as an independent risk factor, in 
predicting low birth weight in the offspring. Our results from the systematic review and 
the UK retrospective study were mixed and did not provide clear-cut conclusions. 
However, the data supported our hypothesis that vitamin B12 insufficiency is not rare in 
the UK population and other non-vegetarian populations worldwide as well as maternal 
obesity and a higher incidence of GDM. This provides independent support to the 
Indian data (Krishnaveni et al. 2009). The plausible biochemical reasons why vitamin 
B12 insufficiency could increase adiposity and insulin resistance, particularly in the 
presence of adequate/high folate, has been discussed in the PMNS study (Yajnik et al. 
2008). On the one hand, vitamin B12 insufficiency will trap cellular folate as 5-
methyltetrahydrofolate (Scott 1992). This will prevent the formation of methionine 
from homocysteine and thus impair protein synthesis and reduce lean tissue deposition. 
On the other hand, MM-CoA mutase, for which vitamin B12 acts as a cofactor, is 
required for the degradation of odd-chain fatty acids and branched-chain-amino acids, 
in particular the conversion of MM-CoA to succinyl-CoA. In the presence of vitamin 
B12 insufficiency, an accumulation of MMA will occur and may increase lipogenesis 
and insulin resistance (Yajnik et al. 2008). Moreover, GDM women with vitamin B12 
insufficiency had heavier babies compared to GDM women with normal levels. It is 
conceivable that higher glucose levels in the presence of low vitamin B12 may 
particularly be adipogenic resulting in a higher birth weight. This observation needs 
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urgent replication in a prospective study along with the measurement of other 1-C 
metabolites in addition to the vitamin B12, folate and homocysteine levels. 
The second part of the thesis focused on replicating this data in the Saudi 
population, where T2DM has already reached epidemic proportions and is of a major 
concern in the Middle Eastern region. In addition, changes in the life style and dietary 
pattern in Saudi are believed to contribute to the increasing prevalence of obesity and 
chronic diseases (Musaiger 2000; Musaiger 2004). As biomarker measurements are 
expensive to estimate in the general population, we conducted a validation study of an 
estimated intake of these 2 vitamins along with the actual blood levels. Thus, we aimed 
first to evaluate the performance of the modified SFFQ and compare the energy, macro- 
and micronutrient estimates to the different dietary assessment methods in a pilot study. 
This in turn helped us to use the SFFQ as a dietary assessment tool along with a 24 h 
FR to answer the  uestion: “Does the estimated dietary intake of vitamin B12 and folate 
correlate with actual blood levels in the Saudi population?”. The thesis showed no 
correlation between dietary intake and serum levels of both vitamins in the Saudi 
population. To our knowledge, this is the first to report a correlation between maternal 
serum and vitamin B12 intake among the Saudi population. This is similar to data from 
one study of a population during pregnancy (Ortiz-Andrellucchi et al. 2009) but slightly 
different to another which showed a weak correlation between serum levels and folate 
intake (Brantsæter et al. 2007). This could be related to the variability in dietary intake 
measurement, individuals’ absorption, availability and metabolism of the vitamins, 
which can be important sources of random variations in the biomarker, unrelated to true 
dietary intake (Kaaks 1997).  
The thesis also demonstrated that Saudi pregnant women in general had vitamin 
B12 at a lower limit and this is relatively similar to what was reported in both a 
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vegetarian population (Yajnik et al. 2008) and that of a non-vegetarian population 
(Saravanan et al. 2010c). This further strengthens the argument that vitamin B12 
insufficiency is not rare during pregnancy even in populations with a high intake of 
animal proteins. The dietary estimate of vitamin B12 was adequate or high (in deed 
higher than the recommended; 5.8 µg by SFFQ) among the Saudi population compared 
to the RDI level. Despite this good intake, vitamin B12 insufficiency was present in 
about half of the pregnant sample. One of the possible factors that could contribute to 
this is the improving hygiene, refrigeration and prolong cooking of meat products 
among the general population which is likely to kill the microbes that are essential for 
vitamin B12 synthesis in meat. It is also possible that the methods used to estimate the 
dietary vitamin B12 intake are inaccurate and over-estimate, as they are old and were 
developed in the 1970s (Church 2006). As hygiene is inversely linked to vitamin B12 
bioavailability (Ball 2004b) this could very well be the reason for such over estimation. 
Functional food studies looking at the bioavailability and nutrient content of different 
food products are therefore urgently required. This may mean the need to revise the 
RDI levels for micronutrients. Perhaps the current RDI derived from levels to prevent 
deficiency disease, which is rare in developed countries, and more attention should be 
given to defining an optimal micronutrients requirement for genomic stability to prevent 
degenerative and developmental disease (Fenech 2001; Fenech 2002). 
Finally, the thesis presented the vitamin B12 and folate status among Saudi 
pregnant and non-pregnant healthy control women. Vitamin B12 insufficiency was 
more pronounced than folate insufficiency in Saudi women, particularly during 
pregnancy. This is consistent with the results from other studies, from both known 
vegetarian and non-vegetarian populations. Serum folate levels ranged within normal 
reference levels in both groups. However, more pregnant women had folate levels 
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above 43 nmol/l compared to the controls. This could be related to the mandatory folic 
acid fortification and the preconception folic acid supplementation practice in Saudi 
Arabia. In addition, the combination of low serum vitamin B12 and adequate serum 
folate levels was higher in the pregnant compared to the non-pregnant women. This 
could be due to the increased metabolic utilization of vitamin B12 during pregnancy, 
especially in the presence of higher folate levels (Saravanan et al. 2010b). Furthermore, 
the previous studies (Selhub et al. 2007; Miller et al. 2009) have provided us with new 
information which would need replicating. In individuals with vitamin B12 
insufficiency, vitamin B12’s enzymatic functions worsen with increasing levels of 
folate. Therefore, the thesis has studied the interaction between low vitamin 
B12/adequate folate on the increased Hcy level during pregnancy and the non-
pregnancy state. The results showed a different pattern between the 2 groups. In non-
pregnant women, Hcy levels were higher in all categories in women with low vitamin 
B12 compared to those with normal vitamin B12 levels. However, such differences 
were not seen in pregnant women. Unlike the previous mentioned studies, we did not 
observe any increase in Hcy levels with increasing folate categories in the vitamin B12-
insufficient group in both pregnant and non-pregnant women. This could very well be 
due to the small sample size in that particular sub-group. 
 
7.2 Conclusion and future research 
 The current thesis highlights the potential role of vitamin B12 and folate in 
foetal programming and the possible contribution to T2DM epidemics. It provides us 
with an overview of the worldwide vitamin B12 insufficiency during pregnancy. In fact, 
vitamin B12 insufficiency is not rare during pregnancy, even in non-vegetarian 
populations such as the Saudi population. Vitamin B12 insufficiency was observed even 
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in the presence of adequate or high levels of estimated vitamin B12 intake. Introducing 
mandatory vitamin B12 fortification is under consideration in the US (Food and 
Nutrition Program of the Pan American Health Organization; March of Dimes; Centers 
for Disease Control and Prevention 2004; Green 2009). However, such a 
recommendation should only be taken after careful evaluation (Saravanan and Yajnik 
2010). These studies should also be designed to look at the adverse effects of 
inadvertent high-dose vitamin B12 supplementation (such as excess accumulation of 
cyanocobalamin) (Carmel 2008). Despite the new knowledge provided by this thesis, a 
number of questions are unanswered in the Saudi population. Further studies should be 
designed to look at: 
a) Causative role of early pregnancy vitamin B12, folate and homocysteine levels 
on maternal adiposity and GDM. 
b) Pre-pregnancy imbalance of vitamin B12/folate levels and the impact on birth 
weight and metabolic risk of offspring. 
c) Functional food studies in traditional animal foods and the bioavailability of 
vitamin B12 in Saudi Arabia. 
d) Mechanistic studies including epigenetic mechanisms contributing to the 
epidemic of metabolic diseases including T2DM and CVD. 
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List of abstracts 
 
Poster presentations:  
1. Bawazeer N, Rafnsson S, Saravanan P. (2011). Does vitamin B12 insufficiency 
during pregnancy happen in non-vegetarian?  7
th
 world congress of 
developmental origins of health and disease (DOHAD), Portland, USA on 18 - 
20 September 2011.  
 
Aims: In most population, both low and high birth weight is associated with onset of 
diabetes in later life. This is called “nutrient” and “fuel” mediated teratogenesis, 
respectively. Studies from India showed children born to mothers with low B12, 
especially in association with high folate levels, have higher adiposity at birth and 
higher insulin resistance at 6 years of age. In addition, mothers with low maternal B12 
had higher incidence of gestational diabetes and future type 2 diabetes. The B12 
insufficiency rate in these studies was high between 40 & 70%, presumably due to 
vegetarianism. It is not known whether similar phenomenon exists in non-vegetarian 
population across the world. We did a systematic review to study the prevalence of B12 
insufficiency during pregnancy. 
Methods: A comprehensive literature search in six electronic databases for publications 
on the prevalence of B12 insufficiency during pregnancy, screening of reference lists, 
and citation search was conducted. All databases were searched using a combination of 
keywords from inception to February 2011. Publications of all studies (longitudinal or 
cross sectional studies) on normal adult pregnancy were further inspected and studies 
mentioned the prevalence of B12 insufficiency were included. 
Results: Thirty-three studies (Americas – 8, Europe & middle east – 4, Africa – 7 & 
Australasia – 11) have reported the prevalence of B12 insufficiency. Studies differed in 
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the population studied, period of blood collection and the cut-off used to define B12 
insufficiency. Number of studies reporting the B12 insufficiency according to the 
trimesters were: 1st – 7, 2nd – 19 and 3rd – 22. The overall B12 insufficiency was 
between 42 - 74% in the vegetarian population (6 from India and 1 from Nepal – all 2nd 
& 3rd trimester) apart from 1 study in Nepal (28.3%; 1st trimester; cut-off 221 pmol/L). 
In non-vegetarian population, it ranged from 4.5 – 80.9%. The deficiency rates 
according to the trimesters were: 1st (n = 6) – 4.3-44.2%, 2nd (n = 17) – 4.5-60% and 
3rd (n = 15) – 5.7-80%. Studies with rates below 10% used lower cut-off values to 
define B12 insufficiency. 
Conclusions: This systematic review showed that B12 insufficiency during pregnancy 
is not uncommon in non-vegetarian population worldwide and can be high similar to the 
levels seen in vegetarian population. Studies correlating the B12 levels and the 
metabolic risk of mothers and offspring in non-vegetarian population are urgently 
warranted. 
 
 
2. Sukumar N, Bawazeer N, Patel V, Saravanan P. (2011) Low B12 level is 
associated with maternal obesity and higher Birth weight in Gestational 
Diabetes. 7
th
 world congress of developmental origins of health and disease 
(DOHAD), Portland, USA on 18 - 20 September 2011.  
 
Background: In most populations, both low and high birth weights are associated with 
onset of T2DM in later life. Studies from India showed low maternal vitamin B12 is 
related to higher incidence of GDM, higher adiposity and insulin resistance in offspring 
and future T2DM in mothers. It is not known whether similar phenomenon exists in UK 
population. We aim to study vitamin B12 status in pregnancy and investigate its 
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relationship with maternal BMI, incidence of GDM and birth weight in women with and 
without GDM. 
Methods: Retrospective study of mothers attending the antenatal diabetes and medical 
clinics (2005-10) in Warwickshire, UK (mainly Caucasian population). Maternal B12 
and folate levels are checked routinely in most women. The inclusion criteria were 
women without pre-gestational diabetes delivering live, singleton babies. 
Results: Of the 270 mothers who met the inclusion criteria, B12 and folate were 
measured in 209 and in 38 of the 60 women with GDM at median 24 weeks. As 
expected, GDM mothers were older than non-GDM (33.5 vs. 30.5 years, p < 0.001) and 
had higher BMI (31.0 vs. 26.1, p < 0.001). The median (IQR) B12 and folate levels 
were 143.9 (106.3, 194.5) pmol/L and 15.9 (10.0, 25.8) nmol/L respectively. Women 
with B12 insufficiency( 150 pmol/L) had higher BMI at booking (28.0 vs. 25.7, p = 
0.013; controlled for age, smoking, folate and presence of GDM). Women who 
developed GDM had slightly lower B12 (146.8 vs. 172.4 pmol/L, p = 0.259) though this 
was not statistically significant. Similarly, a non-significant difference was seen in the 
proportion of B12-insufficient women developing GDM (19.1 vs. 17%). GDM mothers 
with B12 levels below the median had heavier babies (3522.1 vs. 3211.1 g, p = 0.025). 
This difference persisted even after controlling for folate levels, gestation at birth, 
maternal age and booking BMI ( -0.39, p = 0.017). No such difference was seen for 
non-GDM mothers (3421.8 vs. 3345.8g, p = 0.395) 
Conclusions: Our study showed that B12 insufficiency is not rare in UK Caucasian 
population; is associated with maternal obesity; possible higher incidence of GDM and 
macrosomia in GDM. As it is retrospective and observational study, causality cannot be 
ascertained. However, this is the first study to show the possible interaction between 
B12 levels, GDM, and their additive influence on birth weight. Adequately powered 
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prospective studies are urgently needed on the influence of early pregnancy B12 levels 
on the risk of GDM and neonatal outcomes.  
 
Oral presentations 
1. Bawazeer N, Rafnsson S, Saravanan P. (2011). “B12 insufficiency doesn’t 
happen in non-vegetarians: Systematic review of B12 levels in pregnancy”. 
(2011). WISDEM/IAS/CSRI Annual Symposium, University of Warwick, 
Coventry on 11 March 2011.  
 
2. Bawazeer N, Al-Daghri N, Al-Rubeaan K, Sabico SL, Kumar S. (2010). Sleep 
duration strongly predicts childhood obesity among Arabs. 4th Saudi 
International  onference “Saudi minds in action”, University of Manchester, 
Manchester on 30 - 31 July 2010.  
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Appendix I : Worldwide mandatory folic acid food fortification   
 
Worldwide mandatory folic acid food fortification has been introduced in more than 40 
countries in order to reduce and/or prevent the NTDs pregnancies (Figure). In addition 
to the USA and Canada, many South American, African and Middle Eastern countries 
also implement a mandatory folic acid food fortification policy. Australia and New 
Zealand are currently exploring the option of mandatory fortification for the prevention 
of birth defects for the first time. Some European countries permit a range of foods to 
be fortified on a voluntary basis such as Belgium, France, Germany, Greece, Hungary, 
Iceland and Ireland. UK is currently re-examining their policy in this area. On the other 
hand, national legislation in the Netherlands prohibits both mandatory and voluntary 
folic acid food fortification (Food Safety Authority of Ireland 2006). 
 
 
Figure illustrates the 42 countries that have mandatory folic acid food fortification 
program. It includes USA, Canada, South America and Caribbean, Israel, Saudi Arabia, 
Bahrin, Qatar, Oman, Yemen, Morroco, Nigeria, South Africa, Zambia, Malawi, 
Indonesia and Kazakhstan. Figure obtained from (Food Safety Authority of Ireland 
2006). 
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Appendix II : The worldwide trend in wheat flour fortification from 2004 to 2007.  
 
Fortification of wheat flour is an effective, simple and inexpensive method for 
providing folic acid to large segments of the world population. The number of countries 
with documented national regulations for mandatory wheat flour fortification increased 
from 2004 to 2007. Therefore, the worldwide percentage of wheat flour fortified 
increased from 18% in 2004 to 27% in 2007 (Figure). Approximately, 540 million 
additional persons, including 167 million additional women aged 15 - 60 years had 
access to fortified wheat flour and the annual number of newborns whose mothers had 
access to fortified wheat flour during pregnancy increased by approximately 14 million. 
By region, the greatest increase was in the Eastern Mediterranean Region: from 5% to 
44%, while the region with the highest percentage of fortified wheat flour, America, 
increased from 90% to 97% , Africa increased from 26% to 31%, South-East Asia from 
16% to 21%, Europe from 3% to 6%, and the Western Pacific region from 2% to 4% 
(Center for Disease Control and Prevention 2008).  
 
 
 
 
 
 
 
 
 
Figure illustrates the worldwide percentage change of wheat flour processed in roller 
mills that was fortified by World Health Organizations (WHO) region - 2004 and 2007. 
Figure obtained from (Center for Disease Control and Prevention 2008).  
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Appendix III: The quality assessment of the longitudinal studies included in the systematic review (A) 
   
  
 Table 1 The quality assessment of studies included in the review 
 
Quality assessment criteria Lowenstein et al. 
1960 
Whiteside et al. 
1968 
Robert et al. 
1973 
Barbin et al. 
1986  
Knight et al. 
1991 
Bruinse et al. 
1995  
Ackurt et al. 
1995   
1. Research question/ hypothesis clearly defined and stated? √ √ √ √ √ √ √ 
2. Is the targeted population defined? × × √ √ √  √ √ 
3. Is the sampling frame defined? × √ √ √ √ √ √ 
4. Is the study population defined? × √ √ √ √ √ √ 
5. Are the study setting and/or geographic location stated? × × √ √ √ √ √ 
6. Are the dates between which the study was conducted stated 
or implicit? 
× × √ √ √ × √ 
7. Are eligibility criteria stated? × √ × P √ √ √ 
8. Are issue of “selection in” to the study mentioned? × × √ √ √  √ √ 
9. Is the no. of participants justified? × × × × × × × 
10. Are no. meeting and not meeting the eligibility criteria 
stated? 
× × × × × √ √ 
11. For those not eligible, are the reasons why stated? × × × × × √ √ 
12. Are the numbers of people who did/did not consent to 
participate stated? 
× × × × √ √ × 
13. Are the reasons that people refused to consent stated? × × × × × × × 
14. Were consenters compared with non-consenters? × × × × × × × 
15. Was the number of participants at the beginning of the 
study stated? 
× √ √ √ √ √ √ 
16. Were methods of data collection stated? × √ √ √  √ √ √ 
17. Was the reliability (repeatability) of measurement methods 
mentioned? 
√ × × √ √ × × 
18. Was the validity (against a ‘gold standard’) of 
measurement methods mentioned? 
√ × × √ × × × 
19. Were any confounders mentioned? P × √ × √ √ √ 
Based on NICE guidance for public health 2009 which was adapted from the Tooth et al. 2005 checklist criteria. 
(n/a) was indicating, when the question was not applicable to the study design, P = poorly addressed. 
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Cont. Table 1 
Quality assessment criteria Lowenstein et 
al. 1960 
Whiteside et al. 
1968 
Robert et al. 
1973 
Barbin et al. 
1986  
Knight et al. 
1991 
Bruinse et al. 
1995  
Ackurt et al. 
1995   
20. Was the number of participants at each stage/wave 
specified? 
√ × √ √  √ × √ 
21. Were reasons for loss to follow-up quantified? × × × × × √ √ 
22. Was the missingness of data items at each wave 
mentioned? 
× × × ×  × × 
× 
23. Was the type of analyses conducted stated? P √ × √  √ √ √ 
24. Were “longitudinal” analysis methods stated? P √ √  √ √ √ √ 
25. Were absolute effect sizes reported? √ √ √ √ √ P √ 
26. Were relative effect sizes reported? × × × × × × × 
27. Was loss to follow up taken into account in the analysis? × × ×  × × × P 
28. Were confounders accounted for the analyses? × × √ × × √ × 
29. Were missing data accounted for the analyses? × × × × × × × 
30. Was the impact of biases assessed qualitatively? × × × × × × × 
31. Was the impact of biases estimated quantitatively? × × × × × × × 
32. Did authors relate results back to a target population? √ √ √ √ √ √ √  
33. Was there any other discussion of generalizability? × × P × × × √ 
Overall assessment  
 
 
 
 
 
 
 
 
 
Few criteria 
fulfilled-
unfulfilled 
criteria are 
unlikely/very 
likely to alter the 
conclusion 
 
Few criteria 
fulfilled-
unfulfilled 
criteria are 
unlikely/very 
likely to alter 
the conclusion 
 
Some criteria 
fulfilled-
unfulfilled 
criteria 
unlikely to 
alter the 
conclusion 
 
Some criteria 
fulfilled-
unfulfilled 
criteria 
unlikely to 
alter the 
conclusion 
 
Some criteria 
fulfilled-
unfulfilled 
criteria 
unlikely to 
alter the 
conclusion 
 
Some criteria 
fulfilled-
unfulfilled 
criteria 
unlikely to 
alter the 
conclusion 
 
Some criteria 
fulfilled-
unfulfilled 
criteria 
unlikely to 
alter the 
conclusion 
 
Based on NICE guidance for public health 2009 which was adapted from the Tooth et al. 2005 checklist criteria. 
(n/a) was indicating, when the question was not applicable to the study design, P = poorly addressed. 
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Table 2 The quality assessment of studies included in the review 
 
Quality assessment criteria Pagan et al. 
2002 
Milman et al. 
2006   
Murphy et al. 
2007 
Takimoto et al. 
2007 
Yajnik et al. 
2008   
Li et al. 
2008  
Katre et al. 
2010  
Haliloglu et al.  
2010 
1. Research question/ hypothesis clearly defined and stated? √ √ √ √ √ √ √ √ 
2. Is the targeted population defined? √ √ √ √ √ √ √ √ 
3. Is the sampling frame defined? √ × √ √ √  √ √ √ 
4. Is the study population defined? √ √ √ √ √ √ √ √ 
5. Are the study setting and/or geographic location stated? √ √ √ √ √ √ √ √ 
6. Are the dates between which the study was conducted stated 
or implicit? 
√ √ × √ √ √ √ 
× 
7. Are eligibility criteria stated? × √ √ √ √ × √ √ 
8. Are issue of “selection in” to the study mentioned? √  √ √ √ √ √ √ √ 
9. Is the no. of participants justified? × × × × × × × × 
10. Are no. meeting and not meeting the eligibility criteria 
stated? 
× √ × √ √ √ √ 
√ 
11. For those not eligible, are the reasons why stated? × √ × √ √ √ √ √ 
12. Are the numbers of people who did/did not consent to 
participate stated? 
× √ √ √ √ √ √ 
√  
13. Are the reasons that people refused to consent stated? × × × × × × × × 
14. Were consenters compared with non-consenters? × × × × × × × × 
15. Was the number of participants at the beginning of the 
study stated? 
√ √ √ √ √ √ √ √ 
16. Were methods of data collection stated? √ √ √ √ √ √ √ √ 
17. Was the reliability (repeatability) of measurement methods 
mentioned? 
× × √ × × × √ 
× 
18. Was the validity (against a ‘gold standard’) of 
measurement methods mentioned? 
√ × √ √ × × × 
× 
19. Were any confounders mentioned? √ × √ √ √ √ √ × 
Based on NICE guidance for public health 2009 which was adapted from the Tooth et al. 2005 checklist criteria. 
(n/a) was indicating, when the question was not applicable to the study design, P = poorly addressed. 
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Cont. Table 2 
Quality assessment criteria Pagan et al. 
2002 
Milman et al. 
2006   
Murphy et al. 
2007 
Takimoto et 
al. 2007 
Yajnik et al. 
2008   
Li et al.  
2008  
Katre et al. 
2010  
Haliloglu et 
al.  2010 
20. Was the number of participants at each stage/wave 
specified? 
× × √ √ √ √ √ 
× 
21. Were reasons for loss to follow-up quantified? × × × √ √ √ √ √ 
22. Was the missingness of data items at each wave 
mentioned? 
×  
× 
√ √ × √ 
√ × 
23. Was the type of analyses conducted stated? √ √ √ √ √  √ √ √ 
24. Were “longitudinal” analysis methods stated? √  √ √ √ √ √ √ √ 
25. Were absolute effect sizes reported? √ √ √ √ √ √ √ √ 
26. Were relative effect sizes reported? √ × × √ × × √ × 
27. Was loss to follow up taken into account in the 
analysis? 
×  × × × ×  × × × 
28. Were confounders accounted for the analyses? √ × √ √ √ √ √ × 
29. Were missing data accounted for the analyses? ×  × × × √ × × × 
30. Was the impact of biases assessed qualitatively? × × × √ √ √ √ × 
31. Was the impact of biases estimated quantitatively? × ×  × × × ×  × × 
32. Did authors relate results back to a target 
population? 
√ √ √ √ √ √ √ √ 
33. Was there any other discussion of generalizability? × √ × × √ × × × 
Overall assessment  
 
 
 
 
 
 
 
 
 
Some criteria 
fulfilled-
unfulfilled 
criteria 
unlikely to 
alter the 
conclusion 
  
Some criteria 
fulfilled-
unfulfilled 
criteria 
unlikely to 
alter the 
conclusion 
 
Some criteria 
fulfilled-
unfulfilled 
criteria 
unlikely to 
alter the 
conclusion 
 
Most criteria 
fulfilled-
unfulfilled 
criteria very 
unlikely to 
alter the 
conclusion 
 
Most criteria 
fulfilled-
unfulfilled 
criteria very 
unlikely to 
alter the 
conclusion 
 
Some criteria 
fulfilled-
unfulfilled 
criteria 
unlikely to 
alter the 
conclusion 
 
 
Most criteria 
fulfilled-
unfulfilled 
criteria very 
unlikely to 
alter the 
conclusion 
 
Some criteria 
fulfilled-
unfulfilled 
criteria 
unlikely to 
alter the 
conclusion 
Based on NICE guidance for public health 2009 which was adapted from the Tooth et al. 2005 checklist criteria. 
(n/a) was indicating, when the question was not applicable to the study design, P = poorly addressed. 
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Appendix IV: The quality assessment of cross-sectional studies included in the systematic review (A) 
 
 
Table 1 The quality assessment of cross-sectional studies included in the review 
 
Quality assessment criteria Zachau-Christiansen 
et al. 1962 
Ball et al.  
1964 
Cook et al. 
1971 
Marzan  et al. 
1971 
Yusufji et al. 
1973 
Cole et al. 
1974 
       
Study objective       
Clearly stated objective is described 1 0 1 1 1 0 
       
Study population       
Were valid selection criteria used for the study population? 1 0 1 1 1 0 
Did more than 80% of the eligible subjects participate in the study? 1 1 1 1 1 0 
       
Exposure assessment       
Was the exposure measured with a valid and reproducible method? n/a n/a n/a n/a n/a n/a 
       
Outcome assessment       
Was the outcome measured with a valid and reproducible method? 1 1 1 1 1 1 
Were only new and incident patients used? 1 0 1 1 1 1 
       
Analysis       
Were the results adjusted for possible confounders? 0 0 0 0 0 0 
Were more than 100 subjects included in the study* 1 1 1 0 1 1 
       
Total score 6/7 3/7 6/7 5/7 6/7 3/7 
Overall assessment 86% 43% 86% 71% 86% 43% 
Based on checklist from Ariens et al., 2000 and van der Windt et al., 2000.  
Yes = 1 point,  No or unclear = 0 points,  Total score are ≥ 6 or ≥ 75% = high  uality study and < 6 or < 75% = low  uality study, n/a = not applicable. 
*more than 50 participants was a requirement for inclusion in the review. Studies with more than 100 participants were rewarded with an additional point.  
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Table 2 The quality assessment of cross-sectional studies included in the review 
 
Quality assessment criteria Baker et al. 
1975 
Colman et al. 
1975 
Areekul et al. 
1976 
Jacob et al. 
1976 
Osifo et al. 
1976 
Srisupandit et al. 
1983 
       
Study objective       
Clearly stated objective is described 1 0 1 0 1 1 
       
Study population       
Were valid selection criteria used for the study population? 1 1 1 1 0 1 
Did more than 80% of the eligible subjects participate in the study? 1 1 1 1 1 1 
       
Exposure assessment       
Was the exposure measured with a valid and reproducible method? n/a n/a n/a n/a n/a n/a 
       
Outcome assessment       
Was the outcome measured with a valid and reproducible method? 1 1 1 1 1 1 
Were only new and incident patients used? 1 1 1 1 1 1 
       
Analysis       
Were the results adjusted for possible confounders? 1 0 0 0 0 0 
Were more than 100 subjects included in the study* 1 1 1 1 0 1 
       
Total score 7/7 5/7 6/7 5/7 4/7 6/7 
Overall assessment 100% 71% 86% 71% 57% 86% 
Based on checklist from Ariens et al., 2000 and van der Windt et al., 2000. 
Yes = 1 point,  No or unclear = 0 points, Total score are ≥ 6 or ≥ 75% = high  uality study and < 6 or < 75% = low  uality study, n/a = not applicable. 
*more than 50 participants was a requirement for inclusion in the review. Studies with more than 100 participants were rewarded with an additional point.  
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Table 3 The quality assessment of cross-sectional studies included in the review 
 
Quality assessment criteria Giugliani et al. 
1984 
Ho Chao-hung  
et al . 1987 
Frey et al. 
1992 
Black et al. 
1994 
House et al. 
2000 
Bjorke-Monsen 
et al 2001 
       
Study objective       
Clearly stated objective is described 1 1 1 1 1 1 
       
Study population       
Were valid selection criteria used for the study population? 1 1 1 1 1 1 
Did more than 80% of the eligible subjects participate in the study? 1 1 1 1 1 1 
       
Exposure assessment       
Was the exposure measured with a valid and reproducible method? n/a n/a n/a n/a n/a n/a 
       
Outcome assessment       
Was the outcome measured with a valid and reproducible method? 1 1 1 1 1 1 
Were only new and incident patients used? 1 1 1 1 0 1 
       
Analysis       
Were the results adjusted for possible confounders? 0 0 1 0 0 1 
Were more than 100 subjects included in the study* 0 1 1 0 1 1 
       
Total score 5/7 6/7 7/7 5/7 5/7 7/7 
Overall assessment 71% 86% 100% 71% 71% 100% 
Based on checklist from Ariens et al., 2000 and van der Windt et al., 2000.  
Yes = 1 point,  No or unclear = 0 points, Total score are ≥ 6 or ≥ 75% = high  uality study and < 6 or < 75% = low  uality study, n/a = not applicable. 
*more than 50 participants was a requirement for inclusion in the review. Studies with more than 100 participants were rewarded with an additional point.  
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Table 4 The quality assessment of cross-sectional studies included in the review 
 
Quality assessment criteria Bondevik et al. 
2001 
Hinderaker et al. 
2002 
Guerra-Shinohara 
et al. 2004 
Ma et al. 
2004 
Park et al. 
2004 
Schulpis et al. 
2004 
       
Study objective       
Clearly stated objective is described 1 1 1 1 1 1 
       
Study population       
Were valid selection criteria used for the study population? 1 1 1 1 1 1 
Did more than 80% of the eligible subjects participate in the study? 1 1 1 1 1 1 
       
Exposure assessment       
Was the exposure measured with a valid and reproducible method? n/a n/a n/a n/a n/a n/a 
       
Outcome assessment       
Was the outcome measured with a valid and reproducible method? 1 1 1 1 1 1 
Were only new and incident patients used? 1 1 1 1 1 0 
       
Analysis       
Were the results adjusted for possible confounders? 1 0 0 0 0 0 
Were more than 100 subjects included in the study* 1 1 1 1 0 1 
       
Total score 7/7 6/7 6/7 6/7 5/7 5/7 
Overall assessment 100% 86% 86% 86% 71% 71% 
Based on checklist from Ariens et al., 2000 and van der Windt et al., 2000. 
Yes = 1 point,  No or unclear = 0 points, Total score are ≥ 6 or ≥ 75% = high  uality study and < 6 or < 75% = low  uality study, n/a = not applicable. 
*more than 50 participants was a requirement for inclusion in the review. Studies with more than 100 participants were rewarded with an additional point.  
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Table 5 The quality assessment of cross-sectional studies included in the review 
 
Quality assessment criteria Garcia-Casal et al. 
2005 
Jiang et al. 
2005 
Koc et al 
2006 
Hall et al. 
2007 
Ipciglu et 
al. 2007 
Pathak et al. 
2007 
       
Study objective       
Clearly stated objective is described 1 1 1 1 1 1 
       
Study population       
Were valid selection criteria used for the study population? 1 1 1 0 1 1 
Did more than 80% of the eligible subjects participate in the study? 1 1 1 1 1 1 
       
Exposure assessment       
Was the exposure measured with a valid and reproducible method? n/a n/a n/a n/a n/a n/a 
       
Outcome assessment       
Was the outcome measured with a valid and reproducible method? 1 1 1 1 1 1 
Were only new and incident patients used? 0 1 1 0 1 1 
       
Analysis       
Were the results adjusted for possible confounders? 0 1 0 1 0 0 
Were more than 100 subjects included in the study* 1 1 1 1 0 1 
       
Total score 5/7 7/7 6/7 5/7 5/7 6/7 
Overall assessment 71% 100% 86% 71% 71% 86% 
Based on checklist from Ariens et al., 2000 and van der Windt et al., 2000. 
Yes = 1 point,  No or unclear = 0 points, Total score are ≥ 6 or ≥ 75% = high  uality study and < 6 or < 75% = low  uality study, n/a = not applicable. 
*more than 50 participants was a requirement for inclusion in the review. Studies with more than 100 participants were rewarded with an additional point.  
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Table 6 The quality assessment of cross-sectional studies included in the review 
 
Quality assessment criteria Vanderjagat et al. 
2007 
Barbosa et al. 
2008 
Gibson et al. 
2008 
Ray et al. 
2008 
Abdelrahim et al. 
2009 
Hussein et al. 
2009 
       
Study objective       
Clearly stated objective is described 1 1 1 1 1 1 
       
Study population       
Were valid selection criteria used for the study population? 1 1 1 1 0 1 
Did more than 80% of the eligible subjects participate in the study? 1 0 1 1 1 1 
       
Exposure assessment       
Was the exposure measured with a valid and reproducible method? n/a n/a n/a n/a n/a n/a 
       
Outcome assessment       
Was the outcome measured with a valid and reproducible method? 1 1 1 1 1 1 
Were only new and incident patients used? 1 1 1 0 1 1 
       
Analysis       
Were the results adjusted for possible confounders? 0 1 1 0 1 1 
Were more than 100 subjects included in the study* 1 1 0 1 1 0 
       
Total score 6/7 6/7 6/7 5/7 6/7 6/7 
Overall assessment 86% 86% 86% 71% 86% 86% 
Based on checklist from Ariens et al., 2000 and van der Windt et al., 2000. 
Yes = 1 point,  No or unclear = 0 points, Total score are ≥ 6 or ≥ 75% = high  uality study and < 6 or < 75% = low  uality study, n/a = not applicable. 
*more than 50 participants was a requirement for inclusion in the review. Studies with more than 100 participants were rewarded with an additional point.  
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Table 7 The quality assessment of cross-sectional studies included in the review 
 
Quality assessment criteria Krishnaveni et al. 
2009 
Vanderjagat et al. 
2009 
Veena et al. 
2010 
Goedhart et al. 
2011 
Lindstrom et al. 
2011 
Shield et al. 
2011 
       
Study objective       
Clearly stated objective is described 1 1 1 1 1 1 
       
Study population       
Were valid selection criteria used for the study population? 1 1 1 1 1 1 
Did more than 80% of the eligible subjects participate in the study? 1 1 1 1 1 1 
       
Exposure assessment       
Was the exposure measured with a valid and reproducible method? n/a n/a n/a n/a n/a n/a 
       
Outcome assessment       
Was the outcome measured with a valid and reproducible method? 1 1 1 1 1 1 
Were only new and incident patients used? 1 1 1 1 1 1 
       
Analysis       
Were the results adjusted for possible confounders? 1 0 1 1 1 0 
Were more than 100 subjects included in the study* 1 0 1 1 1 1 
       
Total score 7/7 5/7 7/7 7/7 7/7 6/7 
Overall assessment 100% 71% 86% 100% 100% 86% 
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Appendix V : The quality assessment of studies included in the systematic review (B) 
 
 
    Table 1 The quality assessment of studies included in the review 
 
Quality assessment criteria Whiteside et al. 
1968  
Knight et al. 
1991  
Tamura et al. 
1994  
Ackurt et al. 
1995   
Mathews et al 
2004  
Relton et al.  
2005  
Muthayya et al. 
2006  
1. Research question/ hypothesis clearly defined and stated? √ √ √ √ √ √ √ 
2. Is the targeted population defined? × √ √ √ √ √ √ 
3. Is the sampling frame defined? √ √ √ √ √ √ √ 
4. Is the study population defined? √ √ √ √ √ √ √ 
5. Are the study setting and/or geographic location stated? × √ √ √ √ √ √ 
6. Are the dates between which the study was conducted stated 
or implicit? 
× √ × √ √ √ √ 
7. Are eligibility criteria stated? √ √ × √ √ √ √ 
8. Are issue of “selection in” to the study mentioned? × √ × √ √ √ √ 
9. Is the no. of participants justified? × × × × √ × × 
10. Are no. meeting and not meeting the eligibility criteria 
stated? 
× × × √ √ × √ 
11. For those not eligible, are the reasons why stated? × × × √ √ √ √ 
12. Are the numbers of people who did/did not consent to 
participate stated? 
× √ × × √ × √ 
13. Are the reasons that people refused to consent stated? × × × × × × × 
14. Were consenters compared with non-consenters? × × × × × × × 
15. Was the number of participants at the beginning of the 
study stated? 
√ √ √ √ √ √ √ 
16. Were methods of data collection stated? √ √ √ √ √ √ √ 
17. Was the reliability (repeatability) of measurement methods 
mentioned? 
× √ × × 
√ 
× 
√ 
18. Was the validity (against a ‘gold standard’) of 
measurement methods mentioned? 
× × × × 
√ 
√ 
√ 
19. Were any confounders mentioned? × √ × √ √ √ √ 
Based on NICE guidance for public health 2009 which was adapted from the Tooth et al. 2005 checklist criteria. 
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Cont. Table 1 
Quality assessment criteria Whiteside et al. 
1968 
Knight et al. 
1991  
Tamura et al. 
1994  
Ackurt et al. 
1995   
Mathews et al 
2004  
Relton et al.  
2005   
Muthayya et al. 
2006 
20. Was the number of participants at each stage/wave 
specified? 
× √ n/a √ √ × × 
21. Were reasons for loss to follow-up quantified? × × n/a √ √ × √ 
22. Was the missingness of data items at each wave 
mentioned? 
× × n/a × √ × 
× 
23. Was the type of analyses conducted stated? √ √ √ √ √ √ √ 
24. Were “longitudinal” analysis methods stated? √ √ n/a √ √ √ √ 
25. Were absolute effect sizes reported? √ √ √ √ √ √ √ 
26. Were relative effect sizes reported? × × × × × × √ 
27. Was loss to follow up taken into account in the analysis? × × n/a × × × √ 
28. Were confounders accounted for the analyses? × × × √ √ √ √ 
29. Were missing data accounted for the analyses? × × n/a × × × × 
30. Was the impact of biases assessed qualitatively? × × × × √ × × 
31. Was the impact of biases estimated quantitatively? × × × × × × × 
32. Did authors relate results back to a target population? √ √ × √ √ √ √ 
33. Was there any other discussion of generalizability? × × × √ × × × 
 
Overall assessment  
 
 
 
 
 
 
 
 
 
Few criteria  
fulfilled- 
unfulfilled 
criteria are 
likely/very 
likely to alter the 
conclusions  
 
 
 
Some criteria 
fulfilled-
unfulfilled 
criteria 
unlikely to 
alter the 
conclusions 
  
 
 
Few criteria  
fulfilled- 
unfulfilled 
criteria are 
likely/very 
likely to alter 
the 
conclusions  
 
 
Some criteria 
fulfilled-
unfulfilled 
criteria 
unlikely to 
alter the 
conclusions 
 
 
 
Most criteria 
fulfilled-
unfulfilled 
criteria very 
unlikely to 
alter the 
conclusions 
 
 
 
Some criteria 
fulfilled-
unfulfilled 
criteria 
unlikely to 
alter the 
conclusions 
 
 
 
Most criteria 
fulfilled-
unfulfilled 
criteria very 
unlikely to alter 
the conclusions 
(n/a) was indicating, when the question was not applicable to the study design 
  
2
1
1
 
 
     
 
 
Table 2 The quality assessment of the studies included in the review 
 
Quality assessment criteria Mamabolo  et al. 
2006   
Takimoto et al. 
2007  
Yajnik et al. 
 2008  
Hogeveen et al. 
2010  
Hay et al. 
2010   
Veena et al. 
2010  
Takimoto et al. 
2011  
1. Research question/ hypothesis clearly defined and stated? √ √ √ √ √ √ √ 
2. Is the targeted population defined? √ √ √ √ √ √ √ 
3. Is the sampling frame defined? √ √ × √ × √  √ 
4. Is the study population defined? √ √ √ √ √ √ √ 
5. Are the study setting and/or geographic location stated? √ √ √ √ √ √ √ 
6. Are the dates between which the study was conducted 
stated or implicit? 
√ √ √ √ √ √ √ 
7. Are eligibility criteria stated? √ √ √ √ √ √ √ 
8. Are issue of “selection in” to the study mentioned? √ √ √ √ √ √ √ 
9. Is the no. of participants justified? × × × × × × × 
10. Are no. meeting and not meeting the eligibility criteria 
stated? 
√ √ √ √ × √ √ 
11. For those not eligible, are the reasons why stated? √ √ √ √ × √ √ 
12. Are the numbers of people who did/did not consent to 
participate stated? 
√ √ √ × √ × √ 
13. Are the reasons that people refused to consent stated? × × × × × × × 
14. Were consenters compared with nonconsenters? × × × × × × × 
15. Was the number of participants at the beginning of the 
study stated? 
√ √ √ √ √ √ √ 
16. Were methods of data collection stated? √ √ √ √ √ √ √ 
17. Was the reliability (repeatability) of measurement 
methods mentioned? 
× × × 
√ 
× 
√ 
× 
18. Was the validity (against a ‘gold standard’) of 
measurement methods mentioned? 
× √ × 
√ 
√ 
√ 
× 
19. Were any confounders mentioned? √ √ √ √ √ √ √ 
Based on NICE guidance for public health 2009 which was adapted from the Tooth et al. 2005 checklist criteria. 
 
  
2
1
2
 
 
 
 
 
 
Cont. Table 2 
 
Quality assessment criteria Mamabolo  et al. 
2006   
Takimoto et al. 
2007  
Yajnik et al. 
 2008  
Hogeveen et al. 
2010 
Hay et al. 
2009   
Veena et al. 
2010  
Takimoto et al. 
2011 
20. Was the number of participants at each stage/wave 
specified? 
√ √ √ √ √ √ √ 
21. Were reasons for loss to follow-up quantified? n/a  √ √  n/a × √ × 
22. Was the missingness of data items at each wave 
mentioned? 
n/a  √ × n/a × √ × 
23. Was the type of analyses conducted stated? √ √ √  √ √ √ √ 
24. Were “longitudinal” analysis methods stated? √ √  √ √ √ √ √ 
25. Were absolute effect sizes reported? √ √ √ √ √ √ √ 
26. Were relative effect sizes reported? × √  × × × × × 
27. Was loss to follow up taken into account in the 
analysis? 
n/a  × × n/a × × × 
28. Were confounders accounted for the analyses? √ √  √ √ √ √ √ 
29. Were missing data accounted for the analyses? n/a  × √ n/a × × × 
30. Was the impact of biases assessed qualitatively? × √ √ √ √ √ √ 
31. Was the impact of biases estimated quantitatively? × × × × × × × 
32. Did authors relate results back to a target population? √ √ √ √ √ √ √ 
33. Was there any other discussion of generalizability? × × √ × × × × 
Overall assessment  Some criteria 
fulfilled-
unfulfilled 
criteria unlikely 
to alter the 
conclusions 
 
 
Most criteria 
fulfilled-
unfulfilled 
criteria very 
unlikely to alter 
the conclusions 
 
 
Most criteria 
fulfilled-
unfulfilled 
criteria very 
unlikely to 
alter the 
conclusions 
 
Most criteria 
fulfilled-
unfulfilled 
criteria very 
unlikely to alter 
the conclusions 
 
 
Some criteria 
fulfilled-
unfulfilled 
criteria very 
unlikely to 
alter the 
conclusions 
 
Most criteria 
fulfilled-
unfulfilled 
criteria very 
unlikely to 
alter the 
conclusions 
 
Some criteria 
fulfilled-
unfulfilled 
criteria very 
unlikely to alter 
the conclusions 
 
 
(n/a) was indicating, when the question was not applicable i.e. no loss to follow up nor missing data in the study.   
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Appendix VI 
Vitamin B12 insufficiency in pregnancy 
Data collection form 2010 
MOTHER  
 
BABY 
Delivery Date  Sex  
Gestation  Length   
Mode of 
delivery 
Normal vaginal 
delivery / assisted / C-
section 
Weight (kg / 
percentile) 
 
Gravida / Para  Head 
Circumference  
 
Pre-pregnancy 
BMI  
 Congenital 
abnormalities 
 
Pre-eclampsia Yes / No Shoulder 
dystocia  
Yes /No 
GDM Yes / No Neonatal 
hypoglycaemia 
Yes / No 
Other Obstetric 
History 
 
Past medical 
history 
 
 
 
 
 
Smoking Yes / No 
Ex-smoker  Yes / No APGAR scores: 
Alcohol  Yes / No 1 minute  
5 minutes  
Family History   Other 
information 
(infection / 
jaundice etc.) 
 
Drugs  SCBU Yes / No 
 
BIOCHEMISTRY 
 First 
result / 
level 
Weeks’ 
gestation 
of first 
result 
Deficient 
(Yes/No) 
Supplementation 
(Yes/No) 
Repeat 
result / 
level 
Weeks’ 
gestation 
of repeat 
result 
Vit B12       
Folate       
 
 
Banda label here 
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Appendix VII : The food that has been added to the modified DIETQ SFFQ – used in 
the Pilot study. 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
Table shows the list of food that has been added to the modified DIETQ SFFQ 
 
Rice: Kabsa, biryani, bukhari Arabic sweets 
Qursan, Marqook, Mataziz Laban 
Jareesh Dates 
Saleeq Foul (broad beans) 
Harees Falafel 
Marasssea Bread such as tames 
Mehala Muttabeq 
Henini  
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